0001047469-15-006435.txt : 20150730 0001047469-15-006435.hdr.sgml : 20150730 20150730124552 ACCESSION NUMBER: 0001047469-15-006435 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 10 CONFORMED PERIOD OF REPORT: 20150630 FILED AS OF DATE: 20150730 DATE AS OF CHANGE: 20150730 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NUTRACEUTICAL INTERNATIONAL CORP CENTRAL INDEX KEY: 0001050007 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 870515089 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-23731 FILM NUMBER: 151015295 BUSINESS ADDRESS: STREET 1: 1400 KEARNS BOULEVARD STREET 2: 2ND FLOOR CITY: PARK CITY STATE: UT ZIP: 84060 BUSINESS PHONE: 4356556000 MAIL ADDRESS: STREET 1: 1400 KEARNS BOULEVARD STREET 2: 2ND FLOOR CITY: PARK CITY STATE: UT ZIP: 84060 10-Q 1 a2225470z10-q.htm 10-Q

Use these links to rapidly review the document
TABLE OF CONTENTS

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549

FORM 10-Q

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

for the Quarterly Period Ended June 30, 2015

Commission file number 000-23731

NUTRACEUTICAL INTERNATIONAL CORPORATION
(Exact name of registrant as specified in its charter)


Delaware (State of incorporation)		87-0515089 (IRS Employer Identification No.)
1400 Kearns Boulevard, 2^nd Floor, Park City, Utah (Address of principal executive offices)		84060 (Zip code)

(435) 655-6106
(Registrant's telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. YES ý NO o

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). YES ý NO o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act:


Large accelerated filer o		Accelerated filer ý		Non-accelerated filer o (Do not check if a smaller reporting company)		Smaller reporting company o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). YES o NO ý

At July 27, 2015, the registrant had 9,532,469 shares of common stock outstanding.

Table of Contents

NUTRACEUTICAL INTERNATIONAL CORPORATION

INDEX

Description

Part I.	Financial Information		3
	Item 1.	Financial Statements (unaudited)	3
		Condensed Consolidated Balance Sheets—June 30, 2015 and September 30, 2014	3
		Condensed Consolidated Statements of Comprehensive Income—Three Months and Nine Months Ended June 30, 2015 and 2014	4
		Condensed Consolidated Statements of Cash Flows—Nine Months Ended June 30, 2015 and 2014	5
		Notes to Condensed Consolidated Financial Statements	6
	Item 2.	Management's Discussion and Analysis of Financial Condition and Results of Operations	14
	Item 3.	Quantitative and Qualitative Disclosures About Market Risk	22
	Item 4.	Controls and Procedures	22
Part II.	Other Information		23
	Item 1.	Legal Proceedings	23
	Item 1A.	Risk Factors	23
	Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	23
	Item 6.	Exhibits	24

Table of Contents

PART I—FINANCIAL INFORMATION

Item 1. Financial Statements

NUTRACEUTICAL INTERNATIONAL CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS

(unaudited)

(dollars in thousands)

	June 30, 2015			September 30, 2014(1)

ASSETS
Current assets:
Cash	$	4,902		$	6,232
Accounts receivable, net		14,186			15,118
Inventories		59,318			57,914
Prepaid expenses and other current assets		2,774			3,364
Deferred income taxes		1,245			1,222

Total current assets		82,425			83,850
Property, plant and equipment, net		78,350			79,244
Goodwill		24,384			23,622
Intangible assets, net		20,108			21,965
Other non-current assets		1,692			1,203
Deferred income taxes, net		3,946			4,894

Total assets	$	210,905		$	214,778

LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable	$	14,218		$	14,874
Accrued expenses		5,852			6,835

Total current liabilities		20,070			21,709
Long-term debt		32,000			43,000
Other non-current liabilities		171			456

Total liabilities		52,241			65,165

Stockholders' equity:
Common stock		96			97
Additional paid-in capital		8,488			11,112
Retained earnings		150,244			138,347
Accumulated other comprehensive income		(139	)		79
Treasury stock		(25	)		(22	)

Total stockholders' equity		158,664			149,613

Total liabilities and stockholders' equity	$	210,905		$	214,778

(1): The condensed consolidated balance sheet as of September 30, 2014 has been prepared using information from the audited financial statements at that date.

The accompanying notes are an integral part of these condensed consolidated financial statements.

Table of Contents

NUTRACEUTICAL INTERNATIONAL CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(unaudited)

(dollars in thousands, except per share data)

	Three months ended June 30,				Nine months ended June 30,

	2015		2014		2015			2014
Net sales	$	54,382	$	55,625	$	162,830		$	162,034
Cost of sales		27,955		28,473		83,293			81,660

Gross profit		26,427		27,152		79,537			80,374
Operating expenses
Selling, general and administrative		19,061		19,762		58,404			57,625
Amortization of intangible assets		729		704		2,189			1,940

Income from operations		6,637		6,686		18,944			20,809
Interest and other expense, net		257		356		827			1,024

Income before provision for income taxes		6,380		6,330		18,117			19,785
Provision for income taxes		1,930		2,333		6,220			7,329

Net income	$	4,450	$	3,997	$	11,897		$	12,456
Other comprehensive income (loss)
Foreign currency translation adjustment, net of tax		112		1		(218	)		49

Comprehensive income	$	4,562	$	3,998	$	11,679		$	12,505

Net income per common share
Basic	$	0.47	$	0.41	$	1.24		$	1.27
Diluted		0.47		0.41		1.24			1.27
Weighted average common shares outstanding
Basic		9,561,008		9,798,393		9,612,171			9,826,516
Dilutive effect of stock options		2,991		8,400		4,920			9,150

Diluted		9,563,999		9,806,793		9,617,091			9,835,666

The accompanying notes are an integral part of these condensed consolidated financial statements.

Table of Contents

NUTRACEUTICAL INTERNATIONAL CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(unaudited)

(dollars in thousands)

	Nine months ended June 30,

	2015			2014
Cash flows from operating activities:
Net income	$	11,897		$	12,456
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		9,702			8,357
Amortization of deferred financing fees		99			138
Losses on disposals of property, plant and equipment		9			2
Tax benefit from stock option exercises		(55	)		(51	)
Deferred income taxes, net		925			289
Changes in assets and liabilities, net of effects of acquisitions:
Accounts receivable, net		964			(377	)
Inventories		(1,340	)		(4,601	)
Prepaid expenses and other current assets		605			(484	)
Other non-current assets		(107	)		(114	)
Accounts payable		(761	)		(197	)
Accrued expenses		(774	)		705
Other non-current liabilities		19			2

Net cash provided by operating activities		21,183			16,125

Cash flows from investing activities:
Acquisitions of businesses		(1,266	)		(16,211	)
Purchases of property, plant and equipment		(6,523	)		(8,577	)

Net cash used in investing activities		(7,789	)		(24,788	)

Cash flows from financing activities:
Proceeds from debt		2,500			19,500
Payments on debt		(13,500	)		(10,500	)
Payments of deferred financing fees		(420	)		—
Proceeds from issuances of common stock		432			193
Purchases of common stock for treasury		(3,618	)		(3,798	)
Tax benefit from stock option exercises		55			51

Net cash provided by (used in) financing activities		(14,551	)		5,446

Effect of exchange rate changes on cash		(173	)		33

Net decrease in cash		(1,330	)		(3,184	)
Cash at beginning of period		6,232			8,235

Cash at end of period	$	4,902		$	5,051

The accompanying notes are an integral part of these condensed consolidated financial statements.

Table of Contents

NUTRACEUTICAL INTERNATIONAL CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

(dollars in thousands, except per share data)

1. BASIS OF PRESENTATION

Nutraceutical International Corporation and its subsidiaries (the "Company") is an integrated manufacturer, marketer, distributor and retailer of branded nutritional supplements and other natural products sold primarily to and through domestic health and natural food stores. Internationally, the Company markets and distributes branded nutritional supplements and other natural products to and through health and natural product distributors and retailers. The Company's core business strategy is to acquire, integrate and operate businesses in the natural products industry that manufacture, market and distribute branded nutritional supplements. The Company believes that the consolidation and integration of these acquired businesses provide ongoing financial synergies through increased scale and market penetration, as well as strengthened customer relationships.

The Company manufactures and sells nutritional supplements and other natural products under numerous brands, including Solaray®, KAL®, Nature's Life®, LifeTime®, Natural Balance®, NaturalCare®, Health from the Sun®, Pioneer®, Nutra BioGenesis™, Life-flo®, Organix South®, Heritage Store® and Monarch Nutraceuticals™.

The Company owns neighborhood natural food markets, which operate under the trade names The Real Food Company™, Thom's Natural Foods™, Cornucopia Community Market™ and Granola's™. The Company also owns health food stores, which operate under various trade names, including Fresh Vitamins™ and Peachtree Natural Foods®.

In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all necessary adjustments, consisting of normal recurring adjustments, to state fairly the consolidated financial position of the Company as of June 30, 2015, the results of its operations for the three and nine months ended June 30, 2015 and 2014 and its cash flows for the nine months ended June 30, 2015 and 2014, in conformity with accounting principles generally accepted in the United States of America ("US GAAP") for interim financial information applied on a consistent basis. Results for the three and nine months ended June 30, 2015 are not necessarily indicative of the results to be expected for the full fiscal year.

Certain information and footnote disclosures normally included in the annual financial statements prepared in accordance with US GAAP have been omitted. Accordingly, these financial statements should be read in conjunction with the Company's Form 10-K for the fiscal year ended September 30, 2014, which was filed with the Securities and Exchange Commission on November 20, 2014.

Use of Estimates

The preparation of these financial statements in conformity with US GAAP required management to make estimates and assumptions that affected the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of net sales and expenses during the reported periods. Significant estimates included values and lives assigned to acquired intangible assets, reserves for customer returns and allowances, uncollectible accounts receivable, valuation adjustments for slow-moving, obsolete and/or damaged inventory and valuation and recoverability of long-lived assets. Actual results may differ from these estimates.

Table of Contents

NUTRACEUTICAL INTERNATIONAL CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(unaudited)

(dollars in thousands, except per share data)

1. BASIS OF PRESENTATION (Continued)

New Accounting Standards

In May 2014, the Financial Accounting Standards Board ("FASB") issued authoritative guidance, which is included in Accounting Standards Codification ("ASC") 606, "Revenue from Contracts with Customers." This guidance provides a single, comprehensive revenue recognition model for all contracts with customers and requires that a company recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. In July 2015, the FASB delayed the effective date of this guidance by one year. As a result, this guidance is effective for the Company as of October 1, 2018 and shall be applied either retrospectively to each period presented or as a cumulative-effect adjustment as of the date of adoption. The Company is currently evaluating the impact this standard may have on its consolidated financial statements.

The Company periodically reviews new accounting standards that are issued. Although some of these accounting standards may be applicable to the Company, the Company has not identified any other new standards that it believes merit further discussion, and the Company expects that none would have a significant impact on its consolidated financial statements.

2. ACCOUNTS RECEIVABLE

Accounts receivable, net of allowances for sales returns and doubtful accounts, consisted of the following:

	June 30, 2015			September 30, 2014

Accounts receivable	$	15,259		$	16,352
Less allowances		(1,073	)		(1,234	)

	$	14,186		$	15,118

3. INVENTORIES

Inventories were comprised of the following:

	June 30, 2015		September 30, 2014

Raw materials	$	22,485	$	20,559
Work-in-process		8,668		6,909
Finished goods		28,165		30,446

	$	59,318	$	57,914

Table of Contents

NUTRACEUTICAL INTERNATIONAL CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(unaudited)

(dollars in thousands, except per share data)

4. ACQUISITIONS

During the nine months ended June 30, 2015, the Company made two acquisitions of businesses. On November 18, 2014, the Company acquired certain operating assets of Agape Health Products. On June 4, 2015, the Company acquired certain operating assets of ProClay, LLC. The aggregate purchase price of these acquisitions was $1,266 in cash.

During the nine months ended June 30, 2014, the Company made six acquisitions of businesses. On October 16, 2013, the Company acquired certain operating assets of TCCD International, Inc. On November 25, 2013, the Company acquired certain operating assets of Green Luxury Brands, Inc. On December 19, 2013, the Company acquired certain operating assets of Twinlab Corporation. On January 15, 2014, the Company acquired certain operating assets of Peachtree Natural Foods, Inc. On April 11, 2014, the Company acquired certain operating assets of Northwest Health Foods, Inc. On April 17, 2014, the Company acquired certain operating assets of Bio-Genesis Nutraceuticals, Inc. The aggregate purchase price of these acquisitions was $16,211 in cash.

The Condensed Consolidated Statements of Comprehensive Income and the Condensed Consolidated Statements of Cash Flows presented herein include the activities of these acquired businesses from their respective dates of acquisition. The expected long-term sales and expense synergies of acquired businesses generally are not realized immediately following acquisition, as certain transition and integration matters must be completed.

These acquisitions are in keeping with the Company's business strategy of consolidating the fragmented industry in which it competes. These acquisitions were accounted for using the acquisition method of accounting. Accordingly, the aggregate purchase price was assigned to the assets acquired based on their fair values at their respective dates of acquisition. The excess of aggregate purchase price over the fair values of the assets acquired was classified as goodwill. The goodwill relates to expected synergies from these acquisitions. The following reflects the final allocation of the aggregate purchase price for these acquisitions to the aggregate assets acquired:

	Fiscal 2015 Acquisitions		Fiscal 2014 Acquisitions

Aggregate assets acquired:
Current assets	$	111	$	2,733
Goodwill		762		7,675
Intangible assets		393		5,803

	$	1,266	$	16,211

The fiscal 2015 and fiscal 2014 acquired intangible assets totaling $393 and $5,803, respectively, related to trademarks, tradenames and customer relationships, and are being amortized over periods of two to twelve years for financial statement purposes. The fiscal 2015 and fiscal 2014 acquired intangible assets are expected to be deductible for tax purposes over fifteen years. Goodwill, which is not subject to amortization for financial statement purposes, of $762 for fiscal 2015 and $7,675 for fiscal 2014, is expected to be deductible for tax purposes over fifteen years.

Table of Contents

NUTRACEUTICAL INTERNATIONAL CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(unaudited)

(dollars in thousands, except per share data)

5. GOODWILL AND INTANGIBLE ASSETS

The change in the carrying amount of goodwill from September 30, 2014 to June 30, 2015 was as follows:

	Goodwill		Accumulated Impairment			Net

Balance as of October 1, 2014	$	64,016	$	(40,394	)	$	23,622
Goodwill attributable to fiscal 2015 acquisition		762		—			762

Balance as of June 30, 2015		64,778		(40,394	)		24,384

The carrying amounts of intangible assets at June 30, 2015 and September 30, 2014 were as follows:

	June 30, 2015							September 30, 2014

	Gross Carrying Amount(1)		Accumulated Amortization(1)			Net Carrying Amount		Gross Carrying Amount(1)		Accumulated Amortization(1)			Net Carrying Amount		Weighted- Average Amortization Period (Years)
Intangible assets subject to amortization:
Trademarks/tradenames/patents	$	5,530	$	(1,842	)	$	3,688	$	5,418	$	(1,480	)	$	3,938		11
Customer relationships/distribution rights/ non-compete agreements		16,837		(9,217	)		7,620		16,517		(7,390	)		9,127		7
Developed software and technology		772		(772	)		—		772		(772	)		—		5

		23,139		(11,831	)		11,308		22,707		(9,642	)		13,065
Intangible assets not subject to amortization:
Trademarks/tradenames/licenses		8,800		—			8,800		8,900		—			8,900

	$	31,939	$	(11,831	)	$	20,108	$	31,607	$	(9,642	)	$	21,965

(1): Amounts include the impact of foreign currency translation adjustments.

Table of Contents

NUTRACEUTICAL INTERNATIONAL CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(unaudited)

(dollars in thousands, except per share data)

5. GOODWILL AND INTANGIBLE ASSETS (Continued)

Estimated future amortization expense related to the June 30, 2015 net carrying amount of $11,308 for intangible assets subject to amortization is as follows:

Year Ending September 30,	Estimated Amortization Expense

2015(1)	$	679
2016		2,227
2017		1,852
2018		1,662
2019		1,235
Thereafter		3,653

	$	11,308

(1): Estimated amortization expense for the year ending September 30, 2015 includes only amortization to be recorded after June 30, 2015.

General and economic conditions may continue to impact retail and consumer demand, as well as the market price of the Company's common stock, and could negatively impact the Company's future operating performance, cash flow and/or stock price and could result in additional goodwill and/or intangible asset impairment charges being recorded in future periods. Also, the Company periodically reviews its brands to achieve marketing, sales and operational synergies. These reviews could result in brands being consolidated or discontinued and could result in intangible asset impairment charges being recorded in future periods. Such goodwill and/or intangible asset impairment charges could materially impact the Company's consolidated financial statements. The valuation of goodwill and intangible assets is subject to a high degree of judgment, uncertainty and complexity.

6. DEBT

Debt was comprised of the following:

	June 30, 2015		September 30, 2014

Long-term debt—revolving credit facility	$	32,000	$	43,000

The carrying value of the Company's debt approximates fair value at June 30, 2015 and September 30, 2014. Estimated fair values for debt have been determined based on borrowing rates currently available to the Company for bank loans with similar terms and maturities and are classified as Level 2 (significant observable inputs other than quoted prices) in the FASB's fair value hierarchy.

On November 4, 2014, the Company amended its revolving credit facility (the "Credit Agreement"). The Credit Agreement extends the term of the credit facility to November 2019, increases the available credit borrowings to $100,000 with no automatic reductions and provides an accordion feature that can increase the available credit borrowings to $130,000, subject to approval by

Table of Contents

NUTRACEUTICAL INTERNATIONAL CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(unaudited)

(dollars in thousands, except per share data)

6. DEBT (Continued)

the lenders and compliance with certain covenants and conditions. The lenders under the Credit Agreement continue to be Rabobank International and Wells Fargo. To date, the Company has not experienced any difficulties in accessing the available funds under the Credit Agreement. Deferred financing fees of $420 related to the Credit Agreement are being amortized over the term of the Credit Agreement.

At June 30, 2015, the Company had outstanding revolving credit borrowings of $32,000 under the Credit Agreement. Borrowings under the Credit Agreement are collateralized by substantially all assets of the Company. At the Company's election, borrowings bear interest at the applicable Eurodollar Rate plus a variable margin or at a Base Rate plus a variable margin. Base Rate is the higher of: (i) the Prime Lending Rate, (ii) the Federal Funds Rate plus 0.5% or (iii) the one-month Eurodollar Rate multiplied by the Statutory Reserve Rate plus 1.0% (capitalized terms are defined in the Credit Agreement, a copy of which was filed with the Securities and Exchange Commission on November 5, 2014). At June 30, 2015, the applicable weighted-average interest rate for outstanding borrowings was 1.78%. The Company is also required to pay a variable quarterly fee on the unused balance under the Credit Agreement. At June 30, 2015, the applicable rate was 0.25%. Accrued interest on Eurodollar Rate borrowings is payable based on elected intervals of one, two or three months. Accrued interest on Base Rate borrowings is payable quarterly. The Credit Agreement matures on November 4, 2019, and the Company is required to repay all principal and interest outstanding under the Credit Agreement on such date.

The Credit Agreement contains restrictive covenants, including limitations on incurring other indebtedness and requirements that the Company maintain certain financial ratios. As of June 30, 2015, the Company was in compliance with the restrictive covenants. Upon the occurrence of a default, the lender has various remedies or rights, which may include proceeding against the collateral or requiring the Company to repay all amounts outstanding under the Credit Agreement.

7. SHARE PURCHASES

During the three and nine months ended June 30, 2015, the Company purchased 63,276 and 180,301 shares of common stock for an aggregate price of $1,266 and $3,618, respectively. During the three and nine months ended June 30, 2014, the Company purchased 99,541 and 156,661 shares of common stock for an aggregate price of $2,368 and $3,798, respectively. All of these shares of common stock held in treasury were retired prior to June 30 in the respective quarter of purchase, except at June 30, 2015 and 2014, the Company held 1,000 and 9,673 shares of common stock in treasury, respectively. As of June 30, 2015, the Company was permitted to purchase up to 551,723 additional shares under its approved purchase plan, with no expiration date or restrictions. The Company accounts for treasury shares using the cost method.

Table of Contents

NUTRACEUTICAL INTERNATIONAL CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(unaudited)

(dollars in thousands, except per share data)

8. STOCK OPTIONS AND OTHER EQUITY AWARDS

The following table summarizes stock option activity during the nine months ended June 30, 2015:

			Weighted-Average Exercise Price

Options outstanding and exercisable at September 30, 2014	32,500		$	14.22
Exercised	(25,000	)		14.22

Options outstanding and exercisable at June 30, 2015	7,500			14.22

All stock options outstanding at June 30, 2015 expire on September 30, 2015.

No options to purchase shares of common stock for the three and nine months ended June 30, 2015 and 2014 were excluded from the computation of diluted earnings per share because none of the stock options were anti-dilutive.

During the nine months ended June 30, 2015, the Company received proceeds of $356 related to the exercise of stock options. During this same period, the Company recorded a tax benefit of $55 and optionees realized an aggregate pre-tax gain of $141 from these stock option exercises. During the nine months ended June 30, 2014, the Company received proceeds of $115 related to the exercise of stock options. During this same period, the Company recorded a tax benefit of $51 and optionees realized an aggregate pre-tax gain of $133 from these stock option exercises.

On January 28, 2013, stockholders approved the Nutraceutical International Corporation 2013 Long-Term Equity Incentive Plan (the "2013 Plan") and the reservation of 800,000 shares of the Company's common stock for issuance under the 2013 Plan. Equity awards available under the 2013 Plan include stock options, stock appreciation rights and stock awards. In conjunction with the Company's fiscal 2014 and fiscal 2013 incentive compensation (bonus) payments, 24,827 and 31,788 shares of the Company's common stock were issued, respectively. These non-cash stock awards were granted on December 11, 2014 and December 11, 2013 at an aggregate fair value of $504 and $775, respectively, with fair value being determined by the closing price of the Company's common stock on the grant date. These stock awards were registered, unrestricted and fully vested on the grant date. As of June 30, 2015, 743,385 shares of the Company's common stock were available for issuance under the 2013 Plan.

9. SEGMENTS

Segment identification and selection is consistent with the management structure used by the Company's chief operating decision maker to evaluate performance and make decisions regarding resource allocation, as well as the materiality of financial results consistent with that structure. Based on the Company's management structure and method of internal reporting, the Company has one operating segment. The Company's chief operating decision maker does not review operating results on a disaggregated basis; rather, the chief operating decision maker reviews operating results on an aggregate basis.

Table of Contents

NUTRACEUTICAL INTERNATIONAL CORPORATION

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

(unaudited)

(dollars in thousands, except per share data)

9. SEGMENTS (Continued)

Net sales attributed to customers in the United States and foreign countries for the three and nine months ended June 30, 2015 and 2014 were as follows:

	Three months ended June 30,				Nine months ended June 30,

	2015		2014		2015		2014
United States	$	47,671	$	47,804	$	143,203	$	140,089
Foreign countries		6,711		7,821		19,627		21,945

	$	54,382	$	55,625	$	162,830	$	162,034

Certain net sales attributed to customers in the United States are sold to customers who in turn may sell such products to customers in foreign countries, while certain net sales attributed to customers in foreign countries are sold to customers who in turn may sell such products to customers in the United States.

The Company's net sales by product group for the three and nine months ended June 30, 2015 and 2014 were as follows:

	Three months ended June 30,				Nine months ended June 30,

	2015		2014		2015		2014
Branded nutritional supplements and other natural products	$	49,258	$	50,161	$	147,018	$	146,636
Other(1)		5,124		5,464		15,812		15,398

	$	54,382	$	55,625	$	162,830	$	162,034

(1): Net sales for any other product or group of similar products are less than 10% of consolidated net sales.

Table of Contents

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

General

The following discussion and analysis should be read in conjunction with the other sections of this report on Form 10-Q, including Part I, Item 1.

We are an integrated manufacturer, marketer, distributor and retailer of branded nutritional supplements and other natural products sold primarily to and through domestic health and natural food stores. Internationally, we market and distribute branded nutritional supplements and other natural products to and through health and natural product distributors and retailers. Our core business strategy is to acquire, integrate and operate businesses in the natural products industry that manufacture, market and distribute branded nutritional supplements. We believe that the consolidation and integration of these acquired businesses provide ongoing financial synergies through increased scale and market penetration, as well as strengthened customer relationships.

We manufacture and sell nutritional supplements and other natural products under numerous brands, including Solaray®, KAL®, Nature's Life®, LifeTime®, Natural Balance®, NaturalCare®, Health from the Sun®, Pioneer®, Nutra BioGenesis™, Life-flo®, Organix South®, Heritage Store® and Monarch Nutraceuticals™.

We own neighborhood natural food markets, which operate under the trade names The Real Food Company™, Thom's Natural Foods™, Cornucopia Community Market™ and Granola's™. We also own health food stores, which operate under various trade names, including Fresh Vitamins™ and Peachtree Natural Foods®.

We were formed in 1993 to effect a consolidation strategy in the fragmented vitamin, mineral, herbal and other nutritional supplements industry (the "VMS Industry"). Since our formation, we have completed numerous acquisitions of businesses in the VMS Industry. As a result of acquisitions, internal growth and cost management, we believe that we are well positioned to continue to capitalize on acquisition opportunities that arise in the VMS Industry.

Critical Accounting Policies

The preparation of our financial statements in conformity with accounting principles generally accepted in the United States of America required us to make estimates and assumptions that affected the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of net sales and expenses during the reported periods. Significant estimates included values and lives assigned to acquired intangible assets, reserves for customer returns and allowances, uncollectible accounts receivable, valuation adjustments for slow-moving, obsolete and/or damaged inventory and valuation and recoverability of long-lived assets. Actual results may differ from these estimates. Our critical accounting policies include the following:

Accounts Receivable—Provision is made for estimated bad debts based on periodic analysis of individual customer balances, including an evaluation of days sales outstanding, payment history, recent payment trends and perceived creditworthiness. If general economic conditions and/or customer financial conditions were to change, additional provisions for bad debts may be required, which could have a material impact on the consolidated financial statements.

Inventories—Valuation adjustments are made for slow-moving, obsolete and/or damaged inventory based on a periodic analysis of individual inventory items, including an evaluation of historical usage and/or movement, age, expiration date and general condition. If market demand and/or consumer preferences are less favorable than historical trends or future expectations, additional valuation

Table of Contents

adjustments for slow-moving, obsolete and/or damaged inventory may be required, which could have a material impact on the consolidated financial statements.

Property, Plant and Equipment—Depreciation and amortization expense is impacted by our judgments regarding the estimated useful lives of assets placed in service. If the estimated lives of assets are significantly less than expected, depreciation and amortization expense would be accelerated, which could have a material impact on the consolidated financial statements.

We evaluate the recoverability of property, plant and equipment whenever events or circumstances indicate that the carrying amount of an asset group may not be recoverable. We measure recoverability of an asset group by comparison of its carrying amount to the future undiscounted cash flows the asset group is expected to generate. If an asset group is considered to be impaired, the difference between the carrying amount and the fair value of the impaired asset group is recognized as an impairment charge.

Goodwill and Intangible Assets—Goodwill and intangible assets require estimates and judgments in determining the initial recognition and measurement, including factors and assumptions used in determining fair values and useful lives. Intangible assets with finite useful lives are amortized, while intangible assets with indefinite useful lives are not amortized. Amortizable intangible assets are reviewed for impairment when events or changes in circumstances indicate the carrying value may not be recoverable. Goodwill and indefinite-lived intangible assets are tested annually for impairment and when events or changes in circumstances indicate the carrying value may not be recoverable. The appropriateness of the indefinite-life classification of non-amortizable intangible assets is also reviewed as part of the annual testing or when circumstances warrant a change to a finite life. We perform our annual impairment testing as of September 30 each year, which is the last day of our fiscal year.

A two-step process is used to test for goodwill impairment. The first step is to determine if there is an indication of impairment by comparing the estimated fair value of each reporting unit to its carrying value, including existing goodwill. Reporting unit fair values are estimated using market data as well as other factors. Goodwill is considered impaired if the carrying value of a reporting unit exceeds the estimated fair value. Upon an indication of impairment, a second step is performed to measure the amount of the impairment by comparing the implied fair value of the reporting unit's goodwill with its carrying value.

Intangible assets with indefinite useful lives are tested for impairment at the individual tradename level by comparing the fair value of the indefinite-lived intangible asset to its carrying amount. If the carrying amount of an indefinite-lived intangible asset exceeds its fair value, an impairment charge is recognized. Fair values of indefinite-lived intangible assets are estimated using discounted cash flow models.

Amortizable intangible assets are reviewed for recoverability by comparing an asset group's carrying amount to the future undiscounted cash flows the asset group is expected to generate. If an asset group is considered to be impaired, the difference between the carrying amount and the fair value of the impaired asset group is recorded.

General and economic conditions may continue to impact retail and consumer demand, as well as the market price of our common stock, and could negatively impact our future operating performance, cash flow and/or stock price and could result in additional goodwill and/or intangible asset impairment charges being recorded in future periods. Also, we periodically review our brands to achieve marketing, sales and operational synergies. These reviews could result in additional brands being consolidated or discontinued and could result in additional intangible asset impairment charges being recorded in future periods. Such goodwill and/or intangible asset impairment charges could materially impact our consolidated financial statements. The valuation of goodwill and intangible assets is subject to a high degree of judgment, uncertainty and complexity.

Table of Contents

Revenue Recognition—Revenue is recognized when the following criteria are met: (1) persuasive evidence of an arrangement exists; (2) the product has been shipped and the customer takes ownership and assumes the risk of loss; (3) the selling price is fixed or determinable; and (4) collection of the resulting receivable is reasonably assured. We believe that these criteria are satisfied upon shipment from our facilities or, in the case of our neighborhood natural food markets and health food stores, at the point of sale within these stores. Revenue is reduced by provisions for estimated customer returns and allowances, which are based on historical averages that have not varied significantly for the periods presented, as well as specific known claims, if any. No other significant deductions from revenue must be estimated at the point in time that revenue is recognized.

Our estimates and judgments related to our critical accounting policies, including factors and assumptions considered in making these estimates and judgments, did not vary significantly for the periods presented and had no material impact on the consolidated financial statements as reported.

New Accounting Standards

See Note 1 to the Condensed Consolidated Financial Statements for information regarding new accounting standards.

Results of Operations

The following table sets forth certain Consolidated Statements of Comprehensive Income data as a percentage of net sales for the periods indicated:

	Three Months Ended June 30,						Nine Months Ended June 30,

	2015			2014			2015			2014
Net sales		100.0	%		100.0	%		100.0	%		100.0	%
Cost of sales		51.4	%		51.2	%		51.2	%		50.4	%

Gross profit		48.6	%		48.8	%		48.8	%		49.6	%
Selling, general and administrative		35.1	%		35.5	%		35.9	%		35.6	%
Amortization of intangible assets		1.3	%		1.3	%		1.3	%		1.2	%

Income from operations		12.2	%		12.0	%		11.6	%		12.8	%
Interest and other expense, net		0.4	%		0.6	%		0.5	%		0.6	%

Income before provision for income taxes		11.8	%		11.4	%		11.1	%		12.2	%
Provision for income taxes		3.6	%		4.2	%		3.8	%		4.5	%

Net income		8.2	%		7.2	%		7.3	%		7.7	%

Adjusted EBITDA(1)		18.1	%		17.3	%		17.6	%		18.0	%

(1): See "—Adjusted EBITDA."

Comparison of the Three Months Ended June 30, 2015 to the Three Months Ended June 30, 2014

Net Sales. Net sales decreased by $1.2 million, or 2.2%, to $54.4 million for the three months ended June 30, 2015 (the "third quarter of fiscal 2015") from $55.6 million for the three months ended June 30, 2014 (the "third quarter of fiscal 2014"). Net sales of branded nutritional supplements and other natural products decreased by $0.8 million, or 1.8%, to $49.3 million for the third quarter of fiscal 2015, compared to $50.1 million for the third quarter of fiscal 2014. The decrease in net sales of branded nutritional supplements and other natural products was primarily related to a decrease in sales volume of branded products to certain customers, partially offset by price increases of $1.9 million and, to a lesser extent, the net sales contributions of the fiscal 2014 and fiscal 2015 acquisitions. Other net

Table of Contents

sales were $5.1 million for the third quarter of fiscal 2015 and $5.5 million for the third quarter of fiscal 2014.

Gross Profit. Gross profit decreased by $0.8 million, or 2.7%, to $26.4 million for the third quarter of fiscal 2015 from $27.2 million for the third quarter of fiscal 2014. This decrease in gross profit was primarily related to the decrease in net sales. As a percentage of net sales, gross profit was 48.6% for the third quarter of fiscal 2015 and 48.8% for the third quarter of fiscal 2014.

Selling, General and Administrative. Selling, general and administrative expenses decreased by $0.7 million, or 3.5%, to $19.1 million for the third quarter of fiscal 2015 from $19.8 million for the third quarter of fiscal 2014. As a percentage of net sales, selling, general and administrative expenses decreased to 35.1% for the third quarter of fiscal 2015 from 35.5% for the third quarter of fiscal 2014. This decrease in selling, general and administrative expenses was primarily attributable to year-over-year cost improvements in many selling, general and administrative expense areas.

Amortization of Intangible Assets. Amortization of intangible assets was $0.7 million for both the third quarter of fiscal 2015 and the third quarter of fiscal 2014. For each period, amortization expense was primarily related to intangible assets recorded in connection with acquisitions.

Interest and Other Expense, Net. Net interest and other expense was $0.3 million for the third quarter of fiscal 2015 and $0.4 million for the third quarter of fiscal 2014 and primarily consisted of interest expense on indebtedness under our revolving credit facility.

Provision for Income Taxes. Our effective tax rate was 30.3% for the third quarter of fiscal 2015 and 36.9% for the third quarter of fiscal 2014. The decrease in the effective tax rate was primarily related to a decrease in the valuation allowance for foreign tax credits of $0.3 million.

Comparison of the Nine Months Ended June 30, 2015 to the Nine Months Ended June 30, 2014

Net Sales. Net sales increased by $0.8 million, or 0.5%, to $162.8 million for the nine months ended June 30, 2015 from $162.0 million for the nine months ended June 30, 2014. Net sales of branded nutritional supplements and other natural products increased by $0.4 million, or 0.3%, to $147.0 million for the nine months ended June 30, 2015 from $146.6 million for the nine months ended June 30, 2014. The increase in net sales of branded nutritional supplements and other natural products was primarily related to the net sales contributions of the fiscal 2014 and fiscal 2015 acquisitions and price increases of $2.7 million, partially offset by a decrease in sales volume of branded products to certain customers. Other net sales were $15.8 million for the nine months ended June 30, 2015 and $15.4 million for the nine months ended June 30, 2014.

Gross Profit. Gross profit decreased by $0.9 million, or 1.0%, to $79.5 million for the nine months ended June 30, 2015 from $80.4 million for the nine months ended June 30, 2014. As a percentage of net sales, gross profit decreased to 48.8% for the nine months ended June 30, 2015 from 49.6% for the nine months ended June 30, 2014. This decrease in gross profit was primarily related to an increase in manufacturing overhead costs, partially offset by the increase in net sales.

Selling, General and Administrative. Selling, general and administrative expenses increased by $0.8 million, or 1.4%, to $58.4 million for the nine months ended June 30, 2015 from $57.6 million for the nine months ended June 30, 2014. As a percentage of net sales, selling, general and administrative expenses increased to 35.9% for the nine months ended June 30, 2015, compared to 35.6% for the nine months ended June 30, 2014. This increase in selling, general and administrative expenses was primarily attributable to operational and transition costs related to the fiscal 2014 acquisitions, partially offset by year-over-year cost improvements in many selling, general and administrative expense areas.

Table of Contents

Amortization of Intangible Assets. Amortization of intangible assets was $2.2 million for the nine months ended June 30, 2015 and $1.9 million for the nine months ended June 30, 2014. For each period, amortization expense was primarily related to intangible assets recorded in connection with acquisitions.

Interest and Other Expense, Net. Net interest and other expense was $0.8 million for the nine months ended June 30, 2015 and $1.0 million for the nine months ended June 30, 2014 and primarily consisted of interest expense on indebtedness under our revolving credit facility.

Provision for Income Taxes. Our effective tax rate was 34.3% for the nine months ended June 30, 2015 and 37.0% for the nine months ended June 30, 2014. The decrease in the effective tax rate was primarily related to a decrease in the valuation allowance for foreign tax credits of $0.3 million.

Adjusted EBITDA

Adjusted EBITDA (a non-GAAP measure) is defined in our performance measures as earnings before net interest and other expense, taxes, depreciation, amortization and goodwill and intangible asset impairments. Adjusted EBITDA has some inherent limitations in measuring operating performance due to the exclusion of certain financial elements such as depreciation and amortization and is not necessarily comparable to other similarly-titled captions of other companies due to potential inconsistencies in the method of calculation. Furthermore, Adjusted EBITDA is not intended to be a substitute for cash flows from operating activities, as a measure of liquidity, or an alternative to net income in determining our operating performance in accordance with generally accepted accounting principles. Our use of an EBITDA-based metric should be considered within the following context:

•

We acknowledge that plant and equipment (while less important in our line of business due to outsourcing alternatives) are necessary to earn revenue based on our current business model.

•

Our use of an EBITDA-based measure of operating performance is not based on any belief about the reasonableness of excluding depreciation and amortization when measuring financial performance.

•

Our use of an EBITDA-based measure is supported by its importance to the following key stakeholders:

•: Analysts—who estimate our projected Adjusted EBITDA and other EBITDA-based metrics in their independently-developed financial models for investors;
•: Creditors—who evaluate our operating performance based on compliance with certain EBITDA-based debt covenants;
•: Investment Bankers—who use EBITDA-based metrics in their written evaluations and comparisons of companies within our industry; and
•: Board of Directors and Executive Management—who use EBITDA-based metrics for evaluating management performance relative to our operating budget and bank covenant compliance, as well as our ability to service debt and raise capital for growth opportunities, including acquisitions, which are a critical component of our stated strategy. Generally, we have recorded a monthly accrual for incentive compensation as a percentage of Adjusted EBITDA, which has been paid out to executive management, as well as other employees, upon completion of our annual audit.

Table of Contents

The following table sets forth a reconciliation of net income to Adjusted EBITDA for each period included herein:

	Three Months Ended June 30,				Nine Months Ended June 30,

	2015		2014		2015		2014
	(dollars in thousands)
Net income	$	4,450	$	3,997	$	11,897	$	12,456
Provision for income taxes		1,930		2,333		6,220		7,329
Interest and other expense, net(1)		257		356		827		1,024
Depreciation and amortization		3,195		2,942		9,702		8,357

Adjusted EBITDA	$	9,832	$	9,628	$	28,646	$	29,166

(1): Includes amortization of deferred financing fees.

Our Adjusted EBITDA increased to $9.8 million for the third quarter of fiscal 2015 from $9.6 million for the third quarter of fiscal 2014. Adjusted EBITDA as a percentage of net sales increased to 18.1% for the third quarter of fiscal 2015 from 17.3% for the third quarter of fiscal 2014.

Our Adjusted EBITDA decreased to $28.6 million for the nine months ended June 30, 2015 from $29.2 million for the nine months ended June 30, 2014. Adjusted EBITDA as a percentage of net sales decreased to 17.6% for the nine months ended June 30, 2015 from 18.0% for the nine months ended June 30, 2014.

Seasonality

We believe that our business is characterized by minor seasonality. However, sales to any particular customer or of any particular product can vary substantially from one quarter to the next based on such factors as industry trends, timing of promotional discounts, domestic and international economic conditions and acquisition-related activities. Excluding the effect of acquisitions, we have historically recorded higher branded products sales volume during the second fiscal quarter (January through March) due to increased interest in health-related products among consumers following the holiday season.

Liquidity and Capital Resources

We had working capital of $62.4 million as of June 30, 2015, compared to $62.1 million as of September 30, 2014. The increase in working capital was primarily the result of an increase in inventories and a decrease in accrued expenses, partially offset by a decrease in cash.

Net cash provided by operating activities for the nine months ended June 30, 2015 was $21.2 million, compared to $16.1 million for the comparable period in fiscal 2014. This increase in net cash provided by operating activities for the nine months ended June 30, 2015 was primarily attributable to changes in operating assets and liabilities.

Net cash used in investing activities was $7.8 million for the nine months ended June 30, 2015, compared to $24.8 million for the comparable period in fiscal 2014. Our investing activities consisted of acquisitions of businesses and capital expenditures. The capital expenditures primarily related to buildings, building improvements, distribution and manufacturing equipment and information systems.

During the nine months ended June 30, 2015, we made two acquisitions of businesses. On November 18, 2014, we acquired certain operating assets of Agape Health Products. On June 4, 2015, we acquired certain operating assets of ProClay, LLC. The aggregate purchase price of these acquisitions was $1.3 million in cash.

Table of Contents

During the nine months ended June 30, 2014, we made six acquisitions of businesses. On October 16, 2013, we acquired certain operating assets of TCCD International, Inc. On November 25, 2013, we acquired certain operating assets of Green Luxury Brands, Inc. On December 19, 2013, we acquired certain operating assets of Twinlab Corporation. On January 15, 2014, we acquired certain operating assets of Peachtree Natural Foods, Inc. On April 11, 2014, we acquired certain operating assets of Northwest Health Foods, Inc. On April 17, 2014, we acquired certain operating assets of Bio-Genesis Nutraceuticals, Inc. The aggregate purchase price of these acquisitions was $16.2 million in cash.

Net cash used in financing activities was $14.6 million for the nine months ended June 30, 2015 and net cash provided by financing activities was $5.4 million for the comparable period in fiscal 2014. During these periods, financing activities primarily related to borrowings and repayments under our revolving credit facility, payments of deferred financing fees, purchases of common stock for treasury and proceeds from the issuance of common stock related to stock option exercises and the direct stock purchase plan.

In October 2007, we registered a direct stock purchase plan with the Securities and Exchange Commission. The purpose of this direct stock purchase plan is to provide a convenient way for existing stockholders, as well as new investors, to purchase shares of our common stock. A total of 1,500,000 shares of our common stock were registered under the plan, with 3,745 shares purchased during the nine months ended June 30, 2015. As of June 30, 2015, there were 1,377,990 shares of common stock available for purchase.

On November 4, 2014, we amended our revolving credit facility (the "Credit Agreement"). The Credit Agreement extends the term of the credit facility to November 2019, resets the available credit borrowings to $100.0 million with no automatic reductions and provides an accordion feature that can increase the available credit borrowings to $130.0 million, subject to approval by the lenders and compliance with certain covenants and conditions. The lenders under the Credit Agreement continue to be Rabobank International and Wells Fargo. To date, we have not experienced any difficulties in accessing the available funds under the Credit Agreement. Deferred financing fees of $0.4 million related to the Credit Agreement are being amortized over the term of the Credit Agreement.

At June 30, 2015, we had outstanding revolving credit borrowings of $32.0 million under the Credit Agreement. Borrowings under the Credit Agreement are collateralized by substantially all of our assets. At our election, borrowings bear interest at the applicable Eurodollar Rate plus a variable margin or at a Base Rate plus a variable margin. Base Rate is the higher of: (i) the Prime Lending Rate, (ii) the Federal Funds Rate plus 0.5% or (iii) the one-month Eurodollar Rate multiplied by the Statutory Reserve Rate plus 1.0% (capitalized terms are defined in the Credit Agreement, a copy of which was filed with the Securities and Exchange Commission on November 5, 2014). At June 30, 2015, the applicable weighted-average interest rate for outstanding borrowings was 1.78%. We are also required to pay a quarterly fee on the unused balance under the Credit Agreement. At June 30, 2015, the applicable rate was 0.25%. Accrued interest on Eurodollar Rate borrowings is payable based on elected intervals of one, two or three months. Accrued interest on base rate borrowings is payable quarterly. The Credit Agreement matures on November 4, 2019, and we are required to repay all principal and interest outstanding under the Credit Agreement on such date.

The Credit Agreement contains restrictive covenants, including limitations on incurring certain other indebtedness and requirements that we maintain certain financial ratios. As of June 30, 2015, we were in compliance with the restrictive covenants. Upon the occurrence of a default, the lender has various remedies or rights, which may include proceeding against the collateral or requiring us to repay all amounts outstanding under the Credit Agreement.

A key component of our business strategy is to seek to make additional acquisitions, which may require that we obtain additional financing, which could include the incurrence of substantial additional

Table of Contents

indebtedness or the issuance of additional stock. We believe that borrowings under our current revolving credit facility or a replacement credit facility, together with cash flows from operations, will be sufficient to make required payments under the current credit facility or any such replacement facility, and to make anticipated capital expenditures and fund working capital needs for the next twelve months.

Contractual Obligations and Other Commitments

Our significant non-cancelable contractual obligations and other commitments as of June 30, 2015 were as follows:

	Payments Due By Period

Contractual Obligations and Other Commitments	Total		Less Than 1 Year		1 - 3 Years		4 - 5 Years		After 5 Years
	(dollars in thousands)
Revolving credit facility	$	32,000	$	—	$	—	$	32,000	$	—
Interest on revolving credit facility(a)		3,349		770		1,539		1,040		—
Operating leases		6,534		3,780		2,509		245		—

Total	$	41,883	$	4,550	$	4,048	$	33,285	$	—

(a): Represents estimated interest obligations associated with our outstanding revolving credit facility balance of $32.0 million at June 30, 2015, assuming no principal payments are made before maturity, a weighted-average interest rate of 1.78% and an underutilization fee rate of 0.25%.

Off-Balance Sheet Arrangements

Our operating lease commitments are disclosed in the Contractual Obligations and Other Commitments table above. As of June 30, 2015, we had no other off-balance sheet arrangements that have had, or are reasonably likely to have, a material effect on our consolidated financial statements.

Inflation

Inflation affects the cost of raw materials, goods and services we use. In recent years, inflation has been modest. The competitive environment somewhat limits our ability to recover higher costs resulting from inflation by raising prices. We seek to mitigate the adverse effects of inflation primarily through improved productivity and cost containment programs. We do not believe that inflation has had a material impact on our results of operations for the periods presented, except with respect to increased costs in manufacturing, packaging and distribution resulting from increased fuel and other petrochemical costs, as well as payroll-related costs, insurance premiums and other costs arising from or related to government imposed regulations.

Forward-Looking Statements

This Form 10-Q contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 with respect to our financial condition, results of operations and business. These forward-looking statements can be identified by the use of terms such as "believe," "expects," "plan," "intend," "may," "will," "should," "can," or "anticipates," or the negative thereof, or variations thereon, or comparable terminology, or by discussions of strategy. These statements involve known and unknown risks, uncertainties and other factors that may cause industry trends or our actual results to be materially different from any future results expressed or implied by these statements. Important factors that may cause our results to differ from these forward-looking statements include, but are not limited to: (i) changes in or new government regulations or increased enforcement of the same; (ii) unavailability of desirable acquisitions, inability to complete them or inability to integrate

Table of Contents

them; (iii) increased costs, including from increased raw material or energy prices; (iv) changes in general worldwide economic or political conditions; (v) adverse publicity or negative consumer perception regarding nutritional supplements; (vi) issues with obtaining raw materials of adequate quality or quantity; (vii) litigation and claims, including product liability, intellectual property and other types; (viii) disruptions from or following acquisitions including the loss of customers; (ix) increased competition; (x) slow or negative growth in the nutritional supplement industry or the healthy foods channel; (xi) the loss of key personnel or the inability to manage our operations efficiently; (xii) problems with information management systems, manufacturing efficiencies and operations; (xiii) insurance coverage issues; (xiv) the volatility of the stock market generally and of our stock specifically; (xv) increases in the cost of borrowings or unavailability of additional debt or equity capital, or both, or fluctuations in foreign currencies; and (xvi) interruption of business or negative impact on sales and earnings due to acts of God, acts of war, terrorism, bio-terrorism, civil unrest and other factors outside of our control.

We undertake no obligation to update or revise publicly any forward-looking statements to reflect new information, events or circumstances occurring after the date of this Form 10-Q.

Item 3. Quantitative and Qualitative Disclosures about Market Risk

At our election, borrowings bear interest at the applicable Eurodollar Rate plus a variable margin or at a Base Rate plus a variable margin. Base Rate is the higher of: (i) the Prime Lending Rate, (ii) the Federal Funds Rate plus 0.5% or (iii) the one-month Eurodollar Rate multiplied by the Statutory Reserve Rate plus 1.0%. At June 30, 2015, the applicable weighted-average interest rate for borrowings was 1.78% and we had total borrowings outstanding of $32.0 million. A hypothetical 100 basis point change in interest rates would not have had a material impact on our reported net income or cash flows for the nine months ended June 30, 2015 and 2014.

With respect to our international operations, we are subject to currency fluctuations; however, we do not believe that these fluctuations would have a material adverse impact on our financial position or results of operations because the majority of our net sales to foreign customers are transacted in U.S. dollars. Net sales to foreign customers not transacted in U.S. dollars include sales to customers in Barbados, Canada, Dominica, Japan, the Netherlands, Norway, St. Kitts, St. Lucia, Sweden and the United Kingdom. To date, we have not hedged any of our potential foreign currency exposures.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures. We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our Exchange Act reports is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission's rules and forms and that such information is accumulated and communicated to our management, including our principal executive and principal financial officers, as appropriate, to allow for timely decisions regarding required disclosure.

In designing and evaluating the disclosure controls and procedures, we recognize that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and we are required to apply our judgment in evaluating the cost-benefit relationship of possible controls and procedures.

As required by SEC Rule 13a-15(b), we carried out an evaluation, under the supervision of and with the participation of our management, including our principal executive and principal financial officers, of the effectiveness of the design and operation of our disclosure controls and procedures as of June 30, 2015. Based on the foregoing, our principal executive and principal financial officers have concluded that our disclosure controls and procedures were effective at the reasonable assurance level as of June 30, 2015.

Changes in Internal Control Over Financial Reporting. There were no changes in our internal control over financial reporting that occurred during the last fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Table of Contents

PART II—OTHER INFORMATION

Item 1. Legal Proceedings

As discussed in our other filings, we are subject to regulation by a number of federal, state and foreign agencies and are involved in various legal matters arising in the ordinary course of business.

We carry insurance coverage in the types and amounts that we consider reasonably adequate to cover the risks we face in the industry in which we compete.

In the opinion of management, the losses related to individual regulatory and legal matters in which we are presently involved are not probable and no estimate can be made of the range of potential gains or losses. While incapable of estimation, in the opinion of management, none of the regulatory and legal matters in which we are involved are individually expected to have a material adverse effect on our consolidated financial position, results of operations or cash flows. However, our aggregate liability arising from regulatory and legal proceedings related to these matters or future matters could have a material effect on our financial position, results of operations or cash flows.

Item 1A. Risk Factors

There have been no material changes in our risk factors from those disclosed in our 2014 Annual Report on Form 10-K.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

We did not sell any unregistered equity securities during the quarterly period ended June 30, 2015.

Prior to fiscal 2015, our Board of Directors approved a share purchase program authorizing us to buy up to 4,500,000 shares of our common stock. As of June 30, 2015, there were 551,723 shares available for purchase under this program. The shares available for purchase under this program have no expiration date. Purchases under this program during the three months ended June 30, 2015 occurred in April, May and June as follows:

Period		Average Price Paid Per Share

April 1 - 30, 2015	40,302	$	19.83	40,302
May 1 - 31, 2015	21,874		20.09	21,874
June 1 - 30, 2015	1,100		24.74	1,100

	63,276		20.00	63,276	551,723

Table of Contents

Item 6. Exhibits


	31.1		Certifications Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
	32.1		Certifications Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
	101.INS		XBRL Instance Document(1)
	101.SCH		XBRL Taxonomy Extension Schema Document(1)
	101.CAL		XBRL Taxonomy Extension Calculation Linkbase Document(1)
	101.DEF		XBRL Taxonomy Extension Definition Linkbase Document(1)
	101.LAB		XBRL Taxonomy Extension Labels Linkbase Document(1)
	101.PRE		XBRL Taxonomy Extension Presentation Linkbase Document(1)

(1): Filed herewith.

Table of Contents

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.


	NUTRACEUTICAL INTERNATIONAL CORPORATION (Registrant)
Date: July 30, 2015	By:	/s/ CORY J. MCQUEEN Cory J. McQueen Vice President and Chief Financial Officer (Principal Financial and Accounting Officer and Duly Authorized Officer)

EX-31.1 2 a2225470zex-31_1.htm EX-31.1
QuickLinks -- Click here to rapidly navigate through this document

Exhibit 31.1

CERTIFICATIONS

I, Frank W. Gay II, certify that:

1.

I have reviewed this report on Form 10-Q of Nutraceutical International Corporation;

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;

4.

The Registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the Registrant and have:

a): designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;
b): designed such internal controls over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c): evaluated the effectiveness of the Registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d): disclosed in this report any change in the Registrant's internal control over financial reporting that occurred during the Registrant's most recent fiscal quarter (the Registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant's internal control over financial reporting; and

5.

The Registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant's auditors and the audit committee of the Registrant's board of directors (or persons performing the equivalent functions):

a): all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant's ability to record, process, summarize and report financial information; and
b): any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant's internal control over financial reporting.


Date: July 30, 2015		/s/ FRANK W. GAY II Frank W. Gay II Chairman of the Board and Chief Executive Officer (Principal Executive Officer)

CERTIFICATIONS

I, Cory J. McQueen, certify that:

1.

I have reviewed this report on Form 10-Q of Nutraceutical International Corporation;

2.

3.

4.

a): designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;
b): designed such internal controls over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c): evaluated the effectiveness of the Registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d): disclosed in this report any change in the Registrant's internal control over financial reporting that occurred during the Registrant's most recent fiscal quarter (the Registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the Registrant's internal control over financial reporting; and

5.

a): all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant's ability to record, process, summarize and report financial information; and
b): any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant's internal control over financial reporting.


Date: July 30, 2015		/s/ CORY J. MCQUEEN Cory J. McQueen Vice President and Chief Financial Officer (Principal Financial and Accounting Officer)

QuickLinks

Exhibit 31.1

CERTIFICATIONS
CERTIFICATIONS
EX-32.1 3 a2225470zex-32_1.htm EX-32.1
QuickLinks -- Click here to rapidly navigate through this document

Exhibit 32.1

CERTIFICATION PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report on Form 10-Q of Nutraceutical International Corporation ("Nutraceutical") for the period ended June 30, 2015 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Frank W. Gay II, Chairman of the Board and Chief Executive Officer of Nutraceutical, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

(1): the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2): the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Nutraceutical.


/s/ FRANK W. GAY II Frank W. Gay II Chairman of the Board and Chief Executive Officer Date: July 30, 2015

CERTIFICATION PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report on Form 10-Q of Nutraceutical International Corporation ("Nutraceutical") for the period ended June 30, 2015 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Cory J. McQueen, Vice President and Chief Financial Officer of Nutraceutical, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

(1): the Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2): the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Nutraceutical.


/s/ CORY J. MCQUEEN Cory J. McQueen Vice President and Chief Financial Officer Date: July 30, 2015

Signed originals of these written statements required by Section 906 have been provided to Nutraceutical and will be retained by Nutraceutical and furnished to the Securities and Exchange Commission or its staff upon request.

QuickLinks

Exhibit 32.1

CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
EX-101.INS 4 nutr-20150630.xml EX-101.INS 0001050007 nutr:LongTermEquityIncentivePlan2013Member 2013-10-01 2014-09-30 0001050007 nutr:LongTermEquityIncentivePlan2013Member 2012-10-01 2013-09-30 0001050007 nutr:LongTermEquityIncentivePlan2013Member 2015-06-30 0001050007 nutr:LongTermEquityIncentivePlan2013Member 2013-01-28 0001050007 nutr:LongTermEquityIncentivePlan2013Member 2014-12-11 2014-12-11 0001050007 nutr:LongTermEquityIncentivePlan2013Member 2013-12-11 2013-12-11 0001050007 nutr:OtherProductsMember 2015-04-01 2015-06-30 0001050007 nutr:ForeignCountriesMember 2015-04-01 2015-06-30 0001050007 nutr:BrandedNutritionalSupplementsAndOtherNaturalProductsMember 2015-04-01 2015-06-30 0001050007 country:US 2015-04-01 2015-06-30 0001050007 nutr:OtherProductsMember 2014-10-01 2015-06-30 0001050007 nutr:ForeignCountriesMember 2014-10-01 2015-06-30 0001050007 nutr:BrandedNutritionalSupplementsAndOtherNaturalProductsMember 2014-10-01 2015-06-30 0001050007 country:US 2014-10-01 2015-06-30 0001050007 nutr:OtherProductsMember 2014-04-01 2014-06-30 0001050007 nutr:ForeignCountriesMember 2014-04-01 2014-06-30 0001050007 nutr:BrandedNutritionalSupplementsAndOtherNaturalProductsMember 2014-04-01 2014-06-30 0001050007 country:US 2014-04-01 2014-06-30 0001050007 nutr:OtherProductsMember 2013-10-01 2014-06-30 0001050007 nutr:ForeignCountriesMember 2013-10-01 2014-06-30 0001050007 nutr:BrandedNutritionalSupplementsAndOtherNaturalProductsMember 2013-10-01 2014-06-30 0001050007 country:US 2013-10-01 2014-06-30 0001050007 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2013-10-01 2014-06-30 0001050007 us-gaap:RevolvingCreditFacilityMember 2014-10-01 2015-06-30 0001050007 us-gaap:RevolvingCreditFacilityMember 2014-11-04 0001050007 nutr:RevolvingCreditFacilityAccordionFeatureMember 2014-11-04 0001050007 nutr:TrademarksTradeNamesAndLicensesMember 2015-06-30 0001050007 nutr:TrademarksTradeNamesAndLicensesMember 2014-09-30 0001050007 us-gaap:DevelopedTechnologyRightsMember us-gaap:WeightedAverageMember 2014-10-01 2015-06-30 0001050007 nutr:TrademarksTradeNamesAndPatentsMember us-gaap:WeightedAverageMember 2014-10-01 2015-06-30 0001050007 nutr:CustomerRelationshipsDistributionRightsAndNoncompeteAgreementMember us-gaap:WeightedAverageMember 2014-10-01 2015-06-30 0001050007 us-gaap:DevelopedTechnologyRightsMember 2015-06-30 0001050007 nutr:TrademarksTradeNamesAndPatentsMember 2015-06-30 0001050007 nutr:CustomerRelationshipsDistributionRightsAndNoncompeteAgreementMember 2015-06-30 0001050007 us-gaap:DevelopedTechnologyRightsMember 2014-09-30 0001050007 nutr:TrademarksTradeNamesAndPatentsMember 2014-09-30 0001050007 nutr:CustomerRelationshipsDistributionRightsAndNoncompeteAgreementMember 2014-09-30 0001050007 us-gaap:RevolvingCreditFacilityMember 2015-06-30 0001050007 us-gaap:RevolvingCreditFacilityMember us-gaap:PrimeRateMember 2014-10-01 2015-06-30 0001050007 us-gaap:RevolvingCreditFacilityMember nutr:FederalFundsRateMember 2014-10-01 2015-06-30 0001050007 nutr:StatutoryReserveRateMember 2014-10-01 2015-06-30 0001050007 2014-06-30 0001050007 2013-09-30 0001050007 nutr:EmployeeAndNonEmployeeStockOptionsMember 2014-10-01 2015-06-30 0001050007 nutr:EmployeeAndNonEmployeeStockOptionsMember 2013-10-01 2014-09-30 0001050007 2015-04-01 2015-06-30 0001050007 2014-04-01 2014-06-30 0001050007 2013-10-01 2014-06-30 0001050007 us-gaap:MinimumMember 2014-10-01 2015-06-30 0001050007 us-gaap:MaximumMember 2014-10-01 2015-06-30 0001050007 2014-09-30 0001050007 us-gaap:CommonStockMember 2015-04-01 2015-06-30 0001050007 us-gaap:CommonStockMember 2014-10-01 2015-06-30 0001050007 us-gaap:CommonStockMember 2014-04-01 2014-06-30 0001050007 us-gaap:CommonStockMember 2013-10-01 2014-06-30 0001050007 2015-06-30 0001050007 us-gaap:RevolvingCreditFacilityMember us-gaap:EurodollarMember 2014-10-01 2015-06-30 0001050007 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2015-06-30 0001050007 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2014-06-30 0001050007 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2014-10-01 2015-06-30 0001050007 2015-07-27 0001050007 2014-10-01 2015-06-30 nutr:segment nutr:item iso4217:USD xbrli:shares xbrli:pure iso4217:USD xbrli:shares false --09-30 Q3 2015 2015-06-30 10-Q 0001050007 9532469 Yes Accelerated Filer NUTRACEUTICAL INTERNATIONAL CORP P15Y 5803000 393000 P15Y P1M P3M P2M 551723 156661 99541 180301 63276

14874000

14218000

16352000

15259000

15118000

14186000

6835000

5852000

79000

-139000

P12Y

P2Y

11112000

8488000

1234000

1073000

138000

99000

1940000

704000

2189000

729000

214778000

210905000

83850000

82425000

7675000

762000

2733000

111000

5803000

393000

16211000

1266000

8235000

5051000

6232000

4902000

-3184000

-1330000

97000

96000

12505000

3998000

11679000

4562000

81660000

28473000

83293000

27955000

0.01

0.005

one-month Eurodollar Rate

the Federal Funds Rate

Eurodollar Rate

the Prime Lending Rate

0.0178

289000

925000

1222000

1245000

4894000

3946000

8357000

9702000

1.27

0.41

1.24

0.47

1.27

0.41

1.24

0.47

33000

-173000

115000

356000

51000

55000

51000

55000

9642000

7390000

1480000

772000

11831000

9217000

1842000

772000

3653000

679000

1235000

1662000

1852000

2227000

22707000

16517000

5418000

772000

23139000

16837000

5530000

772000

13065000

9127000

3938000

11308000

7620000

3688000

P7Y

P11Y

P5Y

-2000

-9000

7675000

23622000

24384000

762000

<div> <div style="margin-left:0pt;margin-right:0pt;">   5. GOODWILL AND INTANGIBLE ASSETS         The change in the carrying amount of goodwill from September 30, 2014 to June 30, 2015 was as follows:                                                                                                                                                                                      <div style="width:100%"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;CellSpacing:0;margin-left:0pt;"> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:62.72%;padding:0pt;">   </td> <td valign="bottom" style="width:00.78%;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Goodwill </td> <td valign="bottom" style="width:00.78%;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:13.38%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Accumulated Impairment </td> <td valign="bottom" style="width:01.06%;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Net </td> <td valign="bottom" style="width:00.78%;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:62.72%;background-color: #CCEEFF;padding:0pt;"> Balance as of October 1, 2014 </td> <td valign="bottom" style="width:00.78%;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.58%;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:08.66%;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>64,016 </td> <td valign="bottom" style="width:00.78%;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.86%;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:11.52%;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(40,394 </td> <td valign="bottom" style="width:01.06%;background-color: #CCEEFF;"> ) </td> <td valign="bottom" style="width:01.58%;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:08.66%;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>23,622 </td> <td valign="bottom" style="width:00.78%;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:62.72%;background-color: #FFFFFF;padding:0pt;"> Goodwill attributable to fiscal 2015 acquisition </td> <td valign="bottom" style="width:00.78%;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.58%;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.66%;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>762 </td> <td valign="bottom" style="width:00.78%;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.86%;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.52%;background-color: #FFFFFF;padding:0pt;"> — </td> <td valign="bottom" style="width:01.06%;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.58%;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.66%;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>762 </td> <td valign="bottom" style="width:00.78%;background-color: #FFFFFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:62.72%;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:00.78%;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:00.78%;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.06%;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:00.78%;background-color: #FFFFFF;padding:0pt;"> </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:62.72%;background-color: #CCEEFF;padding:0pt;"> Balance as of June 30, 2015 </td> <td valign="bottom" style="width:00.78%;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.58%;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.66%;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>64,778 </td> <td valign="bottom" style="width:00.78%;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.86%;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.52%;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(40,394 </td> <td valign="bottom" style="width:01.06%;background-color: #CCEEFF;"> ) </td> <td valign="bottom" style="width:01.58%;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.66%;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>24,384 </td> <td valign="bottom" style="width:00.78%;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:62.72%;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:00.78%;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2.25pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2.25pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:00.78%;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:01.86%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2.25pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:11.52%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2.25pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.06%;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:01.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2.25pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.66%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2.25pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:00.78%;background-color: #FFFFFF;padding:0pt;"> </td> </tr> </table></div>         The carrying amounts of intangible assets at June 30, 2015 and September 30, 2014 were as follows:                                                                                                                                                                                      <div style="width:100%"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;CellSpacing:0;margin-left:0pt;"> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;padding:0pt;">   </td> <td valign="bottom" style="width:auto;padding:0pt;">   </td> <td colspan="8" valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> June 30, 2015 </td> <td valign="bottom" style="width:auto;padding:0pt;">   </td> <td colspan="8" valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> September 30, 2014 </td> <td valign="bottom" style="width:auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:auto;padding:0pt;">   </td> <td valign="bottom" style="width:auto;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;padding:0pt;">   </td> <td valign="bottom" style="width:auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Gross Carrying Amount(1) </td> <td valign="bottom" style="width:auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Accumulated Amortization(1) </td> <td valign="bottom" style="width:auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Net Carrying Amount </td> <td valign="bottom" style="width:auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Gross Carrying Amount(1) </td> <td valign="bottom" style="width:auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Accumulated Amortization(1) </td> <td valign="bottom" style="width:auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Net Carrying Amount </td> <td valign="bottom" style="width:auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Weighted- Average Amortization Period (Years) </td> <td valign="bottom" style="width:auto;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> Intangible assets subject to amortization: </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> Trademarks/tradenames/patents </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:7.5pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5,530 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:7.5pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(1,842 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;"> ) </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:7.5pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,688 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:7.5pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5,418 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:7.5pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(1,480 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;"> ) </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:7.5pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,938 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:7.5pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>11 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> Customer relationships/distribution rights/ non-compete agreements </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:7.5pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>16,837 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:7.5pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(9,217 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;"> ) </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:7.5pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7,620 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:7.5pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>16,517 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:7.5pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(7,390 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;"> ) </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:7.5pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>9,127 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:7.5pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> Developed software and technology </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:7.5pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>772 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:7.5pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(772 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;"> ) </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> — </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:7.5pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>772 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:7.5pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(772 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;"> ) </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> — </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:7.5pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:7.5pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>23,139 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:7.5pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(11,831 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;"> ) </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:7.5pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>11,308 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:7.5pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>22,707 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:7.5pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(9,642 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;"> ) </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:7.5pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>13,065 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> Intangible assets not subject to amortization: </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> Trademarks/tradenames/licenses </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:7.5pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>8,800 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> — </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:7.5pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>8,800 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:7.5pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>8,900 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> — </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:7.5pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>8,900 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:7.5pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>31,939 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:7.5pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(11,831 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;"> ) </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:7.5pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>20,108 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:7.5pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>31,607 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:7.5pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(9,642 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;"> ) </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:7.5pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>21,965 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2.25pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2.25pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2.25pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2.25pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2.25pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2.25pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2.25pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2.25pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2.25pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2.25pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2.25pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2.25pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> </tr> </table></div> <hr style="border-bottom-style:solid;width:26%;height:1.5pt; ;color:#000000" align="left"></hr> <div style="width:100%"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;CellSpacing:15;margin-left:0pt;"> <tr style="CellSpacing:15;"> <td valign="middle" style="width:04.00%;padding:0.8pt 0.8pt 0.8pt 0.8pt;">   </td> <td valign="middle" style="width:auto;padding:0.8pt 0.8pt 0.8pt 0.8pt;">   </td> </tr> <tr style="CellSpacing:15;"> <td valign="top" style="width:auto;padding:0.8pt 0.8pt 0.8pt 0.8pt;"> (1)  </td> <td valign="top" style="width:auto;padding:0.8pt 0.8pt 0.8pt 0.8pt;"> Amounts include the impact of foreign currency translation adjustments. </td> </tr> </table></div>         Estimated future amortization expense related to the June 30, 2015 net carrying amount of $11,308 for intangible assets subject to amortization is as follows:                                                                                                                                                                                      <div style="width:100%"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 80.00%;CellSpacing:0;margin-left:0pt;"> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Year Ending September 30, </td> <td valign="bottom" style="width:auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Estimated Amortization Expense </td> <td valign="bottom" style="width:auto;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> 2015(1) </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>679  </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> 2016 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,227  </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> 2017 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,852  </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> 2018 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,662  </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> 2019 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,235  </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> Thereafter </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,653  </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>11,308  </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2.25pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2.25pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> </tr> </table></div> <hr style="border-bottom-style:solid;width:26%;height:1.5pt; ;color:#000000" align="left"></hr> <div style="width:100%"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;CellSpacing:15;margin-left:0pt;"> <tr style="CellSpacing:15;"> <td valign="middle" style="width:04.00%;padding:0.8pt 0.8pt 0.8pt 0.8pt;">   </td> <td valign="middle" style="width:auto;padding:0.8pt 0.8pt 0.8pt 0.8pt;">   </td> </tr> <tr style="CellSpacing:15;"> <td valign="top" style="width:auto;padding:0.8pt 0.8pt 0.8pt 0.8pt;"> (1)  </td> <td valign="top" style="width:auto;padding:0.8pt 0.8pt 0.8pt 0.8pt;"> Estimated amortization expense for the year ending September 30, 2015 includes only amortization to be recorded after June 30, 2015. </td> </tr> </table></div>         General and economic conditions may continue to impact retail and consumer demand, as well as the market price of the Company's common stock, and could negatively impact the Company's future operating performance, cash flow and/or stock price and could result in additional goodwill and/or intangible asset impairment charges being recorded in future periods. Also, the Company periodically reviews its brands to achieve marketing, sales and operational synergies. These reviews could result in brands being consolidated or discontinued and could result in intangible asset impairment charges being recorded in future periods. Such goodwill and/or intangible asset impairment charges could materially impact the Company's consolidated financial statements. The valuation of goodwill and intangible assets is subject to a high degree of judgment, uncertainty and complexity. </div> </div>

64016000

64778000

40394000

80374000

27152000

79537000

26427000

19785000

6330000

18117000

6380000

7329000

2333000

6220000

1930000

-197000

-761000

377000

-964000

705000

-774000

4601000

1340000

114000

107000

2000

19000

484000

-605000

8900000

8800000

31607000

31939000

21965000

20108000

1024000

356000

827000

257000

30446000

28165000

57914000

59318000

20559000

22485000

6909000

8668000

65165000

52241000

214778000

210905000

21709000

20070000

32000000

130000000

100000000

0.0025

43000000

32000000

<div> <div style="margin-left:0pt;margin-right:0pt;">   1. BASIS OF PRESENTATION         Nutraceutical International Corporation and its subsidiaries (the "Company") is an integrated manufacturer, marketer, distributor and retailer of branded nutritional supplements and other natural products sold primarily to and through domestic health and natural food stores. Internationally, the Company markets and distributes branded nutritional supplements and other natural products to and through health and natural product distributors and retailers. The Company's core business strategy is to acquire, integrate and operate businesses in the natural products industry that manufacture, market and distribute branded nutritional supplements. The Company believes that the consolidation and integration of these acquired businesses provide ongoing financial synergies through increased scale and market penetration, as well as strengthened customer relationships.         The Company manufactures and sells nutritional supplements and other natural products under numerous brands, including Solaray®, KAL®, Nature's Life®, LifeTime®, Natural Balance®, NaturalCare®, Health from the Sun®, Pioneer®, Nutra BioGenesis™, Life-flo®, Organix South®, Heritage Store® and Monarch Nutraceuticals™.         The Company owns neighborhood natural food markets, which operate under the trade names The Real Food Company™, Thom's Natural Foods™, Cornucopia Community Market™ and Granola's™. The Company also owns health food stores, which operate under various trade names, including Fresh Vitamins™ and Peachtree Natural Foods®.         In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all necessary adjustments, consisting of normal recurring adjustments, to state fairly the consolidated financial position of the Company as of June 30, 2015, the results of its operations for the three and nine months ended June 30, 2015 and 2014 and its cash flows for the nine months ended June 30, 2015 and 2014, in conformity with accounting principles generally accepted in the United States of America ("US GAAP") for interim financial information applied on a consistent basis. Results for the three and nine months ended June 30, 2015 are not necessarily indicative of the results to be expected for the full fiscal year.         Certain information and footnote disclosures normally included in the annual financial statements prepared in accordance with US GAAP have been omitted. Accordingly, these financial statements should be read in conjunction with the Company's Form 10-K for the fiscal year ended September 30, 2014, which was filed with the Securities and Exchange Commission on November 20, 2014. Use of Estimates         The preparation of these financial statements in conformity with US GAAP required management to make estimates and assumptions that affected the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of net sales and expenses during the reported periods. Significant estimates included values and lives assigned to acquired intangible assets, reserves for customer returns and allowances, uncollectible accounts receivable, valuation adjustments for slow-moving, obsolete and/or damaged inventory and valuation and recoverability of long-lived assets. Actual results may differ from these estimates. New Accounting Standards         In May 2014, the Financial Accounting Standards Board ("FASB") issued authoritative guidance, which is included in Accounting Standards Codification ("ASC") 606, "Revenue from Contracts with Customers." This guidance provides a single, comprehensive revenue recognition model for all contracts with customers and requires that a company recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. In July 2015, the FASB delayed the effective date of this guidance by one year. As a result, this guidance is effective for the Company as of October 1, 2018 and shall be applied either retrospectively to each period presented or as a cumulative-effect adjustment as of the date of adoption. The Company is currently evaluating the impact this standard may have on its consolidated financial statements.         The Company periodically reviews new accounting standards that are issued. Although some of these accounting standards may be applicable to the Company, the Company has not identified any other new standards that it believes merit further discussion, and the Company expects that none would have a significant impact on its consolidated financial statements. </div> </div>

5446000

-14551000

-24788000

-7789000

16125000

21183000

12456000

3997000

11897000

4450000

20809000

6686000

18944000

6637000

1203000

1692000

49000

1000

-218000

112000

456000

171000

3798000

3618000

420000

16211000

1266000

16211000

1266000

8577000

6523000

3364000

2774000

51000

55000

193000

432000

19500000

2500000

79244000

78350000

10500000

13500000

138347000

150244000

162034000

140089000

146636000

21945000

15398000

55625000

47804000

50161000

7821000

5464000

162830000

143203000

147018000

19627000

15812000

54382000

47671000

49258000

6711000

5124000

<div> <div style="margin-left:0pt;margin-right:0pt;">                                                                                                                                                                                      <div style="width:100%"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;CellSpacing:0;margin-left:0pt;"> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:64.92%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Year Ending September 30, </td> <td valign="bottom" style="width:01.82%;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:31.42%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Estimated Amortization Expense </td> <td valign="bottom" style="width:01.82%;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:64.92%;background-color: #CCEEFF;padding:0pt;"> 2015(1) </td> <td valign="bottom" style="width:01.82%;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:04.84%;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:26.58%;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>679  </td> <td valign="bottom" style="width:01.82%;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:64.92%;background-color: #FFFFFF;padding:0pt;"> 2016 </td> <td valign="bottom" style="width:01.82%;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:04.84%;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:26.58%;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>2,227  </td> <td valign="bottom" style="width:01.82%;background-color: #FFFFFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:64.92%;background-color: #CCEEFF;padding:0pt;"> 2017 </td> <td valign="bottom" style="width:01.82%;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:04.84%;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:26.58%;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,852  </td> <td valign="bottom" style="width:01.82%;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:64.92%;background-color: #FFFFFF;padding:0pt;"> 2018 </td> <td valign="bottom" style="width:01.82%;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:04.84%;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:26.58%;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,662  </td> <td valign="bottom" style="width:01.82%;background-color: #FFFFFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:64.92%;background-color: #CCEEFF;padding:0pt;"> 2019 </td> <td valign="bottom" style="width:01.82%;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:04.84%;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:26.58%;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>1,235  </td> <td valign="bottom" style="width:01.82%;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:64.92%;background-color: #FFFFFF;padding:0pt;"> Thereafter </td> <td valign="bottom" style="width:01.82%;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:04.84%;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:26.58%;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,653  </td> <td valign="bottom" style="width:01.82%;background-color: #FFFFFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:64.92%;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:01.82%;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:04.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:26.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.82%;background-color: #FFFFFF;padding:0pt;"> </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:64.92%;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.82%;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:04.84%;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:26.58%;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>11,308  </td> <td valign="bottom" style="width:01.82%;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:64.92%;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:01.82%;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:04.84%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2.25pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:26.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2.25pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.82%;background-color: #FFFFFF;padding:0pt;"> </td> </tr> </table></div> <hr style="border-bottom-style:solid;width:26%;height:1.5pt; ;color:#000000" align="left"></hr> <div style="width:100%"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;CellSpacing:15;margin-left:0pt;"> <tr style="CellSpacing:15;"> <td valign="middle" style="width:04.00%;padding:0.8pt 0.8pt 0.8pt 0.8pt;">   </td> <td valign="middle" style="width:auto;padding:0.8pt 0.8pt 0.8pt 0.8pt;">   </td> </tr> <tr style="CellSpacing:15;"> <td valign="top" style="width:auto;padding:0.8pt 0.8pt 0.8pt 0.8pt;"> (1)     </td> <td valign="top" style="width:auto;padding:0.8pt 0.8pt 0.8pt 0.8pt;"> Estimated amortization expense for the year ending September 30, 2015 includes only amortization to be recorded after June 30, 2015. </td> </tr> </table></div>   </div> </div>

<div> <div style="margin-left:0pt;margin-right:0pt;">                                                                                                                                                                                      <div style="width:100%"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;CellSpacing:0;margin-left:0pt;"> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;padding:0pt;">   </td> <td valign="bottom" style="width:auto;padding:0pt;">   </td> <td colspan="8" valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> June 30, 2015 </td> <td valign="bottom" style="width:auto;padding:0pt;">   </td> <td colspan="8" valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> September 30, 2014 </td> <td valign="bottom" style="width:auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:auto;padding:0pt;">   </td> <td valign="bottom" style="width:auto;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;padding:0pt;">   </td> <td valign="bottom" style="width:auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Gross Carrying Amount(1) </td> <td valign="bottom" style="width:auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Accumulated Amortization(1) </td> <td valign="bottom" style="width:auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Net Carrying Amount </td> <td valign="bottom" style="width:auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Gross Carrying Amount(1) </td> <td valign="bottom" style="width:auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Accumulated Amortization(1) </td> <td valign="bottom" style="width:auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Net Carrying Amount </td> <td valign="bottom" style="width:auto;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Weighted- Average Amortization Period (Years) </td> <td valign="bottom" style="width:auto;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> Intangible assets subject to amortization: </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> Trademarks/tradenames/patents </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:7.5pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5,530 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:7.5pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(1,842 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;"> ) </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:7.5pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,688 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:7.5pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5,418 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:7.5pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(1,480 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;"> ) </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:7.5pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>3,938 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:7.5pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>11 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> Customer relationships/distribution rights/ non-compete agreements </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:7.5pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>16,837 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:7.5pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(9,217 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;"> ) </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:7.5pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7,620 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:7.5pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>16,517 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:7.5pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(7,390 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;"> ) </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:7.5pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>9,127 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:7.5pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> Developed software and technology </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:7.5pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>772 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:7.5pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(772 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;"> ) </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> — </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:7.5pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>772 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:7.5pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(772 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;"> ) </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> — </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:7.5pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:7.5pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>23,139 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:7.5pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(11,831 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;"> ) </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:7.5pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>11,308 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:7.5pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>22,707 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:7.5pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(9,642 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;"> ) </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:7.5pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>13,065 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> Intangible assets not subject to amortization: </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> Trademarks/tradenames/licenses </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:7.5pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>8,800 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> — </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:7.5pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>8,800 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:7.5pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>8,900 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;"> — </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;;font-family:Times;font-size:7.5pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>8,900 </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:7.5pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>31,939 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:7.5pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(11,831 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;"> ) </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:7.5pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>20,108 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:7.5pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>31,607 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:7.5pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>(9,642 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;"> ) </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;;font-family:Times;font-size:7.5pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>21,965 </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2.25pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2.25pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2.25pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2.25pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2.25pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2.25pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2.25pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2.25pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2.25pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2.25pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2.25pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2.25pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:auto;background-color: #FFFFFF;padding:0pt;"> </td> </tr> </table></div> <hr style="border-bottom-style:solid;width:26%;height:1.5pt; ;color:#000000" align="left"></hr> <div style="width:100%"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;CellSpacing:15;margin-left:0pt;"> <tr style="CellSpacing:15;"> <td valign="middle" style="width:04.00%;padding:0.8pt 0.8pt 0.8pt 0.8pt;">   </td> <td valign="middle" style="width:auto;padding:0.8pt 0.8pt 0.8pt 0.8pt;">   </td> </tr> <tr style="CellSpacing:15;"> <td valign="top" style="width:auto;padding:0.8pt 0.8pt 0.8pt 0.8pt;"> (1)      </td> <td valign="top" style="width:auto;padding:0.8pt 0.8pt 0.8pt 0.8pt;"> Amounts include the impact of foreign currency translation adjustments. </td> </tr> </table></div>   </div> </div>

<div> <div style="margin-left:0pt;margin-right:0pt;">   9. SEGMENTS         Segment identification and selection is consistent with the management structure used by the Company's chief operating decision maker to evaluate performance and make decisions regarding resource allocation, as well as the materiality of financial results consistent with that structure. Based on the Company's management structure and method of internal reporting, the Company has one operating segment. The Company's chief operating decision maker does not review operating results on a disaggregated basis; rather, the chief operating decision maker reviews operating results on an aggregate basis.         Net sales attributed to customers in the United States and foreign countries for the three and nine months ended June 30, 2015 and 2014 were as follows:                                                                                                                                                                                      <div style="width:100%"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;CellSpacing:0;margin-left:0pt;"> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:31.58%;padding:0pt;">   </td> <td valign="bottom" style="width:01.12%;padding:0pt;">   </td> <td colspan="5" valign="bottom" style="width:30.28%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Three months ended June 30, </td> <td valign="bottom" style="width:01.12%;padding:0pt;">   </td> <td colspan="5" valign="bottom" style="width:34.78%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Nine months ended June 30, </td> <td valign="bottom" style="width:01.12%;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:31.58%;padding:0pt;">   </td> <td valign="bottom" style="width:01.12%;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:14.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2015 </td> <td valign="bottom" style="width:01.12%;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:14.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2014 </td> <td valign="bottom" style="width:01.12%;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:16.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2015 </td> <td valign="bottom" style="width:01.12%;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:16.82%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2014 </td> <td valign="bottom" style="width:01.12%;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:31.58%;background-color: #CCEEFF;padding:0pt;"> United States </td> <td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.24%;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.34%;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>47,671  </td> <td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.24%;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.34%;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>47,804  </td> <td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.24%;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:14.58%;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>143,203  </td> <td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.24%;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:14.58%;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>140,089  </td> <td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:31.58%;background-color: #FFFFFF;padding:0pt;"> Foreign countries </td> <td valign="bottom" style="width:01.12%;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.24%;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:12.34%;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>6,711  </td> <td valign="bottom" style="width:01.12%;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.24%;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:12.34%;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>7,821  </td> <td valign="bottom" style="width:01.12%;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.24%;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:14.58%;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>19,627  </td> <td valign="bottom" style="width:01.12%;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.24%;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:14.58%;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>21,945  </td> <td valign="bottom" style="width:01.12%;background-color: #FFFFFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:31.58%;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:01.12%;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:02.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:12.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.12%;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:02.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:12.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.12%;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:02.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:14.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.12%;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:02.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:14.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.12%;background-color: #FFFFFF;padding:0pt;"> </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:31.58%;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.24%;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.34%;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>54,382  </td> <td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.24%;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:12.34%;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>55,625  </td> <td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.24%;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:14.58%;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>162,830  </td> <td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:02.24%;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:14.58%;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>162,034  </td> <td valign="bottom" style="width:01.12%;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:31.58%;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:01.12%;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:02.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2.25pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:12.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2.25pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.12%;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:02.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2.25pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:12.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2.25pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.12%;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:02.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2.25pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:14.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2.25pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.12%;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:02.24%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2.25pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:14.58%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2.25pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.12%;background-color: #FFFFFF;padding:0pt;"> </td> </tr> </table></div>         Certain net sales attributed to customers in the United States are sold to customers who in turn may sell such products to customers in foreign countries, while certain net sales attributed to customers in foreign countries are sold to customers who in turn may sell such products to customers in the United States.         The Company's net sales by product group for the three and nine months ended June 30, 2015 and 2014 were as follows:                                                                                                                                                                                      <div style="width:100%"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;CellSpacing:0;margin-left:0pt;"> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:59.26%;padding:0pt;">   </td> <td valign="bottom" style="width:00.66%;padding:0pt;">   </td> <td colspan="5" valign="bottom" style="width:18.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Three months ended June 30, </td> <td valign="bottom" style="width:00.66%;padding:0pt;">   </td> <td colspan="5" valign="bottom" style="width:20.70%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> Nine months ended June 30, </td> <td valign="bottom" style="width:00.66%;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:59.26%;padding:0pt;">   </td> <td valign="bottom" style="width:00.66%;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:08.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2015 </td> <td valign="bottom" style="width:00.66%;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:08.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2014 </td> <td valign="bottom" style="width:00.66%;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2015 </td> <td valign="bottom" style="width:00.66%;padding:0pt;">   </td> <td colspan="2" valign="bottom" style="width:10.02%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;padding:0pt;"> 2014 </td> <td valign="bottom" style="width:00.66%;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:59.26%;background-color: #CCEEFF;padding:0pt;"> Branded nutritional supplements and other natural products </td> <td valign="bottom" style="width:00.66%;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.34%;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:07.34%;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>49,258  </td> <td valign="bottom" style="width:00.66%;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.34%;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:07.34%;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>50,161  </td> <td valign="bottom" style="width:00.66%;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.34%;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:08.68%;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>147,018  </td> <td valign="bottom" style="width:00.66%;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.34%;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:08.68%;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>146,636  </td> <td valign="bottom" style="width:00.66%;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:59.26%;background-color: #FFFFFF;padding:0pt;"> Other(1) </td> <td valign="bottom" style="width:00.66%;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.34%;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:07.34%;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5,124  </td> <td valign="bottom" style="width:00.66%;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.34%;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:07.34%;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>5,464  </td> <td valign="bottom" style="width:00.66%;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.34%;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.68%;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>15,812  </td> <td valign="bottom" style="width:00.66%;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.34%;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.68%;background-color: #FFFFFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>15,398  </td> <td valign="bottom" style="width:00.66%;background-color: #FFFFFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:59.26%;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:00.66%;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:01.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:00.66%;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:01.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:00.66%;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:01.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:00.66%;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:01.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:1pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:00.66%;background-color: #FFFFFF;padding:0pt;"> </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:59.26%;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:00.66%;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.34%;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:07.34%;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>54,382  </td> <td valign="bottom" style="width:00.66%;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.34%;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:07.34%;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>55,625  </td> <td valign="bottom" style="width:00.66%;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.34%;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:08.68%;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>162,830  </td> <td valign="bottom" style="width:00.66%;background-color: #CCEEFF;padding:0pt;">   </td> <td valign="bottom" style="width:01.34%;background-color: #CCEEFF;padding:0pt;"> $ </td> <td valign="bottom" style="width:08.68%;background-color: #CCEEFF;;font-family:Times;font-size:10pt;text-align:right;" nowrap="nowrap"><div style="float:left"></div>162,034  </td> <td valign="bottom" style="width:00.66%;background-color: #CCEEFF;padding:0pt;">   </td> </tr> <tr style="CellSpacing:0;"> <td valign="bottom" style="width:59.26%;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:00.66%;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:01.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2.25pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2.25pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:00.66%;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:01.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2.25pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:07.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2.25pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:00.66%;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:01.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2.25pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2.25pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:00.66%;background-color: #FFFFFF;padding:0pt;"> </td> <td valign="bottom" style="width:01.34%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2.25pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:08.68%;border-top:1pt none #D9D9D9 ;border-left:1pt none #D9D9D9 ;border-bottom:2.25pt solid #000000 ;border-right:1pt none #D9D9D9 ;background-color: #FFFFFF;padding:0pt;">   </td> <td valign="bottom" style="width:00.66%;background-color: #FFFFFF;padding:0pt;"> </td> </tr> </table></div> <hr style="border-bottom-style:solid;width:26%;height:1.5pt; ;color:#000000" align="left"></hr> <div style="width:100%"><table cellpadding="0" cellspacing="0" align="center" style="border-collapse:collapse;width: 100.00%;CellSpacing:15;margin-left:0pt;"> <tr style="CellSpacing:15;"> <td valign="middle" style="width:04.00%;padding:0.8pt 0.8pt 0.8pt 0.8pt;">   </td> <td valign="middle" style="width:auto;padding:0.8pt 0.8pt 0.8pt 0.8pt;">   </td> </tr> <tr style="CellSpacing:15;"> <td valign="top" style="width:auto;padding:0.8pt 0.8pt 0.8pt 0.8pt;"> (1)    </td> <td valign="top" style="width:auto;padding:0.8pt 0.8pt 0.8pt 0.8pt;"> Net sales for any other product or group of similar products are less than 10% of consolidated net sales. </td> </tr> </table></div>   </div> </div>

57625000

19762000

58404000

19061000

775000

504000

800000

743385

32500

7500

14.22

133000

141000

14.22

149613000

158664000

31788

24827

25000

9673

1000

22000

25000

3798000

2368000

3618000

1266000

420000

9150

8400

4920

2991

9835666

9806793

9617091

9563999

9826516

9798393

9612171

9561008

EX-101.SCH 5 nutr-20150630.xsd EX-101.SCH 00100 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS link:presentationLink link:calculationLink link:definitionLink 00200 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME link:presentationLink link:calculationLink link:definitionLink 00300 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:calculationLink link:definitionLink 40201 - Disclosure - ACCOUNTS RECEIVABLE (Details) link:presentationLink link:calculationLink link:definitionLink 40301 - Disclosure - INVENTORIES (Details) link:presentationLink link:calculationLink link:definitionLink 40401 - Disclosure - ACQUISITIONS (Details) link:presentationLink link:calculationLink link:definitionLink 40501 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Details) link:presentationLink link:calculationLink link:definitionLink 40502 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Details) (Calc 2) (Imported) link:presentationLink link:calculationLink link:definitionLink 40503 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Details) (Calc 3) (Imported) link:presentationLink link:calculationLink link:definitionLink 00090 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 10101 - Disclosure - BASIS OF PRESENTATION link:presentationLink link:calculationLink link:definitionLink 10201 - Disclosure - ACCOUNTS RECEIVABLE link:presentationLink link:calculationLink link:definitionLink 10301 - Disclosure - INVENTORIES link:presentationLink link:calculationLink link:definitionLink 10401 - Disclosure - ACQUISITIONS link:presentationLink link:calculationLink link:definitionLink 10501 - Disclosure - GOODWILL AND INTANGIBLE ASSETS link:presentationLink link:calculationLink link:definitionLink 10601 - Disclosure - DEBT link:presentationLink link:calculationLink link:definitionLink 10701 - Disclosure - SHARE PURCHASES link:presentationLink link:calculationLink link:definitionLink 10801 - Disclosure - STOCK OPTIONS AND OTHER EQUITY AWARDS link:presentationLink link:calculationLink link:definitionLink 10901 - Disclosure - SEGMENTS link:presentationLink link:calculationLink link:definitionLink 30203 - Disclosure - ACCOUNTS RECEIVABLE (Tables) link:presentationLink link:calculationLink link:definitionLink 30303 - Disclosure - INVENTORIES (Tables) link:presentationLink link:calculationLink link:definitionLink 30403 - Disclosure - ACQUISITIONS (Tables) link:presentationLink link:calculationLink link:definitionLink 30503 - Disclosure - GOODWILL AND INTANGIBLE ASSETS (Tables) link:presentationLink link:calculationLink link:definitionLink 30603 - Disclosure - DEBT (Tables) link:presentationLink link:calculationLink link:definitionLink 30800 - Disclosure - STOCK OPTIONS AND OTHER EQUITY AWARDS (Tables) link:presentationLink link:calculationLink link:definitionLink 30903 - Disclosure - SEGMENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 40601 - Disclosure - DEBT (Details) link:presentationLink link:calculationLink link:definitionLink 40701 - Disclosure - SHARE PURCHASES (Details) link:presentationLink link:calculationLink link:definitionLink 40801 - Disclosure - STOCK OPTIONS AND OTHER EQUITY AWARDS (Details) link:presentationLink link:calculationLink link:definitionLink 40802 - Disclosure - STOCK OPTIONS AND OTHER EQUITY AWARDS (Details 2) link:presentationLink link:calculationLink link:definitionLink 40803 - Disclosure - STOCK OPTIONS AND OTHER EQUITY AWARDS (Details 3) link:presentationLink link:calculationLink link:definitionLink 40804 - Disclosure - STOCK OPTIONS AND OTHER EQUITY AWARDS (Details 4) link:presentationLink link:calculationLink link:definitionLink 40901 - Disclosure - SEGMENTS (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 6 nutr-20150630_cal.xml EX-101.CAL EX-101.DEF 7 nutr-20150630_def.xml EX-101.DEF EX-101.LAB 8 nutr-20150630_lab.xml EX-101.LAB Document and Entity Information Statement [Table] Statement [Line Items] Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Entity Current Reporting Status Entity Filer Category Entity Common Stock, Shares Outstanding Document Fiscal Year Focus Document Fiscal Period Focus CONSOLIDATED BALANCE SHEETS Assets [Abstract] Assets Assets, Current [Abstract] Current assets: Cash and Cash Equivalents, at Carrying Value Cash at end of period Cash at beginning of period Cash Accounts Receivable, Net, Current Accounts receivable, net Accounts receivable, net Inventory, Net Inventories Inventories Prepaid Expense and Other Assets, Current Prepaid expenses and other current assets Deferred Tax Assets, Net, Current Deferred income taxes Assets, Current Total current assets Property, Plant and Equipment, Net. Property, plant and equipment, net Goodwill Goodwill Carrying amount of goodwill Intangible Assets, Net (Excluding Goodwill) Intangible assets, net Net Carrying Amount Other Assets, Noncurrent Other non-current assets Deferred Tax Assets, Net, Noncurrent Deferred income taxes, net Assets Total assets Liabilities and Equity [Abstract] Liabilities and Stockholders' Equity Liabilities, Current [Abstract] Current liabilities: Accounts Payable, Current Accounts payable Accrued Liabilities, Current Accrued expenses Liabilities, Current Total current liabilities Long-term Line of Credit, Noncurrent Long-term debt Long-term debt-revolving credit facility Other Liabilities, Noncurrent Other non-current liabilities Liabilities Total liabilities Stockholders' Equity Attributable to Parent [Abstract] Stockholders' equity: Common Stock, Value, Issued Common stock Additional Paid in Capital, Common Stock Additional paid-in capital Retained Earnings (Accumulated Deficit) Retained earnings Accumulated Other Comprehensive Income (Loss), Net of Tax Accumulated other comprehensive income Treasury Stock, Value Treasury stock Stockholders' Equity Attributable to Parent Total stockholders' equity Liabilities and Equity Total liabilities and stockholders' equity CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME Revenue, Net Net sales Cost of Goods and Services Sold Cost of sales Gross Profit Gross profit Operating Expenses [Abstract] Operating expenses Selling, General and Administrative Expense Selling, general and administrative Amortization of Intangible Assets Amortization of intangible assets Operating Income (Loss) Income from operations Interest Expense, Debt Interest and other expense, net Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest Income before provision for income taxes Income Tax Expense (Benefit) Provision for income taxes Net Income (Loss) Available to Common Stockholders, Basic Net income Net income Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract] Other comprehensive income (loss) Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent Foreign currency translation adjustment, net of tax Comprehensive Income (Loss), Net of Tax, Attributable to Parent Comprehensive income Earnings Per Share [Abstract] Net income per common share Earnings Per Share, Basic Basic (in dollars per share) Earnings Per Share, Diluted Diluted (in dollars per share) Weighted Average Number of Shares Outstanding, Diluted [Abstract] Weighted average common shares outstanding Weighted Average Number of Shares Outstanding, Basic Basic (in shares) Weighted Average Number Diluted Shares Outstanding Adjustment Dilutive effect of stock options (in shares) Weighted Average Number of Shares Outstanding, Diluted Diluted (in shares) CONSOLIDATED STATEMENTS OF CASH FLOWS Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract] Cash flows from operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net income to net cash provided by operating activities: Depreciation, Depletion and Amortization Depreciation and amortization Amortization of Financing Costs Amortization of deferred financing fees Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property Losses on disposals of property, plant and equipment Excess Tax Benefit from Share-based Compensation, Operating Activities Tax benefit from stock option exercises Deferred Income Tax Expense (Benefit) Deferred income taxes, net Increase (Decrease) in Operating Capital [Abstract] Changes in assets and liabilities, net of effects of acquisitions: Increase (Decrease) in Accounts Receivable Accounts receivable, net Increase (Decrease) in Inventories Inventories Increase (Decrease) in Prepaid Expense and Other Assets Prepaid expenses and other current assets Increase (Decrease) in Other Noncurrent Assets Other non-current assets Increase (Decrease) in Accounts Payable Accounts payable Increase (Decrease) in Accrued Liabilities Accrued expenses Increase (Decrease) in Other Noncurrent Liabilities Other non-current liabilities Net Cash Provided by (Used in) Operating Activities, Continuing Operations Net cash provided by operating activities Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract] Cash flows from investing activities: Payments to Acquire Businesses, Net of Cash Acquired Acquisitions of businesses Payments to Acquire Property, Plant, and Equipment Purchases of property, plant and equipment Net Cash Provided by (Used in) Investing Activities, Continuing Operations Net cash used in investing activities Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract] Cash flows from financing activities: Proceeds from Lines of Credit Proceeds from debt Repayments of Lines of Credit Payments on debt Payments of Financing Costs Payments of deferred financing fees Proceeds from Issuance of Common Stock Proceeds from issuances of common stock Payments for Repurchase of Common Stock Purchases of common stock for treasury Proceeds and Excess Tax Benefit from Share-based Compensation Tax benefit from stock option exercises Net Cash Provided by (Used in) Financing Activities, Continuing Operations Net cash provided by (used in) financing activities Effect of Exchange Rate on Cash and Cash Equivalents, Continuing Operations Effect of exchange rate changes on cash Net Cash Provided by (Used in) Continuing Operations Net decrease in cash Cash and Cash Equivalents, Period Increase (Decrease) Net decrease in cash BASIS OF PRESENTATION Nature of Operations [Text Block] BASIS OF PRESENTATION ACCOUNTS RECEIVABLE Loans, Notes, Trade and Other Receivables Disclosure [Text Block] ACCOUNTS RECEIVABLE INVENTORIES Inventory Disclosure [Text Block] INVENTORIES ACQUISITIONS. Business Combination Disclosure [Text Block] ACQUISITIONS GOODWILL AND INTANGIBLE ASSETS Goodwill and Intangible Assets Disclosure [Text Block] GOODWILL AND INTANGIBLE ASSETS DEBT Debt Disclosure [Text Block] DEBT SHARE PURCHASES SHARE PURCHASES Text Block SHARE PURCHASES STOCK OPTIONS AND OTHER EQUITY AWARDS STOCK OPTIONS AND OTHER EQUITY AWARDS Text Block STOCK OPTIONS AND OTHER EQUITY AWARDS SEGMENTS Segment Reporting Disclosure [Text Block] SEGMENTS Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block] Schedule of accounts receivable, net of allowances for sales returns and doubtful accounts Schedule of Inventory, Current [Table Text Block] Schedule of inventories Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block] Schedule of final allocation of the aggregate purchase price for the acquisitions to the aggregate assets acquired Schedule of Goodwill [Table Text Block] Schedule of changes in the carrying amount of goodwill Schedule of Intangible Assets and Goodwill [Table Text Block] Schedule of carrying amounts of intangible assets Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Schedule of estimated amortization expense related to intangible assets subject to amortization Schedule of Line of Credit Facilities [Table Text Block] Schedule of debt Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block] Schedule of stock option activity Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area [Table Text Block] Schedule of net sales attributed to customers in the United States and foreign countries Revenue from External Customers by Products and Services [Table Text Block] Schedule of net sales by product group Accounts Receivable, Gross, Current Accounts receivable Allowance for Doubtful Accounts Receivable, Current Less allowances Inventory, Raw Materials, Net of Reserves Raw materials Inventory, Work in Process, Net of Reserves Work-in-process Inventory, Finished Goods, Net of Reserves Finished goods Number of Businesses Acquired Number of business acquisitions Schedule of Business Acquisitions, by Acquisition [Table] Business Acquisition [Axis] Business Acquisition Acquiree [Domain] Business Acquisition, Acquiree [Domain] Series Of Individually Immaterial Business Acquisitions [Member] Acquisitions Range [Axis] Range [Member] Range [Domain] Minimum [Member] Minimum Maximum [Member] Maximum Business Acquisition [Line Items] ACQUISITIONS Payments to Acquire Businesses, Gross Aggregate purchase price in cash Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net [Abstract] Aggregate assets acquired: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets Current assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill Intangible assets Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net Aggregate purchase price Acquired Finite-lived Intangible Assets, Weighted Average Useful Life Amortization period The amount of intangible assets other than goodwill arising from a business combination that is expected to be deductible for tax purposes. Business Acquisition, Purchase Price Allocation, Intangible Assets Other than Goodwill Expected Tax Deductible Amount Acquired intangible assets expected to be deductible for tax purposes Business Acquisition, Goodwill, Expected Tax Deductible Amount Goodwill expected to be deductible for tax purposes Represents the period over which the amount of acquired intangible assets in connection with a business combination is expected to be deductible for income tax purposes. Business Acquisition, Purchase Price Allocation, Intangible Assets Period for Deduction of Expected Tax Deductible Amount Expected period for deduction of acquired intangible assets for tax purposes Represents the period over which the amount of acquired goodwill in connection with a business combination is expected to be deductible for income tax purposes. Business Acquisition, Purchase Price Allocation, Goodwill, Period for Deduction of Expected Tax Deductible Amount Expected period for deduction of acquired goodwill for tax purposes Goodwill [Roll Forward] GOODWILL Goodwill, Gross Goodwill Goodwill, Impaired, Accumulated Impairment Loss Accumulated Impairment Goodwill, Acquired During Period Goodwill attributable to fiscal 2015 acquisitions Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life and those that exist in perpetuity. Schedule of Finite Lived and Indefinite Lived Intangible Assets [Table] Finite-Lived Intangible Assets by Major Class [Axis] Finite Lived Intangible Assets Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Represents trademarks, trade names and patents held by the entity. Trademarks are rights acquired through registration to gain or protect exclusive use of a business name, symbol or other device or style, trade names are rights acquired through registration of a business name to gain or protect exclusive use thereof and patents are exclusive legal right granted by the government to the owner to exploit an invention or a process for a period of time specified by law. Trademarks Trade Names And Patents [Member] Trademarks/tradenames/patents Represents customer relationships, distribution rights and non-compete agreements held by the entity. Customer relationship that exists between the entity and its customer, for example, but not limited to, tenant relationships, distribution rights are legal rights, generally of a limited duration, to distribute a product or products, often within specific geographic areas or supply channels and agreement in which one party agrees not to pursue a similar trade in competition with another party are non-compete agreements. Customer Relationships Distribution Rights And Noncompete Agreement [Member] Customer relationships/distribution rights/ non-compete agreements Developed Technology Rights [Member] Developed software and technology Indefinite-lived Intangible Assets [Axis] Indefinite Lived Intangible Assets Major Class Name [Domain] Indefinite-lived Intangible Assets, Major Class Name [Domain] Represents trademarks, trade names and licenses held by the entity. Trademarks are rights acquired through registration to gain or protect exclusive use of a business name, symbol or other device or style, trade names are rights acquired through registration of a business name to gain or protect exclusive use thereof and licenses are rights, generally of limited duration, under an arrangement (for example, to sell or otherwise utilize specified products or processes in a specified territory). Trademarks Trade Names And Licenses [Member] Trademarks/tradenames/licenses Weighted Average [Member] Weighted average Finite Lived and Indefinite Lived Assets [Line Items] INTANGIBLE ASSETS Finite-Lived Intangible Assets, Net [Abstract] Intangible assets subject to amortization: Finite-Lived Intangible Assets, Gross Gross Carrying Amount Finite-Lived Intangible Assets, Accumulated Amortization Accumulated Amortization Finite-Lived Intangible Assets, Net Net Carrying Amount Finite-Lived Intangible Asset, Useful Life Weighted-Average Amortization Period Indefinite-Lived Intangible Assets (Excluding Goodwill) [Abstract] Intangible assets not subject to amortization: Indefinite-Lived Intangible Assets (Excluding Goodwill) Carrying Amount Intangible Assets, Net (Excluding Goodwill) [Abstract] Total intangible assets Intangible Assets, Gross (Excluding Goodwill) Gross Carrying Amount Finite-Lived Intangible Assets, Amortization Expense, Maturity Schedule [Abstract] Estimated future amortization expense related to intangible assets Finite-Lived Intangible Assets, Amortization Expense, Remainder of Fiscal Year 2015 Finite-Lived Intangible Assets, Amortization Expense, Year Two 2016 Finite-Lived Intangible Assets, Amortization Expense, Year Three 2017 Finite-Lived Intangible Assets, Amortization Expense, Year Four 2018 Finite-Lived Intangible Assets, Amortization Expense, Year Five 2019 Finite-Lived Intangible Assets, Amortization Expense, after Year Five Thereafter Schedule of Long-term Debt Instruments [Table] Credit Facility [Axis] Credit Facility [Domain] Credit Facility [Domain] Revolving Credit Facility [Member] Restated Credit Agreement Represents information pertaining to the accordion feature of a revolving credit facility. Revolving Credit Facility Accordion Feature [Member] Credit Agreement, accordion feature Variable Rate [Axis] Variable Rate [Domain] Variable Rate [Domain] Represents the interest rate at which depository institutions actively trade balances held at the Federal Reserve, called federal funds, with each other, usually overnight, on an uncollateralized basis. Federal Funds Rate [Member] Federal Funds Rate Eurodollar [Member] Eurodollar Rate Prime Rate [Member] Prime Lending Rate The amount of liquid assets that firms must hold in order to remain solvent and attain partial protection against a substantial investment loss Statutory Reserve Rate [Member] Statutory Reserve Rate EX-101.PRE 9 nutr-20150630_pre.xml EX-101.PRE GRAPHIC 10 g556913.jpg G556913.JPG begin 644 g556913.jpg M_]C_X``02D9)1@`!`0$!AP&'``#__@!*35),3%]'4D%02$E#4SI;3E544D%# M155424-!3%])3E1%4DY!5$E/3D%,74Y55%)!0T555$E#04Q?1E!/7S1#7TQ/ M1T\N15!3_]L`0P`!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$! M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!_]L`0P$!`0$!`0$!`0$! M`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$!`0$! M`0$!`0$!`0$!_\``$0@`60#)`P$B``(1`0,1`?_$`!\```$$`@,!`0`````` M```````'"`D*`P8!!`4+`O_$`%(0``$$`0,"`P,$"PH*"P````(!`P0%!@`' M$0@2"1,A%"(Q"A4601U,W%U@9&QL[2VT1DD.E1T>).WP?`E M-398E):ALM/C\?_$`!T!``$$`P$!```````````````%!@<(`P0)`@'_Q``R M$0`"`@("`@(!`P(%`P4````"`P$$!081$@`'$R$4""(Q%4$6(R0R425"@3-2 M86*Q_]H`#`,!``(1`Q$`/P"_QHT:-'AX:-&C1X>&C1HT>'AHT:-'AX:-&D[W M0SF-@&(VEVYVG+!@FX#'F@T;DAU1:%P"<]Q585Q'5#U(T'A!5.>$S-9>A@,3 MDP MB;'R4<5MHE+[62J8@I\*O/<@^J)9+Q*39>89$77.`9D9R`8.!)B2$\I4"2W]P2<\CRVJ(0EQQRG/K\- MM!,MD8!8.S`1_J%KGELK%D]@CB8@(XB)B)CR<[1K1=M M,KCYK@V.Y''<)SV^O;209]O<4V,JQII%VH@JIRFG3511$][X)\$WK75O$Y*K MF<5C>:CM.OO&+;3+9NN&2\"#;8J1DJ_D$ M455TW;*-]H[+J,8T$=\!4%.5+$T4A5.[N9;`^#`D]WWE%454+U1.%TOJ.W>* MF>;PBEF*U)?C^=:2&%:7L][N&*KJJ?:H-@9/M"*'[R"?":C_`+O.T&R3M_.BHJ=OH/)>[W(G'I^:BGZAO>VS5LTW1_7-\Z$X\C3G\U6"(N3> M&5S^!C[!20I75@I&X\5$4N[*">JB[V+]8^F;.Q449C)53;%WJS'4I*0`JTSU MBS8[0,0+9YE,2<#\8R91/8>).<:WXKI4@(^0MM11><%L9<5$&/&$E1$*8KSJ MDG'KR37(_#W=.%9>:D--OL.`ZR\`N-.MDA@XV:(0&!"JH0D*HJ*B^J+J#BGW M7*S=5B7%>A&8<`1&BM.+W(B-^B>G'H2^OIQ\/KT^_IMW=DR;#Z#7DLGHTIE7 MZ"3*>%2CNM(`'6-J7!&TZ/#K0DI&+JFB%VD@IY]`^_-J;FZVE>RKDK6O8^QE\;7),T5R MZ]1[PT3JC`][%0ADHDD1R;EP4Q*H(AX,)$WN:-&C5[?*W^&C1HT>'AHT:-'A MX:-&C1X>&C1HT>'AHT:-'AX:-&C1X>?DS!L#<<(0`!(S,E1!`!15(B5?1!%$ M525?1$157T344'4!NZ&Z>=.4>/F9T.)++A=R\*DB?YR,R9*=G*=G(=C7)%[J MHJ)Z+QN'67U90157A.?C\?JX3A%YUC7%N51%`45?04543N].?15X3X( MJHG/*)_)I<,^L<>P+'I-[8$*J)(Q%9%OO>?D."2-H#1.!W")(BN*2KVBG*(O M*(C5]LJ3%QR)!@UR2`C#*?/M+N\IHQ4F6R]H=07$9 M0R046G&I8O8MRMJJ8BLYK7MBO77`=VV'\:UQ$F<1Y*CT>V3H8 MUD>-OD@K66$67&817%\IE^(VQ(+U4FQ1R2RIH(*/*D1*//*Z>-I`-J-HDVB5 MCNR%VT2PBL1+63-5`5Z:+;3<5J,IHKBM(\C@L@9H2H0HJ*:\:7_75STWC,_@ MM`P^O;/6BMFL%-G'V(%@N4Y7SG9J/2T>!8J:UA:8(8@88E@1]!YSR]C9'&9C M<,QE\._\BADG!86[XF)@V_$M=@OC:`,'NX#;P<=NK!(OLIB#24;S[F5.UN"7 M&06$T(LTHC\:D:5LGW9-FZ@,QT;9'U,&7'FW7B54$`3DN4]-*F\\U':=??[4;"\-D2)^%X] M9!$AN!'>9:7SV[OB-"U"]>%RPRE MU3:F+`B&)!ICU==D9,9^.DHY=S_MEWP++_U/'-Z8]<-]A[4*[4$C6L"L>`%I>9A,GVTV4Y+.3)??FS720/ M,?><(WRX'W0)55>0'T1.$_-K4IKD!N6U$CJW-=?<%EI!7N<=>,T;%&Q3DE<$ MR%1$44D)![D1.513-S9=/M'A5=5QDCE9S&/(1)!*U(=)M460XK?O_:U'O?D/ M..(K:>6@HXA*@JYT.;$2LD/[*^81'_FYB2`T,*R:54LE05D%)>B2&A=%H'7( MLN/(1UZ.^0CY8]J$NN;_`*UU#->S]@77H$Y2;-IA.NL@S@*ZRYMY"S/_`+A. M9D.Y1+FGT&>Q?=XLAM>&UK2\IO-D?Q,!5=_3M>HJ$4,S-A?92DUA'_8'9?'8 M1^)*X811U7/BQ;7='5198=\YYZ]-A9#=PQX/*BB"2>CF\%VNK:VK;J$3A.57 ME5_?555?KUSHT:DZ(B(XB.(CZB(_B(_X\C_PT:-&CP\-&C1H\/#1HT:/#PT: M-&CP\-=09T4IKE/N>].WE%7A53GCE-=O2(;W#> MT='&W`Q6.LF\Q!QV0Y%%#XF5%AQ!)`=5.PB$A1>X51(_>H#KF2)%M< M8VB;9DS)",-1\R\XR&)'<5#=EQ*\X;@.^<`DRR3QMFVAHZ38KV<(YU"Y]B&[ MMM1936U4^FR(8"5&1,O/-$U(C1C,V`!$<17#]\%[R!>6FV05>0XTW)K'JY3] M]66T+E5[$0$Y55553A4[>4X0D3CUY^"+ZTR]C_J4S#K.0PNK,I(Q93RC/8^+ MA=0HHQ>Q;G4RF0RBP!C];R M()#'UK]:Q,&1_B&4WZQDJ&(!K"KOKLB'K8)2/B>8-@DC-\O8.P60["23[9:3 M54B-T.]7G4<,U%5-QTN2Y,W%X3TXYXDLK;.KJ:^-#9<\N/$CMQVN]Y2-!8!0 M$C1555]WT3T1115157GG35::=`I(JL0P0&^[N-5XY4N%#O,ONB+CT]5^.O5E M7DF7%D-1U,U>;(.>?N`-$$UYY]%4/=14^!+RB]WKJEVRSQJJZ9X`)G MDHDHCY6M,B@2:SF2/F/CB?\`9`\1S,6^UK6[VZ86Q*OBL=$+I5Y^EKF9@6V# MB.`AA#`QUXZBL!&(GB9\27?O*)^=97'KX[SCU54-QV(D9@3(9,X1(3Y`$[5- MQQ>$(NY.>T4)574P'1YLI$VAVHJG9M=$CYCEC#=SDDQMHQDJV^Z_)J:QYQWW M_P#HR'(%HQ$0%7U,NU>T5TQ?ITV*;W%SH95@R84M$Y%L;-UT7Q]J)N6+[4%E M]LA0W/,:17FS)4)H_>Y3A%F81$%$$41!1$1$1$1$1/1$1$X1$1/1$3X)J^7Z M4M+A6.L;;8K0-52_Z5@98$_YIC/.2R(=X[04S`4U-CGLO\B(+@BB:\?J-]@4 MZFOZ]ZEUEOPXW&BJ_G`1,`+F`$%CZSI7P+(8QKK]A9]H^4:1S^X(@4]W8H@R M/;S*JM9]U>2$2'A>[A6M[5] M7-3&ALXIO(X5'E-3%-B1D:-$--=E"`0]K,C5$A2IQ>ZRPKCJ/.@YWJPXA-H^ M&2R$B.\PX`.`\T;9`XG(&)BHJ)I]8%SP2?!4Y1?CJ%'/#6IRB_H[Z#']HB7- MB`QR#S(;;:R#5H61+T1M&%;5HD7T%"'DN%177[[WG:?5^=U;:]>E-JIEJ>0P M>4Q=M;657E38N_3L<@T(795#[(+,8$Y431F6#`B,<^FM:P>]8W8-8SE5KXJ. MK9;'V*;UU\G18\"JVF5#-31:A@IKQ;KO`T&0USB%M"#E6^H3JSL=R*F3M[L] M#L&8ELLB#?7LEDV2?II;`,(S$<;-485YY7VWR$G1)A1'N$O,%4VVKP+&=IJA M^SE/H]=OM-K*D+[J1T;;-489$'%$"X<,7'554-1$R'DE36FQ+^)%'L9:C1T' MA`1IML$X554D[D1%[57U42^OA576"YG6%K#]F:(U9D>Z:H:\$RBJA#QZ^OKZ M>O<7W(HJ^FJ)^QO8&W^SQBH3D8^3IR3F\& MR#+F1M50U''X371TS`U3P.NVK,/S33L2[(YMD=?WY&[(IE@*""A598+2L9Z" M/$3):_7XS;=2>_L&DCQW0IFY!"/!&_%B4M,?F%82%[!:59A*O?'<46W>19(C M%.%G?QN@@XO2U]%7"J1*Z.$=I2%H#,6T01(A9;::%4%$$1;;```1`!01333N MC_9\,'QN=F4^*ZQ:94U%"`#S?DJU1MM`\TX#/FF0I-=-'1)X&I(MMB)@*%PK MS==#?T[:*&IZ+2R%BN2,CG4JL_$P>K*N,&)_`KD/$1!-&2NMGK$][/7^`CRJ M?OS?Z^S9W'ZM@BA>IZ34#%8U*YY78O"`C?NE/,R1=Q&L,S,\_`;/Y;/!HT:- M6`\@'PT:-&CP\-&C1H\/#1HT:/#PT:3O&MWMI\RNI&-XAN=M[E60Q`>`8ML22S!@Q,C)`0G$%'\Q,C,QS',)X*.8GCZGSZ)@?;J0EU*1+J4%U*/Y M$N)G@H_O$\3'_'AK&\TV^TZP\".-/-FTZ!)R)MN"H&!(OQ0A)45/K1=9-&L< MQ!1(E$$)1,$,Q$Q,3'$Q,3]3$Q]3$_4QY[B9B8F)F)B8F)B>)B8^XF)C[B8G M^)\AAZI=@KS:>[+*L88G6&%W,I]UXV(+CT?'GG!3LCRI#3CA,,O%W`RX^V#: MN$``XA*((S%,@F-JC9GV&'(J!(2F/'Q]$5?J^OGU3XK\=68YD*'81GH<^+'F MQ)`H#\64RW(CO`BH2"ZRZ)-N"A(A(ABJ(2(2)RB+IG.\_2=A60P`N<*QBL@W M5>FK+*[+I M0"]-4@@HF"6HIY`8N=ZZ_5+3Q6%JX?>L)< MREJBJ$)S6.FL;[:5Q,(&Y6=*1_(`>JB>ML_*,0PQ$^_R1#8\S=Y#)]GC*X,8 M1%QQ\A,>&U5>X^[X$*<+R2\HG*JJ\)IPE+CB@L.OCA[0^XH@T)$A&\Z:(@CV M*0JZ/>J(H*:`OO!)0-$XC+B^6XB\+P]_I_V.M([D?,<]K6FO.BQY%-32U59L.2$@7VITUE! M5L'#:%.R.7:30FHN#W:JWKWK#=-\V*KA*>+L4*H6`_/>^LU=;')!@189<=(Q M(N@8D07`D4LZQU^OI"VW]349^R88;&,QF/1'*JYFICG,ZQ^^V8B,=N9Y%0QP M/'/)<\>+?L5MVNW>&!"D$16-G+=L9BJ@B(B2J$5L!%QW@?(07"17"]]Q?APB M:6G7"(B(B(B(B(B(B)PB(GHB(B>B(B?!-($8_^H!`@ M,?V$8CPU%+U/[?\`L6X5H\VZ307+(6$,NUT1;+A?-$B,5!WN=-256G4%H2$2 M;#CTE:TW_J!VKD[B8VQ+HD8#)Z-U'H9.MD8S()KQ,@%V>^A$*H^QV^BO-B)H MH*J:BC]0>B9'>="8O"+AN.3L"H33=JK_CDVU6F0A,\,-0K^I*)A MS:)NE_1LS.6HD42:"0T!XF#'N#`["43!C!A'(SQVB9CF.9\B3K,/P43D>55/AZ+RGII>MI]N9.SP MFHCH25^Z16G9+S8*#$=%+D"<=4?<(DT`:7-"OFL>#%[?YZE3G(D2&[`-@Y3X MJ9'PXZTH^2C0$Z+G<(HVO*()4E]2>G=BWW=\2O,U'IU[&W4NS MEBPIU1`*4P2C'DSB1%UDAA;($I($2XXB(CZD?/?J"S6;K6S&&C8&NY:OC2M8 M),ER/92H_:3.)+J,S,QR'/\`,^.O@PXU?#C08@>7%B,MQV&^XC[&FA00'N-2 M(N!1/555==K3.^C:7O\`R<)R!OJ`>R69?Q+Z0Q6S\FI:^C>FP4GW!0GJ^,Q% MKYYQ2QPL6*>4^NCMM9&=['@./L-'Y;Q-=5;%(<'AHT:-'AX:-:UEV98C@%#.RG.PA9M(09#SQV$6L"9'GZYB)CGZY\JS^(!G^0]"?C39AOUTU;=5T4L"V_P#S.";Y[3VRVV%Y[4#8PO/!&+.IGL.N0[K';V$I$<"^QZU8EU-O#-2 M1N9%,V''HSC#[D#MCCE#F/RBO<;$LIJ8%_C.4=%$['LBHK-D959=T=SA%%7V MM38Q7.6Y,&?"?>C26311<:<(53UY1(MKKW(_`UZZY&QF;3;:1X>/5AD#MKMA MEEG*F6,3:G*WG68P!82'25J-(Q@GHF/YJ?*/7&%?1G,B21,J;5D9_P!HQ5+< M+JK*-WQ'KW`9;'S)R;-FQ$5[!9#%C!=F,RN-A7YU`8*2M5BMUP`C!/D` M:OE+NFY[:LK;=VTC,^P=AQ60&1$%ZMEAM)5C\ER,P"\3DI,:60F8@:UO\2S) M"HW3+B)N(4+_`,H^J;U*R$U8Q.CUS(2EMQF5D2["1'D1W0?8D,/%)<9>9>; M(FW6G6S%QIQLE!QLA,54215V;J\SK=J!XRW0#M7B^\VZ&(;99QMYD67YQMUC MN9759A67S<(M\HUB??8C,NR9+S4>.P MV;S[[YBTRRRT"N.NNN&H@VTTV)&XX:B#8"1FJ"*JD*7CY[G;G[.=!;^XFT.Y MF?[5YK4;L81$C9'MYE-EBEH]`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`9W6 M$\?HGP3C]Y->)DN24.'8_=Y7E-O78_C>.54^\OKRVE-0:RHIZN,Y,L;*PF/D M#,:'#BM./R'G"00;!57UX18'/'DW8WBV?QKHYO=H=W-R-K'7ECVF4(?NR\..\;7;QS-/#DWXF#FF< M8W"P&CK\MD4&+VK$*JS[YNOZ:%$QK/4?@3+*YQ47)*63]5%GUR3+*)!D6+\N M/&*,YXQVFS:C1GVLBJO4W3+VL6LE)8Y]#\/(T\>UC0_:#2:5P#2('Q'$_*0? M?F3);C%0=Y55Q['V]+Q-?),%KUI3>_*QEG)+6L_LE"H*Q"TCC[F8ZMWI[V3VVZ8DSKIFW#JA?W3WU4KHTP28LB]&?WS8!_, ME/\`,\>!3/,P+IAV3D)6SS4,XZ,,NZ:OX0?3#,K^F;I%ZB)'4MU5W_SOLE53 MSV5R3=I++8>`MY62H#4&MV_^9&UB5M"WV/8]&^=G2KY;8O*\Z"`RWI75[NGN MU1>-5T#[08YNUN=C.U>=;;20XXRZM;8L/!5U MS$R[LF0/5-ZU*K"X_U85XF09\GT4]WU.-0_^(GU=;VXYO7T MW]!W2I8P,1WYZH9,NPN-W;:KC7T;9W:RK?D1[S*:B@D*<:URIUB#;RJT;%DX M$&-5NNFR](EQ29P7'A$QYMSC>>5_7AUYENI07F+W9YCEF]AY74VC=%<5]I84 M\S#0K*.K"GNV8DBN.$Q)`(,::8M^TBR+9H"M9K5\?CLAGRJ-JRM!+&G6L6DO37(C8]D(:W\>$RIC5YFR6;%_(X_!8@\N>'L5ZF M4>RZC'UD67H5:FK78T&E:M(JN2ZP$+4E?S+7+_EDP"8C7'*?G3]]%3^=$]?S M?'34>K3IPR[JPN>]*77KN_E^7SMWL;Q_=# MINWMW^@[N+F^%VK[<&7>2+ONK\H6;%Q;R28)=6+$`4+,4/2J9";+4!)D MJL MZP#KUK#$["U8K?D9`,G259*7M6HHIXYW0K4H)@R8%8KM9$%%9;R@1*3OQXL> MJ;_PQ>H%RTA,3':!W`LBIU?#S!AW,'-Z5B)-`/@3C+4R2"(OHHND*^BZI[>9 M+_SAG_P435R'QQ2[_#`ZF"XX[JC"UXYYX[L\QHN.>$YXYXYXY5/75.+M_./^ MS_\`LU8[T-,QHUG]Q?6SY.(CL41'_3<%/U$3$1S/\_7W_P#E>O=ZQG>$SU'F M=;Q?,S'W/_4,S$?+)M/*B/?*4626&\+W9QW$)=ZIPO*3`]<71[M[UP]/&9;%Y\#<)ZS:&XP MC+195^=@N>5;3Q8[E$-L3;60S&?=VI>Q>BZBZI:4?#56*X/8MP3$1$<'$3TGM M$QR)20S,>33I>.IY/&;[C5N1<-'RJ..>>.K)&"B8*)B" M&1*(F*5OA/SM]<+\8/']C^IVRESMT-D>G[P&KC%A:L.Y7 MK^I^C3[I&N95><]CZ,]U%%4-PT*EA;M>G,)54G8J& M4H6;5,87U#X3ME977(2`I&5$S]\L&.*.*/7_`%SO*:]Y]EFH[U=S=2S=CYG6 M_P"@W\5D45;1=ADH#AN+Y149-=AB]+"NG['(K&-1RYR4]**383<2QM2B,64B2U'KEE.J M:-S';MT]GE'0-N#28_&*TM[OI1O8-3$842FC\'78O]4&W?\`9.KTA>PL*C1L+K&$ MJ.;>+!;?G;16['1?Y;GT]:LQU0L?],H!K+7TEU@B*39\D04`*QZVS[M\S&S9 MBW730C/ZA@$Q6KR39J)5:V&K,$]G'Y+3*PQGR?#7&!A:_BF1)APZ>!+U-]/E M-X=^P^V5]O9MA2;C5>:;@8B]@=WFE%3YD5_E>Z>37&+T\/&+.7$N["9=5EU7 M/P`@09(R''7F6C)V+*!GQ?'^D1F9Q_0XSIPW ML#6Q7NO7[J7/9_BQ%[:W+;(3--NP&]>>[>5/SYG6&[69]E&(57D^U),R*DQJSLJ@"A(#A3P"9':?*O:`W MK`6EA,B3L@$6NAX8.3^'SOCT].=3O73N7L[NMU1P\VR:RW.O^JC/*&ZGX5)B MSD#'XF"X1G5JE!C^,NTZ1/FD,5QUM)\Q7JXSD3(OLC-H6I_ZJK?]!@_U9C7S M?+O\:NW^O=[^U,K36]38=.RX?<\*-FWA[=5='-3FL8V%7W4Z07%NPIS(\C2M MDX7'(-&/F2HG*L""Q!T>V\V[6LMIN9*M3S%2ZVWA/Z+DU2V@FW=91:K,@,'U M*Y5%9H$344REK(4VN1&1V!O`YQZJW8V)\4C#,(G53-;N/O-FM%BTN&V4*IC5 M>;;>7U9C-A'@+&9EUM4C,R,<=A^OCO,QV2:]D`F?+3L^!]U@[?=,.%9UX=W5 MA=5.P6^&T>Y&86%!&W(FQ,/H\GI[9^*5K`KKJZ.%7NV<&]C3[*N*5*8#(\>N MZJ51K+]FEM@K?@;??<\0;]<[7[>S#4>_RF'[YNV_Z)4W[5G:=T*J[K[$VK0+ MZG(H;2W7)W,/D\5@:PU[$0:(7?4VMO MM4WZ@U3;^JHSF)LT6)(:>8QN3S+H<@I%TMHL39JHLU7`5CXY$E,6Y9SY9FW7 MSS9[JRVKZB.FW9W>';S.-PLDV/SFEF0\,RFKRMK&"S*@LLYV_R3IAZY]BMAL(ZQ=FLMRBIR MT-_Z>JQJ_P`UHCMU6LE1KG)I\:'86%"9)1/U+Y3?14U=Q:B%HFU1UH`XF+*W3=L[X4^%[]18 MO2GB/3''W\Q3%;ZW\W9>Z6XN)[$_*&<,RO=JXBX%ANZ72-783A^79.ZW28O99"KE]V MP3OK'V>M$BGU8U)NI)[8MG.JHDHV%L(PNH)\F$_['[_?Z-AG[W,Y"T3;R0R-)-L;B@;\\?'6L" M)+HFPA(9,9L"1]Q5K^=_,]1X_?*>,QF)9B,G4VU.'H5H52<>-R!UYIM-ZO(51 M"E6$UO:F?9+&AM*](2%2WM/.Z2IPBZI<;*?@-8 M%_KIX9^R"U]!?<#[T6:_JYR+^S4S6#>*:-%+UMCJ?RWO\*['GW2ZR8+G(.1E M<%D)GHIHK82;T(]&&U\7>K:Z9N8.T^/X@6WS M&=8R[G2Y/20["3;T_P!$FK([Y9E=$CNS)0)`[&80^V$0QE%Q6E=:DZ+&\?+P MUQ?>8!9&S&0Q61=,`4Y$FRW?\D0[EY)U4`O+;1.2[E[555XU$-X$OXTS)/T7 MW6_8S>I4^NS\=MT(_P`'8-^V<[TH7\#7UWV7M"4O?:C+Z-MF<,G?&!)9G\5? M:2!Z!P8U?GZPR8$G=.TBKMP.GC=AL[/ZVUNQ80BJ>,WC5<*`H[D+5X'-8P(> M4,*9`[4U^9")F$P?6"9(]I\GQ6IF7=&/B.]'/B0'B^1Y#LI1T+NUV[5M4,/V M3>*Q))75-:,NMB8QJIZWQ+*9-A0N3'&(EO;4LZL)UJ6]'5R;6OZ].BZSP.'N M5"ZI-BWL0GUT6QB3RW(QAFP?;FMM.1(8XV]8!DPWDE7V66L=*G2^.8ZW!"N* M88,EDZZ_P0.H/]6]U_,UKYP?39^&=MM^N["O[=4.OFFZ?1]L:?%G)6+&*O>O M<:[%A9IPMXYC%"5O*U*[TN$8JV*;'V*X6EL<+$FN#K=E1)>MPVV_ZKVWX,[*,:G7&#S,YB%>P*YK#<@S2'(K;G%\5A1)4 M!_)V8[;*,MIW[JY>8DONUKIKE-^T[=NMK*CC..+(<9>]\HP_`LH M_P!.IG["FZK,;&_BWMTO]:':;^J91IQ>NL4BWJ6F[0FQ>QR\!FSQ-S#T+,)I M9VY;R+B5E\@7QR4V4JM*K&LP?#:]12TLJC,Q#:]C9NQC]NVW7'5:&2/-8->; MIY6_6^:Y@ZU.E6!F)Q\?)'2NYM9MH&B:I78MM-JK/4?+>7CCV,1OPM^HIXY4 M=H+&JP-B&XZ\VV+[\K-<;?[\1_]D_ ` end EXCEL 11 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0````(`.]E_D9V;+^IJ@$``/`4```3````6T-O;G1E;G1?5'EP97-= M+GAM;,V8RV[",!!%?P5E6Q%CT]*'@$WIMD5J?\!-)L0B?L@V`?Z^=H"JC6@% M+9%FDP=W//M`=?;R$JY25)Z;QX(<5D)DKM4&U!!*;25W(=;NR"& M9TN^`,(&@Q')M/*@?-_''LET_%*#M2*'WN-.B+TG"3>F$AGW0BM2J[S5M:^+ M0F20ZVPEPY+4!VNX"GK2FW/KG[D,+W M%;AC_COEX#R#@J\J?Y;Q_MVE%JJFQI7"[*V>-J&+"[]-DJ"ZDQS:"W]+)F0< MFE&+;ROB_1^?I?42:UG-+%^+ED'=V9CB.952@PZP!,%" M5(H%J10+4RD6J%(L5*58L$JQ<)5B`2O%0E:&A:P,"UD9%K(R+&1E6,C*L)"5 M82$KPT)6AH6L#`M9AUC(.OPD*VG^Z)Q^`%!+`P04````"`#O9?Y&2'4%[L4` M```K`@``"P```%]R96QS+RYR96QSK9++;L)`#$5_)9I]<4HE%A%AQ88=0OR` M.^,\E,QXY#$B_?N.V(#"0ZW$TJ][CZZ\#JFL#C2B]AQ2U\=43'X,JQW8OG*\M"_V/ MZ'D4X$G1H>)%]2-F`Q+M*;V"^GH`A3&^.R6:E((C-Z."N[_8_`)02P,$%``` M``@`[V7^1F2&T#=T`0``RA,``!H```!X;"]?0#@3VR1^(*FTN7U=+XK[T-!% MX-O8V(+1'PP_A'=MR+=/ MVF'UW/G&Q>'1EZ9WQ<658CC/E\9/YV2'W<_9L^-IG_GCB;+9B_.EQ'WVUOE+ MJ$1B,..-'H8-AN5;+__9OCN?ZT(>N^*UD3;^46&^-LA,.HC300P)LND@"PF: MIX/FD*!%.F@!"5JF@Y:0H%4Z:`4)6J>#UI"@33IH`PFB7)$QQR1I6&.T)H5K MPGA-"MB$$9L4L@EC-BEH$T9M4M@FC-NDP$T8N4FAFS!VDX(W8?1F16_&Z,V* MW@PZ:VN';8S>K.C-&+U9T9LQ>K.B-V/T9D5OQNC-BMZ,T9L5O1FC-RMZ,T9O MJ^AM,7I;16^+T=M.]`Z5\W)ZCKYNRW#OFF_#U:()WB'>KG+_E'&JVC#1.@X[ MB1FO=_]$X]3/$//KM]WA`U!+`P04````"`#O9?Y&RKQ[770"``"Y"```$``` M`&1O8U!R;W!S+V%P<"YX;6R]5MMRFS`0_14-3^U#@R^97CP.,QC4F"D!:F%G M^JB`;&N"!2,I'CM?7P$QQ0Z66S^4%U:KLV=WSXK+F(G>*.)Y0;BD1(#=)F-B MI)QWQEK*8F2:(EF3#18W"L+4[C+G&RS5DJ_,?+FD"7'SY&5#F#0'O=YGD^PD M82E)/Q4-J6&-RRQV460TP9+FS'J@"<]%OI0`[A*2CZM7 M8]JN"H,2G!%'Y;*6.!.D1OUQ5A@GWQ28[HS*V.=-68KDK:Q[SRL[*X3DUF/.G\6:$"G&9N.LS#:V;=-;:]BO$,HZ1II-9]:;;$=]EYZ8 MRHR(6$@0L#!%V@ M+!3ZGFO':C&Q?3MP(/B7&!2KVP,,KHBY[8R9V,A#(/P.HAE$,%!0+^QFMQTG MG`()9QY$9WA^SCWDE7FZ`?=AZ#YZO@_LP`6>*BFX M]U0R8",$X^X0%T[BS@TTM6<01/.9,[71F8)0'#H_0!A5%55)PW@*9P"J.N-? MW>-!\%Y-X4PU'4J!#S%^4L?XXR7)],"V=GJD7L3NIDH5]:Q:J?K?M%)=ZJQ# M,Y=(3+._$4V+/%9-"]7*-NA^A&K9M+0GQ_`26J?RX,L5,5^OB#DS35W,L'?A M!'2U_>X30 M>%M8\Z'$4]=_3Y9U+0,NO7&K:[^/7\=)R2WEQL&3,Q8<2O!7!U5K3[E=)%M$ M2PGQ?`N*^4FHT"&Y-DXQ#*';$,OXCFV`%%DV(PJ0"8:,'(&I[8E)50I.N0.& MQG5XP7N\W;LZP@0G4(,"C9[DDYPDU8O>:=/HD@SZJ@R.:^9Q:81<2Q"W[5#V M.Q4Z(SCE3W(0??OX]T\/,4.2KO+@95_5-,VDF<:Z,'!.WI:/S_%L4JD],LTA MJ+RDV%I8).?.K].[^]5#4A59?I-F\W2:K?*"7L]I,7L_3G;A;S"LNB'^K>.S MP;A=E%C#R-U&C8C+C9\1),!S)RU*HT?A(N:;.,+\_N,3.(X'=<)XV7;0-L8) M7\7[-43'EQ-6MC&N/:5^1!>OJOH"4$L#!!0````(`.]E_D:97)PC$`8``)PG M```3````>&PO=&AE;64O=&AE;64Q+GAM;.U:6W/:.!1^[Z_0>&?V;0O&-H&V MM!-S:7;;M)F$[4X?A1%8C6QY9)&$?[]'-A#+E@WMDDVZFSP$+.G[SD5'Y^@X M>?/N+F+HAHB4\GA@V2_;UKNW+][@5S(D$4$P&:>O\,`*I4Q>M5II`,,X?+&A`T%116F]?(+3E M'S/X%/F7/Z3H=,H%N,!M8('_.;Z?D3EJ( MX53"Q,!J9S]6:\?1TDB`@LE]E`6Z2?:CTQ4(,@T[.IU8SG9\]L3MGXS*VG0T M;1K@X_%X.+;+THMP'`3@4;N>PIWT;+^D00FTHVG09-CVVJZ1IJJ-4T_3]WW? MZYMHG`J-6T_3:W?=TXZ)QJW0>`V^\4^'PZZ)QJO0=.MI)B?]KFNDZ19H0D;C MZWH2%;7E0-,@`%AP=M;,T@.67BGZ=90:V1V[W4%<\%CN.8D1_L;%!-9ITAF6 M-$9RG9`%#@`WQ-%,4'RO0;:*X,*2TER0UL\IM5`:")K(@?5'@B'%W*_]]9>[ MR:0S>IU].LYKE']IJP&G[;N;SY/\<^CDGZ>3UTU"SG"\+`GQ^R-;88C'(CN]WV6'WV3T=N(]>I MP+,BUY1&)$6?R"VZY!$XM4D-,A,_")V&F&I0'`*D"3&6H8;XM,:L$>`3?;>^ M",C?C8CWJV^:/5>A6$G:A/@01AKBG'/F<]%L^P>E1M'V5;SCFED)O816:I^JAS0^J!XR"@7QN1X^Y7IX"C>6QKQ0KH)[ M`?_1VC?"J_B"P#E_+GW/I>^Y]#VATK\>WZV22$KYI9+2,6D$N!LT$DN/R+RO`JQ`GH M9%LE"0AMNZ5/U2I77Y:^Y*+@\6^3IKZ%T/BS/^3Q?Y[3-"S-# MMW)+ZK:4OK4F.$KTL@'37[]EUVY".E,%.70[@:0KX# M;;J=W#HXGIB1N0K34I!OP_GIQ7@:XCG9!+E]F%=MY]C1T?OGP5&PH^\\EAW' MB/*B(>ZAAIC/PT.'>7M?F&>5QE`T%&ULK"0L1K=@N-?Q+!3@9&`MH`>#KU$" M\E)58#%;Q@,KD*)\3(Q%Z'#GEUQ?X]&2X]NF9;5NKREW&6TB4CG":9@39ZO* MWF6QP54=SU5;\K"^:CVT%4[/_EFMR)\,$4X6"Q)(8Y07IDJB\QE3ON>;G*YZ(G;ZEW?!8/+]<,E'#^4[YU_T74.N?O;=X_INDSM(3)QYQ1$!=$4" M(Y4U#VT%SU&\Z.9X!ZSAW.;>KC"1:S_6-8> M^3+?.7#;.MX#7N83+$.D?L%]BHJ`$:MBOKJO3_DEG#NT>_&!()O\UMND]MW@ M#'S4JUJE9"L1/TL'?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6: M&C/5BZPYC0IO0=5`Y3_;U`UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+ MOP%02P,$%`````@`[V7^1J'-[4X]`@``@@D```T```!X;"]S='EL97,N>&UL MS59M:]LP$/XK0AFCA1';*?7H:AM&(3#8RJ#YT&]%MF5'H!=/EC.[OWYZ\4L< M".FRKC1?='IT]]QS9^7LJ%8=Q0];C!5H&>5U#+=*55\\K\ZVF*%Z*2K,]4DA M)$-*;V7IU97$**]-$*/>RO=#CR'"81+QAJV9JD$F&JYBN!HAX.+O1(YC^'3Q M\5>E&"")ZF>P0U3[!\8]$U1(H'2OM`:+<,2P\[A#E*22&+!`C-#.P2L# MV/;V?HQP(6UNE^$PS]*?,LDRC:'?_UZ>+IW8[6+*(Y3.R]-`$E5(*2SY6F]` M;V^Z2A?'!<=.I/4[X5U*U`6KZ[T`N^B\J9`YEF/F``Y0$E%<*!T@2;DUJQ*5 MD2Z4$DP;.4&EX(@:RB&B-S1MABE],)?YL9AQMP5P/N89^Q`8%8.I&]&;TS6P M3?7VV1SW/JU_%B]HBS&!CD951;NOE)2<82?606O1[T[1!T?HDP@-K&`K)'G6 M_N8B9!K`$H(=EHID^\AOB:H-;E5_@[VV.*;PW)+_IZ;7[]JD1E_!MV[/VR=AKOFS-MIKMM3A5+]033+HLER7*"& MJI]D)Y0]C.%D?S?R@W#TVHP4,9SL'S@G#;NQ"J:OKN0/4$L#!!0````(`.]E M_D;*'T/@0`,``(H*```/````>&PO=V]R:V)O;VLN>&ULE99=4^(P%$#_2J9/ MNR\+#1\J(\X4&K6SV+JDZNQCI$$RI@W3!'7]]9L4T5O),/I$T^:>W.2>EGNJ M1\^J?KQ7ZA&]E++2HWH MJ\6FY)7IX&YWV*FY9$:H2J_$6@=O-/T5FE[7G!5ZQ;DIY196,E$%9Z=ZM!22 MW_):6S!BZW7*2CX.7F2`)-.&%,+P8AST[5`]\]:->K.>;(1T@T%W$'0<;+?5 MZQHM5,&WL'PE]-W;@P`5?,DVTN0VV=VZXR#$?8R'6X:;=BOXLX9`=P.QA1%/ M/&?WXZ`;(+8QZEQ(P^N8&7Y1J\U:5`^6%:"EJ+6A;KO-S%)4HA2O+F\[TBOU M?*EJ\:HJPR1=U$K*)LH]:(+L"OK]CLW1B$5KHF'W)<3#L6N"3T.)>2&'^ MC8/F6G*WD\ZGK33'_W&%JN9P=B5&K"H0J8REH*3:%L\>CFM7S.8)H2#H"`0=^5;\30FRX4I[L_GUY&C1CI(+:U=KGR$4+/08YJDL M^F'?7LGU3\B!?H4>P4"1O?%0L-!KV$>]O0`H6>BQ['#I6^<(U0L][KGJ>W.` M]H4>_0[6,CR!*"A@Z#%P5TM?'ACJB#TZ>HL:<\.$;(.@G-@C9ZNJ/D#K0^A1 MLEU6'P$*BCV"'JPKAI]`#!W%'D>W=?4E`>W$'CL_O=]^"#04>PP]:`<^@BAH M*/88>AAU#%'06?Q=9S%T%D-GL<_90ZA>%_[M08-[O@_JN_Z>D^Y!;7OA6Z?P MT1S8_DA4O'"MDV[(MO=8N'[*_FP_I/V!>P'=^,KV6./`-4*VY]E(.;7WLFJF M6-,N;,F[#NKL/U!+`P04````"`#O9?Y&VS6YO%`"``#S!P``&````'AL+W=O M;#*9 MB]UKVM)J1L4%6F?__?*A%HD9O5'!]SW/`0Z0MI1]\IP0X7U59,,(OFA3508(@"2H<%'[6:K[WEF6TKLHBYJ\ M,X_?JPJS?P=2TG;G0[_O^"ANN5`=098&@^]25*3F!:T]1JX[?P^W1Q@IB5;\ M+DC+K6]/)7^B]%,U?EYV/E`YD)*M!CJ0L521)_ML%?3*5T?[NH[_J MX1RVR![UW(%=]+\4';-]*-(58!S[3D^NF=[US0JK?X7H6_ MS+NH];LU?R+8V:8-J#.@P1"&WQK"SA`.!C-U@6/9JW1[T],O;(LL?C_(SB8"N2>4#L`&++OAH#8@,PBMK,,(@! M`*MY3.)@$@NSGAR'K=C,`U8.8&77`9@DC"0+:F7M(-:V'TTB1I(%U;)Q$!O; M'TTB1I)X'@&!PU"GQS-",@D9:Q:L-X0N9;0QIY=\K%FPZ!"YE-'^!5/U>^PT MIH`W<8BB9`DJ=%'V3D9PVAL:.666=)R1QJVSP#IC*\)N M^N[AWIG>:V&.V*%WN-_V2)_13WF6-OA&?F%V*VKNG:B0)[T^EJ^4"B*3`"]R MT+F\@8=&2:Y"?:[4;)@[R30$;?HK=KCGL_]02P,$%`````@`[V7^1C`%!VG: M`P``AA$``!@```!X;"]W;W)KKKVM=VLF]>^*H_V:QMUKW5=M/]O;=6<'U>PNESX M5KX<^O%"O%G'U[A=6=MC5S;'J+7[Q]4'>,@Q&R63XM_2GCMR'HWFGYKF^]CX M9_>X2D8/MK+/_9BB&`YO-K=5-68:>OZQ)/W=YQA(SR_9/TW#'>P_%9W-F^J_ M[C$&-"9^;JIO^1\^O7=_4EY!55!<_YV-YG([G M^9=4+&%\`"X!>`T`^=<`L00(+R">G4WC^ECTQ6;=-N>H.Q5CM>%AD+=CDB%S MU$W9VGFZAI%UP]6W#D\>G] M>'&)EW.\H/':M:CG0B%`7>=R(])Y(Z,6XG:G8B22<@P:2< M*G=4"L#<]Z(\+XIZR5@OBO2B,@&LX]Q1Z0SD?2^IYR4E7D3">DE)+ZBU9*U0 MD1!I@!/M.='4";!.-)U[E(IUXHHP8*T8SXFA3I!U8D@G!B7R5AR5,"JY[R7S MO&34BV"]9*07;81BJY@[J@QE0(4@\7)E(0^H$ MX/NA?!-L#;:+9NDH@82_E5P99&D`+0%]/Y27@N7'=M$LZS/-V/65NRI,1(`; M'[Y`Z2LT[X:256229YZCDB8+63L^@($26/`$!ND4(0,D($F^@W),9'3+'/D*!,E3R#`7*1V74C?5'5:D1 M(7>#CU&@')4\1\$X=V>B>7BY,M!)2+5\E`)EJ>19"A238C!TPP^524%EM_=6 M/DV1TE3R-$6*2=!L27-')%7`/@U]DB(E*?]@W2)%I$+D%UCNR%(%(23%/S:> ME*0R9$0^_9#23_+T0\JUC&>?J]$!3GSR(26?Y,F'E&A&&AX2C@J&OX"')OJ[ M3Z38D_SV$^G.$E2"_/+,79TP0H9,D(]1I!CEMR];I'Q\!X+UG3LJ'0`)]!&* M%*&*1RA2.+Z[L??S1"&5\@&*%*`\J+=HG$J9-+U1*4#MF2 M]\,X#[;871N5W??CJ1XG8/Y,,#?ZYG3YZG']]++Y!5!+`P04````"`#O9?Y& M3^,F#&D$```B%```&````'AL+W=O--F-; M^<[EYT4_A]M+U_\8#L:,T:^V.0U/F\,XGA_C>'@YF+8>'KJS.=F_O'9]6X_V M9_\6#^?>U/LYJ&UB8$S&;7T\;7;;^=G7?K?MWL?F>#)?^VAX;]NZ_SN&>9_HY?W8>S::\@F:NM? MR^?Q-']>EK]HYL+H`'`!<`NXU:$#$A>0?`2(_PT0+D"LK9"Z@#2H$"_:YY$K MZ['>;?ON$@WG>EI/_-'B_93$9HZ&.5N_3(@=N\$^_;E+Q3;^.>5Q",Q([B$I MA908X3E(-%!4X5&IA)2B2DQQ"3IA%%8%&$O$Y\K20%F*E65^ MF24B3U$94%FXD!:J\"@M5$)1):9T`AE)51[%I62?ZY*!+HET24;JDKAC*4"1 MNCQ*\11(79BR0Y20N2I,:9:H%?.E@I6LL*X5&U8'XZ)Q/*DEUWA990Q5P>/B M4XK.56(JU8()49GB,@UWKA,72W)6:`:S)1E7G# M(U:L8,X"29-9?F@B>\D=L]21DEYW14!I2>KR**M+T)/E8<`TRU9HXZ$V[#N2 M?*/DCG&%TCO2,)2$!G-5AB%-;_3*@SB#%9N30R@+&Y4DF\D=XR8CT>3+J0BH MT`&NPL";,L[O2`-_L^H5&XPGH39LHI(LE#OF6HCNNO`H2!+:*CQ*`I"Y*H]2 M":Q9C*&[5A=0: M93R8=<"&JE:L&PB]"[!W*=J[`!M)EDK.&+E%"Q]4F4[HHW[I@Y(##[>CV_0^ MJ$&F?,7[$$(7`^QBBG8Q\/PIR^@#L$?9HRWMT!XELCLNYE$93U<<%R%T,<`N MIF@7`^'/GWUAT>=@']3,OK'NS)_PYT\Q>KBJ(*,]JLEP_F)T`=*:_FV^>AJB ME^[]-"[_I[\]O5UO?8'I`B5XGO/'@A//2_Y8+9=7'^EWVW/]9OZJ^[?C:8B> MNW'LVOF.Y;7K1F,[9P]6P<'4^]N/QKR.TU^WLC=K@5W_P%0 M2P,$%`````@`[V7^1NN*LH$]!```"A0``!@```!X;"]W;W)KMN^!75=;MR^K4=9?G,&QW)UT5 M[1=ST77_GX-IJJ+K'YMCV%X:7>S'H*H,(8J2L"K.]6JS'M]]:S9K\]Z5YUI_ M:X+VO:J*YI^M+LWU9256MQ??S\=3-[P(-^MPB=N?*UVW9U,'C3Z\K%[%V_%:W.3?GW>=^=>K?1*MCK0_%>=M_-]7<]YS`ZW)FR'?\& MN_>V,]4M9!54Q:_I\UR/G]?I/UDTA_$!,`?`$K#TPP?@'("?`7+,='(VYO6U MZ(K-NC'7H+T4PVR+YU[>#(WT+0?MV%HS#5>?6=N__=BD:AU^#.W,$A@E6RH1 MBR+L&V=[@)4=#B0W>#G%2Q*?9+;%=$IB MDM33&(A,I9PJMU0@?7*)G5QBFHO':"=.+@F-=X8[GG))B$N51JPHIZ(,X_2Q MD]1QDE(GR#I)J1/%^J`2@=EC&YEC(Z,V)&LCHS98%U0!CSTHQX.B'F+6@R(] M/,6L)K,R4E!(\G.P%12` M3VDB>#>62BB?A>-R4E!02K:?K4@M-^F=94Q5*9G.^V9<6@J*2\GC4E`:"AZ8 MXG\24[C(%!8S[Y"*`A'Z8YD]97)+)A(!'@,#"SEG6@$E9^9Q#H%P,@*+=SP@ M9LUM/4'";I7I@(MKK)'5FJ/)8YND4A6FCCYP!IO7>G/+4U'D1"%Y%( M$:GX@@YM]LDXYH]F2Q=+Z?.[TB4D6H3DD8T6^D3*`])2H<>J09>.2.DH^$VY M1:?`Y.N^W):A\*GIT"TP45J&>%ZC56'"G4UEJ3)`CP,:7=1B;-EQ.II_QB.E MJ%2\*K=46`J$!``"Q`P``&````'AL M+W=O&,"*[2&V6=*_CR]`=JND?<$SPSEGSOA23FA>;`_@R)N2VNYI[]RP M8\S6/2ANKW``[?^T:!1W/C4=LX,!WD22DBS/LF],<:%I5<;:DZE*')T4&IX, ML:-2W/PY@,1I3S=T*3R+KG>AP*J2K;Q&*-!6H"8&VCV]W>P.14!$P"\!DSV+ M2?!^1'P)R4.SIUFP`!)J%Q2X7TYP!U(&(=_X==;\:!F(Y_&B?A^G]>Z/W,(= MRM^B<;TWFU'20,M'Z9YQ^@GS"-=!L$9IXY?4HW6H%@HEBK^E5>BX3NE/GL^T MSPGY3,A7PDT6C:=&T>8/[GA5&IR('7@XN\W.PTT0\JDVV M+=DI",V81#E<8%8$\^J?MLCI)3T_H^?_IV\7^C8YW'[A\$N!8A$HDD#QKQ$3 MYG")*?YJPL[V5('IXM6QI,91N[2E:W6]G;?Q$-D'O"H'WL$C-YW0EAS1^9.- MQ]`B.O`FLJMK2GK_?M9$0NM"^-W')EVIE#@ROM+J'5!+`P04````"`#O M9?Y&QNH*^J$!``"Q`P``&````'AL+W=OX+M-.S?XTL26@2[+_', MY)PS9WPI1C0OM@-PY$U);?>T%AB=#[*`4-W\/(''`T9[%)'@_(KZ$Y&>]IUFP`!(J%Q2X7TYP!U(& M(=_X==+\:!F(Y_&L_A"G]>Z/W,(=RC^B=ITWFU%20\,'Z9YQ?(1IA&T0K%#: M^"758!VJF4*)XF]I%3JN8_J39Q/M:T(^$?*%7]/R,GO^? MOI[IZ^1P_8W#;P4VL\`F"6S^-6+"'"XQUY^:L+,]56#:>'4LJ7#0+FWI4EUN MYVT>S^0#7A8];^$7-ZW0EAS1^9.-Q]`@.O`FLJLM)9U_/TLBH7$A_.%CDZY4 M2ASV\P-97FGY#E!+`P04````"`#O9?Y&#'3,$:$!``"Q`P``&````'AL+W=O MT*XHRLZ%YY%V[E08&7!%EXM%&@K4!,#S8[>K;;[34!$P!\!HSV)2?!^ M0'P)R:]Z1[-@`214+BAPOQSA'J0,0K[QZZ3YWC(03^-9_3%.Z]T?N(5[E']% M[3IO-J.DAH8/TCWC^!.F$:Z#8(72QB^I!NM0S11*%']+J]!Q':<_^43[G)!/ MA'PAW&;1>&H4;3YPQ\O"X$ALS\/9K;8>;H*(5R8VJIDTO3=J??58KK*;@AV# MT(1)E/T99D$PK_YIBYR>T_,3>OX]?3W3U\GA^H+#BP*;66"3!#9?C9@P^W/, M[81??SY)(:%P(;WQLTI5*B<-^?B#+*RW_`U!+`P04````"`#O9?Y& M#Q1S?:$!``"Q`P``&````'AL+W=O+F"@?HW9\&M>+6I;IE9M#`ZT!2DF5) MIOMC[A$!\$O`9#8Q\=Y/B*\^>:H/-/$60$)EO0)WRQGN0$HOY!J_ MS9H?+3UQ&R_J#V%:Y_[$#=RA_"UJVSFS"24U-'R4]@6G1YA'N/:"%4H3OJ0: MC46U4"A1_#VNH@_K-/_)9]KGA&PF9"OA>Q*,QT;!YCVWO"PT3L0,W)]=NG=P M[46<,C%!3[;?SMLL MG,D'O"P&WL)/KEO1&W)"ZTXV'$.#:,&92*ZN*>G<^UD3"8WUX3<7ZWBE8F)Q M6![(^DK+OU!+`P04````"`#O9?Y&DW*%&Z$!``"Q`P``&````'AL+W=OX!RF#D&_\LFB^M0S$RWA5?XC3>OY2_1NL&; MS2AIH>.3=$\X?X-EA-L@V*"T\4N:R3I4*X42Q5_3*G197[GA=&9R)'7DXNWSOX2:(>&5BHYI)TWNCUE?/=9X7%3L'H063 M*,S^-6+"'*\QY5]- MV,6>*C!]O#J6-#AIE[9TJVZW\ZZ(9_(&KZN1]_"#FUYH2T[H_,G&8^@0'7@3 MV8;090W-[@"-K_Z=`H[GQJ>F9'`[R-)"59D66W M3'&A:5W%VK.I*YR<%!J>#;&34MS\/H#$>4]SNA1>1#^X4&!UQ59>*Q1H*U`3 M`]V>WN6[0QD0$?!#P&PO8A*\'Q%?0_+8[FD6+("$Q@4%[I<3W(.40<@W_G76 M?&\9B)?QHOX]3NO='[F%>Y0_1>L&;S:CI(6.3]*]X/P`YQ&V0;!!:>.7-)-U MJ!8*)8J_I57HN,[IS\+Z&%^<\<6*_YI%WZE/=/F-.UY7!F=B1QZ.+M]YN`DB M7IG8J&;2\-ZG]=53G>=EQ4Y!Z(Q)E,,59D4PK_YABX)>TXL+>O%_^F:A;Y+# MS2<./Q4H%X$R"93_&C%A#M>8[5]-V,6>*C!]O#F6-#AIE[9TK:Z7\ZZ(9_(. MKZN1]_#$32^T)4=T_F3C,72(#KR)[&9+R>"?SYI(Z%P(O_C8I!N5$H?C\C[6 M1UK_`5!+`P04````"`#O9?Y&7#,%.J$!``"Q`P``&0```'AL+W=OP)$W);4]T-ZY8<^8K7M0W-[@ M`-K_:=$H[GQJ.F8'`[R))"59D64[IKC0M"IC[``I@Y!O_#IKOK<,Q,MX47^,TWKW)V[A`>4OT;C>F\TH M::#EHW3/.'V#>83;(%BCM/%+ZM$Z5`N%$L7?TBIT7*?YSVZF?4PH9D*Q$KYD MT7AJ%&U^Y8Y7I<&)V(&'L\OW'FZ"B%ZK`=/'J6%+CJ%W:TK6ZWL[[(I[).[PJ!][!#VXZH2TYH?,G&X^A173@360W MMY3T_OVLB836A?#.QR9=J90X')8'LK[2Z@]02P,$%`````@`[V7^1JU="V"B M`0``L0,``!D```!X;"]W;W)K&ULA5/+;MLP$/P5 M@A\02K+3NH8L($X1M(<"00[MF996$A&2JY"4E?Y]^9`4NTC:B[B[FIF=Y:.< MT#S;'L"15R6U/=#>N6'/F*U[4-S>X`#:_VG1*.Y\:CIF!P.\B20E69%EGYCB M0M.JC+5'4Y4X.BDT/!IB1Z6X^7T$B=.!YG0I/(FN=Z'`JI*MO$8HT%:@)@;: M`[W+]\=M0$3`3P&3O8A)\'Y"?`[)]^9`LV`!)-0N*'"_G.$>I`Q"OO'+K/G6 M,A`OXT7](4[KW9^XA7N4OT3C>F\VHZ2!EH_2/>'T#>81;H-@C=+&+ZE'ZU`M M%$H4?TVKT'&=TI_-;J:]3RAF0K$2=EDTGAI%FU^YXU5I<")VX.'L\KV'FR#B ME8F-:B9-[XU:7SU7>;XKV3D(S9A$.5YA5@3SZN^V*.@UO;B@%_^G;Q;Z)CG< M?.#P0X'M(K!-`MM_C9@PQVO,E[^:L(L]56"Z>'4LJ7'4+FWI6EUOYUT1S^0- M7I4#[^`'-YW0EIS0^9.-Q]`B.O`FLIM;2GK_?M9$0NM"^-G')EVIE#@R MOM+J#U!+`P04````"`#O9?Y&PPQ66Z`!``"P`P``&0```'AL+W=O*VPOL M0?L_#1K%G4]-RVQO@->1I"3+L^P'4UQH6A:Q=F_*`@9/',WF#ET7/6_C+32NT)0=T_F3C,32(#KR)[.*2 MDLX_GR61T+@0_O2Q23P)=\[U1T)LU8%D]D;WH/R?1AO)G$]-2VQO@-61)`6A6?:#2,85 M+HM8>S)EH0,([/!>>>=NY4"!E019>S24HR[5"!IH3 MOML=SWE`1,!?#J-=Q2AXOVC]$I+?]0EGP0((J%Q08'ZYPCT($81\X]=)\Z-E M(*[C6?TQ3NO=7YB%>RW^\=IUWFR&40T-&X1[UN,OF$8X!,%*"QN_J!JLTW*F M8"396UJYBNN8_MQF$^UK`IT(]!.!I$;1Y@-SK"R,'I'M63B[W='#31#QRLA& M-9.F]T:MKU[+':4%N0:A"9,HYPUF01"O_F4+BK=TNJ+3[^G[F;Y/#O?K[MGA M>X%\%LB30+X9<;\=,6'.6TS^J0E9[:D$T\:K8U&E!^72EB[5Y7;>T7@F'_"R MZ%D+?YAIN;+HHIT_V7@,C=8.O(GLYH!1Y]_/D@AH7`A_^MBD*Y42I_OY@2RO MM'P'4$L#!!0````(`.]E_D9R5QO>I`$``+$#```9````>&PO=V]R:W-H965T M)HE&#%(FJ]7N8:4HA^3L@0:L M^,':9LC^??P``JM(N>#NIJJZVH]BU.;-=@`.O4NA[`EWSO5'0FS5@63V1O>@ M_)]&&\F<3TU+;&^`U9$D!:%9=DLDXPJ71:P]F;+0@Q-"\^\[5PHD+(@"Z_F$I3E6B$#S0D_[([G/"`BX(7#:%8/YEA9&#TBV[-P=KNCAYL@XI61C6HF3>^-6E^]ECMZ*,@U"$V81#EO M,`N">/4O6U"\I=,5G7Y/W\_T?7*X7W?/[KX7R&>!/`GDFQ%OMR,FS'F+^;\) M6>VI!-/&JV-1I0?ETI8NU>5V/M!X)I_PLNA9"W^8:;FRZ**=/]EX#(W6#KR) M[.:`4>??SY((:%P([WQLTI5*B=/]_$"65UI^`%!+`P04````"`#O9?Y&0$8! MC*(!``"Q`P``&0```'AL+W=O/FIA!*:[?3B!Q/-*4SH4GT;36%UB1LX57"06=$=@1 M#?61WJ:'T]XC`N!9P&A6,?'>SX@O/OE;'6GB+8"$TGH%[I8+W(&47L@U_C]I M?K3TQ'4\J_\.TSKW9V[@#N4_4=G6F4THJ:#F@[1/./Z!:81K+UBB-.%+RL%8 M5#.%$L5?XRJZL([QSTTRT;XF9!,A^T1@L5&P><\M+W*-(S$]]V>7'AQ<>Q&G M3$Q0TW%Z9]2XZJ5(LYN<7;S0A(F4TP:S()A3_[)%1K?T;$7/OJ?O9OHN.MRM MNZ?)]P+[66`?!?:;$7]M1XR8TP:S^]R$K?94@6["U3&DQ*&S<4N7ZG([;[-P M)A_P(N]Y`P]<-Z(SY(S6G6PXAAK1@C.17%U3TKKWLR02:NO#GR[6\4K%Q&(_ M/Y#EE1;O4$L#!!0````(`.]E_D9:>Y]RO0$``'L$```9````>&PO=V]R:W-H M965TU)+Q:FQH6J([A70RI,X(TD498333N`B][E75>1R,*P3\*J0'CBGZN\) MF!R/.,9SXJUK6N,2I,C)PJLZ#D)W4B`%]1$_Q8=3YA`>\+N#4:_VR-5^EO+= M!3^K(XY<"<"@-$Z!VN4"S\"8$[+&'Y/FEZ4CKO>S^HOOUE9_IAJ>)?O35::U MQ48855#3@9DW.?Z`J86]$RPET_Z+RD$;R6<*1IQ^AK43?AW#R;=HHMTF)!,A MN2*08.3+_$X-+7(E1Z1[ZOY=?+!PY42L,M)>387N;:':9B]%G,8YN3BA"1,H MIPUF01"K?M,BP5MZLJ(G]^GI3$]#A>G:/?X/@=TLL`L"NTV+R;;%@#EM,>E] MD_V5R7XCL+MILL7L[YMD5R;91B"[:;+%/%Z9D-5T<%"-OP0:E7(0)@S'DEWN MV5/BI^L+7N0];>`754TG-#I+8V?4#U0MI0%;1/1@6VWM2[`$#&KCMH]VK\+E M"(&1_7S5E_>F^`=02P,$%`````@`[V7^1I5J1@"E`0``L0,``!D```!X;"]W M;W)K&ULA5/;;IPP$/T5RQ\0`TN:=,4B95-5[4.E M*`_MLQ<&L&(SU#9+^O?U!0A$D?*"9X9SSISQI9A0OY@.P))7)7MSHIVUPY$Q M4W6@N+G!`7KWIT&MN'6I;ID9-/`ZD)1D69)\88J+GI9%J#WILL#12M'#DR9F M5(KK?V>0.)UH2I?"LV@[ZPNL+-C*JX6"W@CLB8;F1!_2XSGWB`#X+6`RFYAX M[Q?$%Y_\K$\T\19`0F6]`G?+%1Y!2B_D&O^=-=]:>N(V7M2_AVF=^PLW\(CR MCZAMY\PFE-30\%':9YQ^P#S"K1>L4)KP)=5H+*J%0HGBKW$5?5BG^<_=3/N8 MD,V$;"7<)\%X;!1L?N.6EX7&B9B!^[-+CPZNO8A3)B:HZ3B],VI<]5JFA_N" M7;W0C(F4\PZS(IA3_[!%1O?T;$///J0"L?>QBU=J^OM?,C"F;S!RV+@+?SBNA6](1>T M[F3#,32(%IR)Y.:6DLZ]GS61T%@?WKE8QRL5$XO#\D#65UK^!U!+`P04```` M"`#O9?Y&A`PU>:0!``"Q`P``&0```'AL+W=O<.>-+,:%^-1V`)>]2*'.BG;7#D3%3=2"YN<$!E/O3H);!U(4K`L2;XQR7M%RR+4GG59X&A%K^!9$S-*R?7?,PB<3C2E2^&E;SOK"ZPL MV,JK>PG*]*B(AN9$']+C.?>(`/C=PV0V,?'>+XBO/OE9GVCB+8"`RGH%[I8K M/((07L@U?ILU/UIZXC9>U)_"M,[]A1MX1/&GKVWGS":4U-#P4=@7G'[`/,*M M%ZQ0F/`EU6@LRH5"B>3O<>U56*?X)[^;:9\3LIF0K83[)!B/C8+-[]SRLM`X M$3-P?W;IT<&U%W'*Q`0U':=W1HVK7LLT3PMV]4(S)E+..\R*8$[]TQ89W=.S M#3W[FGY8Z(?H\+#MGMY_+9`O`GD4R'RI!M^'J&%+A MJ&SM.-AQ#@VC!F4AN;BGIW/M9$P&- M]>&=BW6\4C&Q."P/9'VEY3]02P,$%`````@`[V7^1M*@.XVN`0``%@0``!D` M``!X;"]W;W)K&ULA53+;J,P%/T5RQ]0$T+:*B)( M34>CF<5(51?MVH$+6/6#L4UH_[Y^`(4H4C:Q?3FOJVLG'Y3^,"V`19^"2W/` MK;7=GA!3MB"HN5,=2/>E5EI0ZXZZ(:;30*M`$IRD27)/!&42%WFHO>@B5[WE M3,*+1J87@NJO(W`U'/`&3X57UK36%TB1DYE7,0'2,"61AOJ`GS;[X\XC`N"- MP6`6>^2SGY3Z\(>_U0$G/@)P**U7H&XYPS-P[H6<\?]1\\?2$Y?[2?UWZ-:E M/U$#SXJ_L\JV+FR"404U[;E]5<,?&%L("4O%3?A%96^L$A,%(T$_X\ID6(?X MY3$9:=<)Z4A(+P@D&H68OZBE1:[5@$Q'_>PV>P?77L0I(Q/4=.S>!36N>BXV M69:3LQ<:,9%R7&%F!''J5RU2O*:G"WIZF[Z=Z-N8<+MT3Y/;`MDDD$6!;-7B M;MUBQ!S7F/O;)KL+D]U*X.&JR1KS>&%"%H,3H)MP/PTJ52]MG-MD&P$3O@G?Z$#?&]'N$]*D! MP?2#[*&S;VJI!#-VJ,Y(]PI8Y4V"(Y(D&R18V\5%[N=>5)'+B^%M!R\JTAVZ,FT!%CFZ^JA70Z59VD8+Z$#_A?4F=P@M^M##H63]R M[$<]Z?T+[Y:2W]D&DK) M?[:5:2QL$D<5U.S"S:LI,@"[!*02:*,'PBD\ M@"9+R&TH(VBZ44/HXYJJ7*@V*24?PV1W,-D"!B^7H0$FFRWS"2?;=$U5+E4D MS3Z&H7 M..?X^S%V,3'^+EI"I/?1TT$<_5;*\0"`.+>DQ^*)C610;QK&>RS5D%^`&#G! MM3'U%$1!D(`>=X-?%F;NE9<%NTK:#>25>^+:]YC_>2&434<_])>)M^[22CT! MR@+'_U`(Q!*SE(G M8-7<2$4HU4%JX=]SYK\EM='M+^E?3;6*_H0%J1C]U=6R5;"![]6DP5^"LGZQ>)[/?ZP;3>8=K)O8#K;]@W1;(CNAA!^:HAG0[PQ M`$MFZOJ")2X+SB9/C%AO=GA00Z:V#*L9+&0$,[2G MJE:J`*'\,0S5QF.WNT4J5YB'&ULE5?!;J,P$/T5Q`<4;(--(H+4)%KM'E:J>M@]T\1)4`&GV&FZ?[\V M=E)LN8E[">"\>?-FF!D-Y9D-K_Q`J8@^NK;GB_@@Q'&>)'QSH%W-']B1]O*? M'1NZ6LC'89_PXT#K[6C4M0E,4YQT==/'53F>/0U5R4ZB;7KZ-$3\U'7U\&]) M6W9>Q""^'#PW^X-0!TE5)E>[;=/1GC>LCP:Z6\2/8+Z&F8*,B#\-/?/)?:3$ MOS#VJAY^;1=QJC30EFZ$HJCEY9VN:-LJ)NGYS9!^^E2&T_L+^X\Q7"G_I>9T MQ=J_S58$&];R\3?:G+A@W<4DCKKZ0U^;?KR> M]3^$&#._`30&\&H`\YL&R!B@4(/,&&2?!CHU.I0Q$>M:U%4YL'/$C[4J#S"7 M\$&12.:(CVR#SJ],!9>G[Q7(<9F\*R*#@2-F:6&NB$2R>UW`V#:'E@OB<[&R M,84/L[8QL_M"T$4(TK&B*0%([Q-D%P+]^)A-"7!JJ\QUM!K3CQCH0ZRF"'Q? M1.Y$D5LB`MX'=J+`$P*4V1*)#@)/@\A0X46M+13"$-[70APMQ`HF@*!PLE%\ M-QLS1\',(D!VH!JSM#'9?2<@=;RH"32AR`,H@!,I`-\-%4!7!0P(U@$%5"A` MKA^KTS`)H,C<:*U>2P.Z'>2N"KM3"F^E&Y`N8@`Q]J%6-@I#$))][(:$O_T" MW78!=K_,O!/(@(S8B=3I$+)`D"`4H*9PU10W)LE%3#'Q0[!_(CH@$M(>;A\# MJTF)?S@;D':$9LBO9@K*BS0@-=#M=VCU._&^@Z4!?55[1HZ-"JL]"%P]UO`@ MWM>P-*#;V;%`@=EQYQ"T1@Q!WLXTH"\JQS2F`PJI'.A.*VA-*Y)YIZ(#"O'C M;@_0&FD$^_UD-_TDD^VNH\-^7)-YM&&G7NC-ZWIZ7<4?H=H.G?,EF*_TUOA) M4Y7'>D]_U\.^Z7GTPH38H%)=^B"+X"`_(JX/+=T)=4M4=>BU6C$ M=KQ$5P_5:K_4$L#!!0````(`.]E_D;398YH<@0``.,7```9````>&PO=V]R M:W-H965T#&8/"PSF ML'MV&S4)QHZSMM/,_OOU5U*14!KFTL3N$]^CI$[M;8+?E?EOGU< M;+ON\!"&[>O65D7[M3[8??^?M[JIBJY_;#9A>VALL1X'564(2L5A5>SVB]5R M?/>C62WK8U?N]O9'$[3'JBJ:_YYM69\>%WIQ?O%SM]EVPXMPM0POX]:[RN[; M7;T/&OOVN'C2#WD$`V1$_+VSI];Y'@SB7^KZU_#PY_IQH08-MK2OW1"BZ#_> M;6[+[5J$:SM6W$LNY_U MZ;N=<@BJ(K?T^=N/WZ>IO^D:A[F'P#S`+@,N/#X M!^`\`#\&F#'32=F8UQ]%5ZR637T*VD,QK+9^Z.'-$*2/'+1CM&::KCZSMG_[ MOM))L@S?AT`S!D;,,\%<$&$?W4L!"SH&Z?$)21+I[0#F M',!,`8P3``W5F$Q93)#]"(E-XK`XJ)RBE(YO:XF8EH@DDU&::!(3.31?C,+, M^&#Y)["KQ

DEBT (Details) - USD ($) $ in Thousands	9 Months Ended
DEBT (Details) - USD ($) $ in Thousands	Jun. 30, 2015	Nov. 04, 2014	Sep. 30, 2014
DEBT
Long-term debt-revolving credit facility	$ 32,000		$ 43,000
Statutory Reserve Rate
DEBT
Reference rate	one-month Eurodollar Rate
Margin over reference rate (as a percent)	1.00%
Restated Credit Agreement
DEBT
Available credit borrowings		$ 100,000
Deferred financing cost		420
Outstanding revolving credit borrowings	$ 32,000
Weighted-average interest rate (as a percent)	1.78%
Quarterly fee on the unused balance (as a percent)	0.25%
Restated Credit Agreement \| Federal Funds Rate
DEBT
Reference rate	the Federal Funds Rate
Margin over reference rate (as a percent)	0.50%
Restated Credit Agreement \| Eurodollar Rate
DEBT
Reference rate	Eurodollar Rate
Interval for payment of accrued interest under option one	1 month
Interval for payment of accrued interest under option two	2 months
Interval for payment of accrued interest under option three	3 months
Restated Credit Agreement \| Prime Lending Rate
DEBT
Reference rate	the Prime Lending Rate
Credit Agreement, accordion feature
DEBT
Available credit borrowings		$ 130,000

XML 14 R9.htm IDEA: XBRL DOCUMENT

GOODWILL AND INTANGIBLE ASSETS

9 Months Ended

Jun. 30, 2015

GOODWILL AND INTANGIBLE ASSETS

GOODWILL AND INTANGIBLE ASSETS

5. GOODWILL AND INTANGIBLE ASSETS

The change in the carrying amount of goodwill from September 30, 2014 to June 30, 2015 was as follows:

	Goodwill		Accumulated Impairment			Net
Balance as of October 1, 2014	$	64,016	$	(40,394	)	$	23,622
Goodwill attributable to fiscal 2015 acquisition		762		—			762

Balance as of June 30, 2015		64,778		(40,394	)		24,384

The carrying amounts of intangible assets at June 30, 2015 and September 30, 2014 were as follows:

	June 30, 2015							September 30, 2014
	Gross Carrying Amount(1)		Accumulated Amortization(1)			Net Carrying Amount		Gross Carrying Amount(1)		Accumulated Amortization(1)			Net Carrying Amount		Weighted- Average Amortization Period (Years)
Intangible assets subject to amortization:
Trademarks/tradenames/patents	$	5,530	$	(1,842	)	$	3,688	$	5,418	$	(1,480	)	$	3,938		11
Customer relationships/distribution rights/ non-compete agreements		16,837		(9,217	)		7,620		16,517		(7,390	)		9,127		7
Developed software and technology		772		(772	)		—		772		(772	)		—		5

		23,139		(11,831	)		11,308		22,707		(9,642	)		13,065
Intangible assets not subject to amortization:
Trademarks/tradenames/licenses		8,800		—			8,800		8,900		—			8,900

	$	31,939	$	(11,831	)	$	20,108	$	31,607	$	(9,642	)	$	21,965


(1)	Amounts include the impact of foreign currency translation adjustments.

Estimated future amortization expense related to the June 30, 2015 net carrying amount of $11,308 for intangible assets subject to amortization is as follows:

Year Ending September 30,	Estimated Amortization Expense
2015(1)	$	679
2016		2,227
2017		1,852
2018		1,662
2019		1,235
Thereafter		3,653

	$	11,308


(1)	Estimated amortization expense for the year ending September 30, 2015 includes only amortization to be recorded after June 30, 2015.

- Definition

The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss.

+ References + Details

XML 15 R29.htm IDEA: XBRL DOCUMENT

STOCK OPTIONS AND OTHER EQUITY AWARDS (Details 3) - USD ($) $ in Thousands	9 Months Ended
	Jun. 30, 2015	Jun. 30, 2014
STOCK OPTIONS AND OTHER EQUITY AWARDS
Proceeds from exercise of stock options	$ 356	$ 115
Tax benefit from stock option exercises	55	51
Pre-tax gain from exercise of stock options	$ 141	$ 133

XML 16 R28.htm IDEA: XBRL DOCUMENT

STOCK OPTIONS AND OTHER EQUITY AWARDS (Details 2) - shares	9 Months Ended	12 Months Ended
	Jun. 30, 2015	Sep. 30, 2014
Stock options
Antidilutive securities
Options to purchase shares of common stock excluded from the computation of diluted earnings per share (in shares)	0	0

XML 17 R30.htm IDEA: XBRL DOCUMENT

STOCK OPTIONS AND OTHER EQUITY AWARDS (Details 4) - 2013 Plan - USD ($) $ in Thousands			12 Months Ended
	Dec. 11, 2014	Dec. 11, 2013	Sep. 30, 2014	Sep. 30, 2013	Jun. 30, 2015	Jan. 28, 2013
STOCK OPTIONS AND OTHER EQUITY AWARDS
Shares of common stock reserved for issuance						800,000
Equity compensation payments (in shares)			24,827	31,788
Equity compensation payments	$ 504	$ 775
Shares of common stock available for issuance					743,385

XML 18 R31.htm IDEA: XBRL DOCUMENT

SEGMENTS (Details) $ in Thousands	3 Months Ended		9 Months Ended
SEGMENTS (Details) $ in Thousands	Jun. 30, 2015 USD ($)	Jun. 30, 2014 USD ($)	Jun. 30, 2015 USD ($) segment	Jun. 30, 2014 USD ($)
SEGMENTS
Number of operating segments \| segment			1
SEGMENTS
Net sales	$ 54,382	$ 55,625	$ 162,830	$ 162,034
Branded nutritional supplements and other natural products
SEGMENTS
Net sales	49,258	50,161	147,018	146,636
Other
SEGMENTS
Net sales	5,124	5,464	15,812	15,398
United States
SEGMENTS
Net sales	47,671	47,804	143,203	140,089
Foreign countries
SEGMENTS
Net sales	$ 6,711	$ 7,821	$ 19,627	$ 21,945

XML 19 R8.htm IDEA: XBRL DOCUMENT

ACQUISITIONS

9 Months Ended

Jun. 30, 2015

ACQUISITIONS.

ACQUISITIONS

4. ACQUISITIONS

	Fiscal 2015 Acquisitions		Fiscal 2014 Acquisitions
Aggregate assets acquired:
Current assets	$	111	$	2,733
Goodwill		762		7,675
Intangible assets		393		5,803

	$	1,266	$	16,211

- Definition

The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=25497992&loc=d3e1497-128463

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=25497992&loc=d3e1490-128463

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=25497992&loc=d3e1392-128463

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 30

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e7008-128479

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=25497992&loc=d3e1486-128463

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 30

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=39739317&loc=d3e4845-128472

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=25497992&loc=d3e1500-128463

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 7

-URI http://asc.fasb.org/extlink&oid=25497992&loc=d3e1524-128463

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 30

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e7000-128479

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=39739317&loc=d3e4922-128472

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=39739317&loc=d3e4934-128472

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=39739317&loc=d3e4926-128472

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=25497992&loc=d3e1383-128463

Reference 15: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 30

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6996-128479

+ Details

XML 20 R2.htm IDEA: XBRL DOCUMENT

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jun. 30, 2015	Sep. 30, 2014
Current assets:
Cash	$ 4,902	$ 6,232
Accounts receivable, net	14,186	15,118
Inventories	59,318	57,914
Prepaid expenses and other current assets	2,774	3,364
Deferred income taxes	1,245	1,222
Total current assets	82,425	83,850
Property, plant and equipment, net	78,350	79,244
Goodwill	24,384	23,622
Intangible assets, net	20,108	21,965
Other non-current assets	1,692	1,203
Deferred income taxes, net	3,946	4,894
Total assets	210,905	214,778
Current liabilities:
Accounts payable	14,218	14,874
Accrued expenses	5,852	6,835
Total current liabilities	20,070	21,709
Long-term debt	32,000	43,000
Other non-current liabilities	171	456
Total liabilities	52,241	65,165
Stockholders' equity:
Common stock	96	97
Additional paid-in capital	8,488	11,112
Retained earnings	150,244	138,347
Accumulated other comprehensive income	(139)	79
Treasury stock	(25)	(22)
Total stockholders' equity	158,664	149,613
Total liabilities and stockholders' equity	$ 210,905	$ 214,778

XML 21 R6.htm IDEA: XBRL DOCUMENT

ACCOUNTS RECEIVABLE

9 Months Ended

Jun. 30, 2015

ACCOUNTS RECEIVABLE

ACCOUNTS RECEIVABLE

2. ACCOUNTS RECEIVABLE

Accounts receivable, net of allowances for sales returns and doubtful accounts, consisted of the following:

	June 30, 2015			September 30, 2014
Accounts receivable	$	15,259		$	16,352
Less allowances		(1,073	)		(1,234	)

	$	14,186		$	15,118

- Definition

The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.

+ References + Details

XML 22 R22.htm IDEA: XBRL DOCUMENT

INVENTORIES (Details) - USD ($) $ in Thousands	Jun. 30, 2015	Sep. 30, 2014
INVENTORIES
Raw materials	$ 22,485	$ 20,559
Work-in-process	8,668	6,909
Finished goods	28,165	30,446
Inventories	$ 59,318	$ 57,914

XML 23 R24.htm IDEA: XBRL DOCUMENT

GOODWILL AND INTANGIBLE ASSETS (Details) - USD ($) $ in Thousands	9 Months Ended
	Jun. 30, 2015	Sep. 30, 2014
GOODWILL
Goodwill	$ 64,778	$ 64,016
Accumulated Impairment	(40,394)	(40,394)
Goodwill attributable to fiscal 2015 acquisitions	762
Carrying amount of goodwill	24,384	23,622
Intangible assets subject to amortization:
Gross Carrying Amount	23,139	22,707
Accumulated Amortization	(11,831)	(9,642)
Net Carrying Amount	11,308	13,065
Total intangible assets
Gross Carrying Amount	31,939	31,607
Net Carrying Amount	20,108	21,965
Estimated future amortization expense related to intangible assets
2015	679
2016	2,227
2017	1,852
2018	1,662
2019	1,235
Thereafter	3,653
Net Carrying Amount	11,308	13,065
Trademarks/tradenames/licenses
Intangible assets not subject to amortization:
Carrying Amount	8,800	8,900
Trademarks/tradenames/patents
Intangible assets subject to amortization:
Gross Carrying Amount	5,530	5,418
Accumulated Amortization	(1,842)	(1,480)
Net Carrying Amount	3,688	3,938
Estimated future amortization expense related to intangible assets
Net Carrying Amount	$ 3,688	3,938
Trademarks/tradenames/patents \| Weighted average
Intangible assets subject to amortization:
Weighted-Average Amortization Period	11 years
Customer relationships/distribution rights/ non-compete agreements
Intangible assets subject to amortization:
Gross Carrying Amount	$ 16,837	16,517
Accumulated Amortization	(9,217)	(7,390)
Net Carrying Amount	7,620	9,127
Estimated future amortization expense related to intangible assets
Net Carrying Amount	$ 7,620	9,127
Customer relationships/distribution rights/ non-compete agreements \| Weighted average
Intangible assets subject to amortization:
Weighted-Average Amortization Period	7 years
Developed software and technology
Intangible assets subject to amortization:
Gross Carrying Amount	$ 772	772
Accumulated Amortization	$ (772)	$ (772)
Developed software and technology \| Weighted average
Intangible assets subject to amortization:
Weighted-Average Amortization Period	5 years

XML 24 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 25 R7.htm IDEA: XBRL DOCUMENT

INVENTORIES

9 Months Ended

Jun. 30, 2015

INVENTORIES

INVENTORIES

3. INVENTORIES

Inventories were comprised of the following:

	June 30, 2015		September 30, 2014
Raw materials	$	22,485	$	20,559
Work-in-process		8,668		6,909
Finished goods		28,165		30,446

	$	59,318	$	57,914

XML 26 R3.htm IDEA: XBRL DOCUMENT

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
Net sales	$ 54,382	$ 55,625	$ 162,830	$ 162,034
Cost of sales	27,955	28,473	83,293	81,660
Gross profit	26,427	27,152	79,537	80,374
Operating expenses
Selling, general and administrative	19,061	19,762	58,404	57,625
Amortization of intangible assets	729	704	2,189	1,940
Income from operations	6,637	6,686	18,944	20,809
Interest and other expense, net	257	356	827	1,024
Income before provision for income taxes	6,380	6,330	18,117	19,785
Provision for income taxes	1,930	2,333	6,220	7,329
Net income	4,450	3,997	11,897	12,456
Other comprehensive income (loss)
Foreign currency translation adjustment, net of tax	112	1	(218)	49
Comprehensive income	$ 4,562	$ 3,998	$ 11,679	$ 12,505
Net income per common share
Basic (in dollars per share)	$ 0.47	$ 0.41	$ 1.24	$ 1.27
Diluted (in dollars per share)	$ 0.47	$ 0.41	$ 1.24	$ 1.27
Weighted average common shares outstanding
Basic (in shares)	9,561,008	9,798,393	9,612,171	9,826,516
Dilutive effect of stock options (in shares)	2,991	8,400	4,920	9,150
Diluted (in shares)	9,563,999	9,806,793	9,617,091	9,835,666

XML 27 R17.htm IDEA: XBRL DOCUMENT

GOODWILL AND INTANGIBLE ASSETS (Tables)

9 Months Ended

Jun. 30, 2015

GOODWILL AND INTANGIBLE ASSETS

Schedule of changes in the carrying amount of goodwill

	Goodwill		Accumulated Impairment			Net
Balance as of October 1, 2014	$	64,016	$	(40,394	)	$	23,622
Goodwill attributable to fiscal 2015 acquisition		762		—			762

Balance as of June 30, 2015		64,778		(40,394	)		24,384

Schedule of carrying amounts of intangible assets

	June 30, 2015							September 30, 2014
	Gross Carrying Amount(1)		Accumulated Amortization(1)			Net Carrying Amount		Gross Carrying Amount(1)		Accumulated Amortization(1)			Net Carrying Amount		Weighted- Average Amortization Period (Years)
Intangible assets subject to amortization:
Trademarks/tradenames/patents	$	5,530	$	(1,842	)	$	3,688	$	5,418	$	(1,480	)	$	3,938		11
Customer relationships/distribution rights/ non-compete agreements		16,837		(9,217	)		7,620		16,517		(7,390	)		9,127		7
Developed software and technology		772		(772	)		—		772		(772	)		—		5

		23,139		(11,831	)		11,308		22,707		(9,642	)		13,065
Intangible assets not subject to amortization:
Trademarks/tradenames/licenses		8,800		—			8,800		8,900		—			8,900

	$	31,939	$	(11,831	)	$	20,108	$	31,607	$	(9,642	)	$	21,965


(1)	Amounts include the impact of foreign currency translation adjustments.

Schedule of estimated amortization expense related to intangible assets subject to amortization

Year Ending September 30,	Estimated Amortization Expense
2015(1)	$	679
2016		2,227
2017		1,852
2018		1,662
2019		1,235
Thereafter		3,653

	$	11,308


(1)	Estimated amortization expense for the year ending September 30, 2015 includes only amortization to be recorded after June 30, 2015.

XML 28 R1.htm IDEA: XBRL DOCUMENT

Document and Entity Information - shares	9 Months Ended
Document and Entity Information - shares	Jun. 30, 2015	Jul. 27, 2015
Document and Entity Information
Entity Registrant Name	NUTRACEUTICAL INTERNATIONAL CORP
Entity Central Index Key	0001050007
Document Type	10-Q
Document Period End Date	Jun. 30, 2015
Amendment Flag	false
Current Fiscal Year End Date	--09-30
Entity Current Reporting Status	Yes
Entity Filer Category	Accelerated Filer
Entity Common Stock, Shares Outstanding		9,532,469
Document Fiscal Year Focus	2015
Document Fiscal Period Focus	Q3

XML 29 R18.htm IDEA: XBRL DOCUMENT

DEBT (Tables)

9 Months Ended

Jun. 30, 2015

DEBT

Schedule of debt

	June 30, 2015		September 30, 2014
Long-term debt—revolving credit facility	$	32,000	$	43,000

XML 30 R4.htm IDEA: XBRL DOCUMENT

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Jun. 30, 2015	Jun. 30, 2014
Cash flows from operating activities:
Net income	$ 11,897	$ 12,456
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	9,702	8,357
Amortization of deferred financing fees	99	138
Losses on disposals of property, plant and equipment	9	2
Tax benefit from stock option exercises	(55)	(51)
Deferred income taxes, net	925	289
Changes in assets and liabilities, net of effects of acquisitions:
Accounts receivable, net	964	(377)
Inventories	(1,340)	(4,601)
Prepaid expenses and other current assets	605	(484)
Other non-current assets	(107)	(114)
Accounts payable	(761)	(197)
Accrued expenses	(774)	705
Other non-current liabilities	19	2
Net cash provided by operating activities	21,183	16,125
Cash flows from investing activities:
Acquisitions of businesses	(1,266)	(16,211)
Purchases of property, plant and equipment	(6,523)	(8,577)
Net cash used in investing activities	(7,789)	(24,788)
Cash flows from financing activities:
Proceeds from debt	2,500	19,500
Payments on debt	(13,500)	(10,500)
Payments of deferred financing fees	(420)
Proceeds from issuances of common stock	432	193
Purchases of common stock for treasury	(3,618)	(3,798)
Tax benefit from stock option exercises	55	51
Net cash provided by (used in) financing activities	(14,551)	5,446
Effect of exchange rate changes on cash	(173)	33
Net decrease in cash	(1,330)	(3,184)
Cash at beginning of period	6,232	8,235
Cash at end of period	$ 4,902	$ 5,051

XML 31 R12.htm IDEA: XBRL DOCUMENT

STOCK OPTIONS AND OTHER EQUITY AWARDS

9 Months Ended

Jun. 30, 2015

STOCK OPTIONS AND OTHER EQUITY AWARDS

STOCK OPTIONS AND OTHER EQUITY AWARDS

8. STOCK OPTIONS AND OTHER EQUITY AWARDS

The following table summarizes stock option activity during the nine months ended June 30, 2015:

	Number of Options			Weighted-Average Exercise Price
Options outstanding and exercisable at September 30, 2014		32,500		$	14.22
Exercised		(25,000	)		14.22

Options outstanding and exercisable at June 30, 2015		7,500			14.22

All stock options outstanding at June 30, 2015 expire on September 30, 2015.

XML 32 R11.htm IDEA: XBRL DOCUMENT

SHARE PURCHASES	9 Months Ended
SHARE PURCHASES	Jun. 30, 2015
SHARE PURCHASES
SHARE PURCHASES	7. SHARE PURCHASES During the three and nine months ended June 30, 2015, the Company purchased 63,276 and 180,301 shares of common stock for an aggregate price of $1,266 and $3,618, respectively. During the three and nine months ended June 30, 2014, the Company purchased 99,541 and 156,661 shares of common stock for an aggregate price of $2,368 and $3,798, respectively. All of these shares of common stock held in treasury were retired prior to June 30 in the respective quarter of purchase, except at June 30, 2015 and 2014, the Company held 1,000 and 9,673 shares of common stock in treasury, respectively. As of June 30, 2015, the Company was permitted to purchase up to 551,723 additional shares under its approved purchase plan, with no expiration date or restrictions. The Company accounts for treasury shares using the cost method.

- Definition

The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(d),(e))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21484-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 4.E)

-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21488-112644

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29-31)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 4

-Subparagraph (SAB TOPIC 4.C)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187143-122770

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 30

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Preferred Stock

-URI http://asc.fasb.org/extlink&oid=6521494

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 11

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21564-112644

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph d

-Article 4

Reference 15: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30, 31

-Article 5

Reference 16: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 4

-Section E

Reference 17: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Article 4

Reference 18: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 4

-Section C

Reference 19: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

+ Details

XML 33 R23.htm IDEA: XBRL DOCUMENT

ACQUISITIONS (Details) $ in Thousands	9 Months Ended
ACQUISITIONS (Details) $ in Thousands	Jun. 30, 2015 USD ($) item	Jun. 30, 2014 USD ($) item	Sep. 30, 2014 USD ($)
ACQUISITIONS.
Number of business acquisitions \| item	2	6
Aggregate assets acquired:
Goodwill	$ 24,384		$ 23,622
Minimum
Aggregate assets acquired:
Amortization period	2 years
Maximum
Aggregate assets acquired:
Amortization period	12 years
Acquisitions
ACQUISITIONS
Aggregate purchase price in cash	$ 1,266	$ 16,211
Aggregate assets acquired:
Current assets	111	2,733
Goodwill	762	7,675
Intangible assets	393	5,803
Aggregate purchase price	1,266	16,211
Acquired intangible assets expected to be deductible for tax purposes	393	5,803
Goodwill expected to be deductible for tax purposes	$ 762	$ 7,675
Expected period for deduction of acquired intangible assets for tax purposes	15 years
Expected period for deduction of acquired goodwill for tax purposes	15 years

XML 34 R19.htm IDEA: XBRL DOCUMENT

STOCK OPTIONS AND OTHER EQUITY AWARDS (Tables)

9 Months Ended

Jun. 30, 2015

STOCK OPTIONS AND OTHER EQUITY AWARDS

Schedule of stock option activity

	Number of Options			Weighted-Average Exercise Price
Options outstanding and exercisable at September 30, 2014		32,500		$	14.22
Exercised		(25,000	)		14.22

Options outstanding and exercisable at June 30, 2015		7,500			14.22

XML 35 R15.htm IDEA: XBRL DOCUMENT

INVENTORIES (Tables)

9 Months Ended

Jun. 30, 2015

INVENTORIES

Schedule of inventories

	June 30, 2015		September 30, 2014
Raw materials	$	22,485	$	20,559
Work-in-process		8,668		6,909
Finished goods		28,165		30,446

	$	59,318	$	57,914

XML 36 R13.htm IDEA: XBRL DOCUMENT

SEGMENTS

9 Months Ended

Jun. 30, 2015

SEGMENTS

SEGMENTS

9. SEGMENTS

Net sales attributed to customers in the United States and foreign countries for the three and nine months ended June 30, 2015 and 2014 were as follows:

	Three months ended June 30,				Nine months ended June 30,
	2015		2014		2015		2014
United States	$	47,671	$	47,804	$	143,203	$	140,089
Foreign countries		6,711		7,821		19,627		21,945

	$	54,382	$	55,625	$	162,830	$	162,034

The Company's net sales by product group for the three and nine months ended June 30, 2015 and 2014 were as follows:

	Three months ended June 30,				Nine months ended June 30,
	2015		2014		2015		2014
Branded nutritional supplements and other natural products	$	49,258	$	50,161	$	147,018	$	146,636
Other(1)		5,124		5,464		15,812		15,398

	$	54,382	$	55,625	$	162,830	$	162,034


(1)	Net sales for any other product or group of similar products are less than 10% of consolidated net sales.

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 34

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8981-108599

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 41

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9038-108599

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 33

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8971-108599

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 12

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8595-108599

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8380-108599

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 32

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 26

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8844-108599

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 35

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8984-108599

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 40

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9031-108599

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 42

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9054-108599

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 10

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8538-108599

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 29

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8864-108599

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 31

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8924-108599

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 30

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8906-108599

+ Details

XML 37 R14.htm IDEA: XBRL DOCUMENT

ACCOUNTS RECEIVABLE (Tables)

9 Months Ended

Jun. 30, 2015

ACCOUNTS RECEIVABLE

Schedule of accounts receivable, net of allowances for sales returns and doubtful accounts

	June 30, 2015			September 30, 2014
Accounts receivable	$	15,259		$	16,352
Less allowances		(1,073	)		(1,234	)

	$	14,186		$	15,118

XML 38 R16.htm IDEA: XBRL DOCUMENT

ACQUISITIONS (Tables)

9 Months Ended

Jun. 30, 2015

ACQUISITIONS.

Schedule of final allocation of the aggregate purchase price for the acquisitions to the aggregate assets acquired

	Fiscal 2015 Acquisitions		Fiscal 2014 Acquisitions
Aggregate assets acquired:
Current assets	$	111	$	2,733
Goodwill		762		7,675
Intangible assets		393		5,803

	$	1,266	$	16,211

ZIP 39 0001047469-15-006435-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001047469-15-006435-xbrl.zip M4$L#!!0````(`,-E_D80.E)R?W4``',]"P`1`!P`;G5T MV7NK`L$VCT#2O960I&]VTTDF2>^]\RDE;`&:-K9'MDF87W^/)`/&0'@9,$0] M-=W&DL_['!V]S_[YUK51CS"?NL[GG%8HYA!Q3->B3OMS+O3SV#O;W?!XU&,$!L5"SC[X1QJAMHX;+/)?A``"@?#ZJ^'\7C[?(E$K MHY-ZL58O5M#Y-UGQK)^J^&J*W5:K5C43JL"H`L.JP;AULYEH6#JA9) MU/.)66B[O6,HX+R6\D4M;VAQR'0)'ITP8&/5^0MLDC"@)K8+IML5`BU6C.+@ M$["!-L;>\*L6]IL"050PA2KJNR5=J[Y'EZPQ^,!T0R=@_>F<1X4=1AI?79?:B]&D?\HO43R M>'FPL7.'N^3\C?HO'.G+K>NTGPGK7OT1TJ!_`_IP`MHCO"('\XUTFX1)I@`G M+PSZT2_X32W^ID4)0X)9,B;7@90:-__.?2D6BUJQ#']7SXY'GXU`^:3-_7'X M`EY)\ZN3-\^F)@TD+IRMW!?.5WTAOLZ.IZ(8$74\3M79\9@` MSCS"J&O%>`@P"RXA"'P1!J$5P28`QO#ML")QK$$UL,]:WBART%:LTMEQ#/C9 M<:3L!32OQS5O*,WO0//Z8IHWUM/\N?]RWWJI1)HN*TUO1].RV0JX`LOY8D4H MC M:NNVNP-M&V.Z5^Z\HYQK$=T;*>F^)%.N,M?\E(:8N59H!O?LB;`>-6,&C5LG3>JY*<`0'-.OA*WS;#7X9W5D::O M749HVVF(?B(E>Z+LF4Q%&I_.U<=1^FS/OF#8L8AU!\^4`\+V4^A!=Y^S[9\[ MEO"5.QP`'OM@`L#J3'\H0WS\W_PBI+VQ?:'2H<\+#XWWKQK%HCUHA MMNW^3;<+!#&*[2E?[TDLF,%W[LO04%9D_!!M9\:87H,1BP;7V*0V,#!F-H^D MY]H]ZK3'Z^R';4SR-3*+=QD[@+&_:.&E!MV]L3BA=+UA7<>67H*F->@(KKEV M=A$5BH1O!IOGINDR"X1U37C>0_97GR+#6XK+K"MW,A9#,T5:U*$!N:4]8MTX M`+M-FS8Y]WT2^!?];_AWES5L#&W64///#%NDB]D/7SSQ)8L\V;V%W-CQ]Z6K MMR3GD3DLQ'K6U\=/;F)29K!?9C#CUCG/<)P>T\:CB5$-,H0YLAHGN$L0]]0 MS"/L4^5\`#GH)JSZO4#W`"0ZRJ[GQ,0Q*2G+SI9E-T(_<+N$/1);(/`[U/,O MJ1\PV@SY"QF60(UWKF.Z78\$Y+S-B!@*4X8O#3\%(2J_2'6_[@;REH,RVY3R MD%WW8[;4M!^4ZE-KJ@]`^2D$[L.SC2VT9KLVG

MB]HA/TOLB9@A7[U._*LWTPXM8ETSM]N`1#T,!+#[UA5F#D13_X&PIPYFY*(_ M'<#(U:^ZGNWV"9%9_^#74^":/^Z]/5KONT%!13%D44D=0$19]$AE99W*.G=X M[//44Z=VWDADX!RN\3V\V9)()K;`9DLDV=KU,;D\Y!MU:#?L[D>HG;*J8HS^ M0VR>%]<&C(<5DQ7U+)"QC)@N)4==UQ/O] M,-N9+(W,>(*G#W1PI-+XH02O94^.40K_(.?**(UGJ:N=XKK=+.4G>S_9?!4R MUW)M&[/]<(&,SN,-2I+B/(`&=M::%G6F1\;/]-C4$FIUK,L^FL":DZ"+ME3* M)#)N$CMK0:HO>C6+^5LUKU#MQ(^_W8:E/)T*!3Z18N"&`UP"D^,28'7NPN[!)3JCF6& M`\#1S<3U[T^7X]BDA*9_+\!>$L?M4F<68'%5<]WGTZS^+,B3(,Z.8QS,9MB8 MD)E$Y\'CHD+3)V#,E,5L(#/HF,9V'`B8UW/HV21I7_#^2AZ>F"RQ"*V?0X'% M"Z]MW$:1O3[RNY[G>FT+VSY(9@+*"'@C9(R_I+Z)[=\(9E?269;#DQ^,;K\' M_\Y;#^:DB$,\'-PLB)6@$?_WL:QB&X27R2F)5D&H]@ M,T%.8GSN>TLB@F#ZZS@*#F,$^4I$Y@:\9]CFY\:\_9OTET,1C_TS04Y@'(T` MB64;_GT8\+;-@H[Q&/IDLXRXQXD2Z:S((B;M@BM\SMW<7>>^U,J&7JK4QDAY M!]<$7=*^'XGGL@#*Q6K()4WI-QXFYH%,(KZF-F$-T'K;94LJX-PTB%D@I^.ZGY;#>?7]^/&]&#^6UK9=4]#QU76M5VH/(P"[)/SD M6;D&Z,V#R$JL9_P6O>7[>[K\#--E>-I"]^!!*_]V=KP=UE<21/9":D8;4!*]IR>W5S;[4]%2D]NK&9";R8DA.AW&`GP7?/;>L MZ/#_NY#COF_)U/D\##HNHW^"U[L79/29]5[+,S=I+Y>UJFY$K*5$4(S%9R;Z M[/U8%T!$0)!>P_6#;P1`6.\K/\7I^WG"T,J52D6+A+$0Z>FPFO[2E+E]M5JY MM`-&-[#J:JY.>?*Y.YVFN*)P'J<50Z]6EF=TN/O#%%=/^!"P>$R,^LY3@LMH M(>B\K%,KG51+(N]\'\F*A,R,^2&'_I" M;L$"0;3W+>@!K26QZH2Q+X,Z;;H7EVU>,U*E7+8-[QS7DSCT\[M/6J%]2UNK M=7CF;OIXT/3?XLRM3E_V.!W?J/2P(4:'6?L#I@"D@3T:8#N65JP7D.%/PKGG M(DR!P,4=Y*1T?;;MOF+')'SHQ0V;`8AY,KZGTKCI1B)+6@9UNE0OT?H5 MJT9J5'?Y!,V?T<9B,'X`PSOOD*K.F0%*[)B<2[21,(IW$*=%8F+Z9AZ)M5HJ M%";#1KIBK'&#G4EE$O?Z=$[?,CRW<2^6MDKEBAJ'OLE[.M^8-,O+D5G5UZ!R MO:,%%AG=S_SI#^_TWXNY+W'!IB&LKJXP!^T2*:)>TJ>Q.17M\HL&]G:^OEJI MCHLE5=YW(]8,S,%7*_JVI0IQJLE7A`*,2^J;MLO73SZ#A"[L9/]J[JJC7^S@ M%"3R2SLX1=$S\H.^33[GNIBUJ9.W22NH%[W@-/K->$=5O,CQK_[VU[_\A7_H MC7]6+WL!XI6:+K,(RS?=('"[=0W>.JY#T$^7-?X?.K6!I7Q']'[K6K'X\VD+ MR,^W<)?:_?HS[1(?W9%7].AVL2/+?/HGJ2--]X(A`8("7C@@PJ*^9^-^'5&' M(Y"D_H*[WJG3]+U37OV8UX]S<.PMP4_@>FDR4UR&F0F@\LVKQ-MT;2L&6QMJ MJE1`YXU?O]\\W?!594]KR&!7;":UF,H3N`A?(QET"((&GZ`NH.WXB/`[V]&_ M0H>,JAK%(\3=YDC4YND"=OJHBRV"@E<7X5CT0&X+-2-_)7X!W3OHSNV)D#*" MIYT(>*5Q>#@:+4(F80&F#G(]OAB1$XEE&@"PS]O8(^A_"+:##AK<&B_0C)-< MFD;Q0A@`:`/4<32"=7O;**!G@(/;;4;:?)'N8'88>3RV\<\`#_P<$\4K]M$G M[4BO5$"UR,1^IZ",;U7C*TTQ/I^^S3.^>S-PQVVO(L`9*UC&.."$P@/R^0T#;,1`)K&VP4L:[!@AZ_)#; M!8`+0/_RA%A'?%P'2 M[G,=FT.#';2R+8;%SD.N4<<"%4"#`H!?.]3L(!J@Z.X17UC51*P!>X8W8O(# M`+1TCB++ZX!J>T*0.)#S]+\%A?P5.37NJXK(OM4]Y3ST.(:3OUW\$:::LO M7T4_ZCQRL#RU"%^TZ74VX]<;\6+UI)[4DWI23^IIKY[FM^VQ0?)7:@4=D7++ M1A1*`[X@!GH"MNUABZ=[?"92_/8];`Y^BS;_<\[DN2C+##B5>!`@*O#TO@'0GB2T>O$T.5(_WO(';`!]_*M1+5G-XHF=($H.UN?&>2R7 M"_K)SZ<13PD\B^4\J_=,TAD5?V\68%S+D=8#:SD9%;659!1+`J4]K"RU:OI" M&T&O%LH#AM84(I@U^`)(4<^]+U"]6"CI/[\_Z1(5"NN?61J;?Q(]0O134?P9 M5I#36I/?'[XNY;D<8II@0IE-AHX'SYO`'9]PW8@[&D7ECNFZ8TFYXY;TFQ]M387W:9FH7R6A6[W.TJGNBT<@AQWUEV/NLKE,]D#=(CNJVVQPBU+L`]6B"FX?P4.RW]_(VE8-/4VE MZ"GM95.SUYL?FMU386UU%=_.YM_$09MJ_BT[8[)[*JRMKN/;G;>(DR.5NZBQ MV#W/2-58[!Z.Q>H%O9RMOFYVM+=7P['94Z0:M/@(3I+]$=GL>49VM+=7@[+9 M4Z0*<1_!2=;I>\B?_#S&9+]O4/I1#E1'K=$I;^)(^M'OTNCL;II<'8L"-P!3 M=-KHDU$SQ(>?Q.JEH]C9XOPXQH]X;Q)QJ+Z\@I*?;L[/'?<(HZXESQM_=06&5V+W".H3S'QQ MAG=+7J`*_/B#6PGX4=^>ZY/!B>&KL<^)&AY.#IB;!%G#.[KD\>'X;8A*TMNB MK8!?5R+(*Z#!7JRCP2'SOKA8P`^;OP-8#A3'KMRB>FV'6Y6-WSV@[8H'EYK.KB@^]R)7V,/96&76-'1`G.O8,S`'7]ZU1B_ MO7EC0%O_=!A[#G#A[>3IAM@R]#4[0Q%M8J>3FB:)X9=RSH#MJ[IE)7 M85=T0]^U+.??G%VJ%3=$Y8/HPMTX)B/8)Y=$_OO^3<5&_*;B^2+.&]I):0'J MIY.R*282URW/94(3^7LZ3+C=KNL\!=`W6M^`:]5QJA*PE\:\N$AJE>4PC^XQ ME-<80N2\;SU#[S9-8]-TB#M)NF9A7I/$TA1+FD^A4:N=;(G`%6U=TRK5VG9E M6%Z.PE(Y<;?[$@3Z\)JWZ#XX+Z0>/6H2_\FUK53-\$03J<<8A;,0KT?@:D:H MGY2JQE;H6]$&3PR]MAT"5[-`O5HK)^/,8O1=DF8P991L*>E]B991#WC[*PS05MZ/*^S^'UX6JBSO5DWI23^I)/:FG0WN:W[;O[N+.DYW=VXG# MP-VGK0?3<]T9:DYE/=5*$OHPMY(-1+CP)8%"G.J*P`UJ\E^A0T;:-(I'$PK= M]$6!4R\+58ZH'/%C.>(3\0(Q2[QS;YR\*U1YXT:]<8.['*7?9O_\AY2VF=ZZ M3CL/EM)%%FD&0AU\Z;=6.F6DY]H]OB389,2B`6J!1&T:]#=D[!]^Z^Y'%-4& M]KG/D=#V=[D;^A$TV".C4-I7CJ(<98JCE`SE**DZR@[2I`^_"4Y);TO2.]RM MM=G1W49WTAZZ&C_J#FD5W)17[(/N5'!3P4T%-W7XPZ8/?S"C#3OL)]!3QPL#'[E\"RH0@AWT1^AR=CW& MEV7_-U3X?_:NK;=M)%F_'^#\!\([P3J`HO`B45)F)X`=VX$7&3MP/#N8)X,F M6Q83BM0V23N>7[_5W=2-NI$22?%2+PEEB>SJK^JKJKZPFLMW=?;M_)]+H(YL M0@UJCEX3559H@IW>NM*-]QPSI4XK*F"QJ&5C3%R+E>L`Z##M$WH"J_(X;G"+(&,S[;%;50R3!,"+2\/ M0ICQ$F9L`=#:G;6>K'&--]Y:JC[":`]&*3V^\F/\_::+1F* M=V9!(O;P/]GV*^D*#-^#IWN2!;Y@V1Q&AJBHP@J<4)N`L$!B^+ME#X&QH<.) M;G,0"9`<3&49JF'(]+Y9V+9T08:$L@(Q46$6>,20$%Z1YI>.*B\5OUG7VXVE M;>+&MM(T.@=Q=;8I!L5-`8`%CQR`Y?#`$?<."WQ@RA/K(EMU?SZ_8XL]\QC" MMOR!-B%W8PH&.@'+F"B!S5XVE^"?:5FAY0#B8WN25*4Y4<6+OF0QM!V[A MCI&W3VUL7X[HBQKWE9K#-RA=4+78U$.L=9%#4 M>")SLV"Y$L^#%GFP8$1,<*7=Z[^)XF#$'%"PX?@>,":JA06^;&*\+EK%?T.# M0B-@R>#\6%>83*$;^CQI% MA2Y"7T!T_J19,LD)-7T$1#O.0;"L%J\IQ@I@C4!0B=N9O[[%.1O6MS7#9T.& MP=-.%C4V)SH#40HM6%;,HDXHX5H!5P(I)H2B210FYX(NJ'V+PP(A_!#LF(53 MC#(+0Z6UJ0KD/$P-?@!I/:MX-T^`>/KGA!QN!T8:@2AKQ_"%+V#$PKX0XP.V MZ^81;)#5!N$ZB_3*6O%%0K>H^+%ANR+9BI*N>54X_MHFLU)NQ4D"(R,3S]N6 M\SGVD[7=:DM_3"*&>Z88>)E\W&@P5VF`WVTM)(L\!6-^P@L93&-`D-DYE?B\ MC#^M?#<&RQ5H$9;=FH1PV(PG!J_H_#R&\MLY0-.,;=J7)19`0A4R^)*9_3'+ MV&UX(W?UM=UK`(.&3%SP.+;_;0+YO77K_B?RP\P#*6G>XYV5P%E\`J^-XX8! M?9B%S"ABLF_7E[[1%E]/OKZY.ODHMV5EN8=)A"^PR\(`KJ+!VU)!H+MI;KC\ M&]'U'9A%60Q/8E+B)7>S!>R"^":U)PR,V^'B7?QQQ=C)QXTIVJ:^;I>ZX/X6 M:R0?UZ?!#45J^L7<;J8PH24MWLY'5W$K6AUR9872G]'XXDP,+ZZC[))GOTFJ ML>T+Q%87VA$!I]=?[N466>,=$],XHG++O?'S\N>$N#XY)RX,_X),2[.H_>7: M-CO:SE#0E"50!FKW<$'A9Z*8W4+ENAL21#5,#ZH\I:BJNE;`[6UF)&>*@PG5W83LCF M[PJSHZC!`Z3*P98.%RH/>\H,JBQM:KU0PR$Q@]OA=&Z>Y8BW[OH:FY_$$B4\ M\W9":#2MEV5\B)7J/U2V(GN:NJQI+]>^CB>.]TI(5`UOZE*(Q68,(7?E]["G MWA&3V,_$NJ+>^/(GH:;MD]LA+R9Z.\E>P8JRG!%F*.>1`$BI=ZVKEP@`R!>C M0%8N4)M'=@Q('8/&3;?F8W\_N6]]&Y%OV=`@^<)<0OSXAS/3#,!:5O M/T_Y9U-I6QY[_OJ[\=VCG]B^QOF4]*?H_*V[Q>.W+FRV`/@8\H,*^((=!&$V MBF8:"LAL\2SA>0@];2#7$KS[V;EF_.J&G6H&2'V%UB%-27I:1*=?.W2F]URP M;;/>A%CWQ!RYGN,]O0I[2FHYO1*R+DU!\[ZFE+@#Y78;`U7IU1*\;-Q&OXP1 MZ3!TJN@V%FZ*UD7.A@&A?QHD--`=,=.M=+7%'=@AR2(_N"-MZ9!%Z.[SB M9TBRAQ[4L_A!#QG(:3\9#NZ'%QZF&T77D]-GLPR']N.>;[\\ MJ"/][J$=X4(1)36F0R21AZ7:4?I5Z?H1D))MNIW`LFJ(ECL,9"U=VGO:U@GE:EH%% MMZLEGH\H0\]+S]/UYY6FV.^DR7KBQ'+E6-#]!2LW0P=*\J2H%*!D0DYMH"4. MHH?W.LU,ER8?0[!RVVB/#Z0J!$HV-JKW\S"%/WPR#)TO]C#5`:M'-9#Y#F>V MI6$I6L6V*$_W<'_M_94$MSD6944OB27M`8^B5!^?A`G+'NAT#P+GLV&[7R"Q MN77!RB>>.//\=BAZD>W)S,N9UM:&,Y,Q[0ZEP=XR1L>V;SO%_/B'U/?TWG)2 M.14[<6=2S`=I>FS+?NK&4@QJ.UKLV._]&RN#FM(`QQN@Q`+CM]TG<29XIJS8 M),ZZAC>(Z*YX2#R5MMZGTG;;TN?;VXL_K[]\D*M=O:^_=/4;PVI-]Y6;(V]%K^A3!M[^9^5 M*^&GX/IX!BY>X15>X15>X57=KG;']N.=@0L-'>L07%UM]]0W53IT97URO4'3 MF=25!NWT^NDQ:LR)?ZG/WU3DMMIY@R=PYJG+Z40#TJ'\=-#:6A_ID*LN%S8X MKR@S[U-HK\<3PZ9L/2P',BIM64 M:"N>)*<=N:4-.HTIFHT3U)*.$V:;ZXQ`[)>>GLTWY.]K1X<% MSK?#%3EBR.!4S`J9]8&^'\%*$00BL(H/`CT]GPB`VD\Q;D"P4@P@]@1KA3B9 MHK?_>LCR,<5*)Q_#VS!N0Y6:U2N? M(G%BKPDDR6^`5U]FE$=[E5J5+9\B&^OB<&$6L[B*:`^S.'1QF,7EN#PK/K*W M3N,36M-OFU-1?KF&/%]RM6=',$B&.#O%"#85BS=<:VN9^1=""5:3QRN\PBN\ MPBN\JO'5[MC>R&KR1AAXA2UDEKS>9GZ`-:9DZ13"6?'>_H[BO1Q.+-V;HR:+ MVJ2*Q$!B5$J36Z8&D!U'9L>NFN^8MJ#]90AA;`X6$VRTU))#F,Y38AZ1HR8_ M4\_W5Y28]Q$UGZ+%D<(;/N.+,:=*#EOND?I(_4II\IAG5`$/:6#_S0^81S8B M&Y&-ZPZIJGD81M8CZQO.>DR_D?I(_492']/OZNL0V5@736+ZC:Q'UC>-]7_R M'Q#K7?$4?";4>")'C?R%-_Z54-NSI-._B$%]S#H*]C_BB=?HY#G`JJ'=, MT9`HZU*T@891!J-,C9`[`HL4!0VA\HLL![Z%5HU%ED^A#X@0*E'B\-?-_)$] M\<&._8#:CR'[B\0IX;]GK_D"..,)"8AD/%%"QL6NQ#1ZE1&1.R9RQX@A>JNO M]=`8RF<,B%R%:'0Z:*E*CC2JH`$4./)'QE2/,;V6KN8Q58:V@,@UAT60OG7S MC#MH#(A<`VATVFMI@QRC404-`-,W9,P6Q@Q:BHIQIX2V@,A5B$7(H.HOX#3B M+9D+\DP<;T(LR?>&P8M!B62XEA00<^0"#D^OQ;&UT0N4B%S#UOA[O1RW_*,E M('(-X-!IKB2JH/H+'-LC7PI&KA*%`_[QDYT%7WXPRXA=-UZ=&PX21%7,D1<6>/OY?-J M>:W&H'>\@Q\;HC@I_^A34QVN!,9&*;49[$!*5%1QZ-;0K:%;0[=6,\6A6T.W MAFX-W5K-%(=N#=T:NC5T:S53'+HU=&OHUM"MU4QQZ-;0K:%;PW5D1*_TK*XB MG!5%3WRN4DW??J9OA"MJE@I1C[DYKM&E#1"YAA4'4;66H@W0&,IG#(A=`8$+GFT$A56ST92[R5T!@0N0K1Z'30 MTG,Y^!KS-V1,+1FC:"U9S^-]3C0&1*XBR%6BI$$UH*P'@"1 MJQ)RN8:J1RJ]GW:\6;"B02)R2.5:P(H&B<@AE6L!*QHD(H=4K@6L:)"('%*Y M%K"B02)R2.5:P(H&B<@AE6L!:ST,4GRNT@MXU3B3]9X:%@'I?_B`+ERZ!OST MO6.;Q/6)7YQQ-WI7`2+7L+UU_59?EM$6RF<+B!QNK8N5"BCTM"`T0T0.PR#: M`K*HHL@=A44#9%$9;0&1PV02D\D&F2$BAV$0;0&1JWP85.2#L:P:=O6P.O&Y M[.\GUJLV**)7$'HUK1M>'L5A[?=]=5CB*M%8^QW=&KHU=&OHUM"MH5NKD>+0 MK:%;0[>&;JUFBD.WAFX-W1JZM9HI#MT:NC5T:^C6:J8X=&OHUM"MX3HRHE=Z M5E<1SHJB)SY78!L.'A>+51<0N6W(_5(X8`DDRWKOM*:T!KF<$EL/&T#V('N. MI>FY'`5;#QM`]B![CG$" M+"9I2)0Z$4556H-<#GZMAPU@F&D`538XFW4>#F*'1NZ-S0N:%S0^>&SJV.ND/GALX-G1LZMUKJ M#IT;.C=T;NC<:JD[=&[HW-"YH7.KI>[0N:%S0^>&:\V(7A58744X*XJ>^#S; MJB,^&H\.F=T<[6R-9"EOO^!\_\*CUJ\!@H3;;@;6X74GI_BJL0(3R97/A`JW=Y02W;=[F-+8M MRR$Q>Y4[O.V97;;[[%WS^+^I;37GE]#S>>5\+4"B3CK,[DZM(/[+$1$$L: MAD%(B62,/1K8?PNPR<\)<7TB4>+PWP0>5]6_0Y?,'Z')+4F5E:[DDD`R#4I? MP5K9J#$9Y:/<7%2)5WB% M5WB%5WA5J:O=L?UXP_3^ZBA=WFN0ON>K2,>KL%JQ=\M>1,N/GF.M'W/\10PJ M7;JL3](W,@G(^)'0N16R+#:GB<$#WG`4UEIZ;#>0.2F$0#I@*F"HGM2+$]73 MY&P\N*+(1RJ]GU[GT?+9PNBO\,8OQ4`7'4"Q#B#Y9&-F;_+N=P;UK!BK,M// MK!JKDMVDT/[S0FP"ALU$%K:T5?!9WE5^6;^B4!58425":/MRY-KB#P<65-%[ M@[E%H.H/9,D1W/E^*^Q5<.=ZI;8I5,A*$:KRE,G*Q:FK+57MY>K6FV4%F*5G MZ-9[F'>6T%KYNO5E6 M@-EZAFY]@"EH"7T50E6%;%W5NIBM5]FMUS1;OQ\12HQA0"@FHB7T6`A5^7-V MK:5W-0%>M1&!6(Y-:UP3,"J1YZ;FU->=8N3A6;.Z5 MU>T@6^MV\.IS42U!7_)?O69N(0: MCF2XE@28N][8-B7XW[*9-GQI;+RRCX'MAH3I)JK\2$E@V.(N^-8/QZ`DBT"' MK18K!?@"?H7]SVP"T/M!`FE";9.P$H/L;Y\\>(S[^D\?[AZ/0>M^X)D_6M'S M0L>27/($]O!,P#RB)I?OBRH@>A.0/F#F!A=#EENY)FE)IN&/I*'CO;`GOO>H M>'XDP[P12OS0"0!QB5&4=1B0>/(\Z\5VG.FM\3*(7!Z;LJJ6DCD"TP!]/Q(F MPLQHX8&1?""5[5E^6SIS?*^UV(?H*]LT'.@C)<\V>?$E.X"'46C9YT46S9%- MGJ<00A,MR3<<:(]U(>HZE]E_!2T^V00:NA\17@12/"_>S^C90EZF.9:!<5Y# M3\$$IZJVUJ*4#13?0G.T%\I"'.:&J,U16VL92[T:VBY8A,T@"N`/HA0IPX@Y M[5!X'+#)16G6U+VTETM?2B/@/IC[$R7_(\+>3 M,__A=O@P>-#D!W#&G1/HO"V^^0,N%/4$$#(A:#C^;R?OM)./>D=6=$CD5^7B MST[7K!XUVTW0;*_73]OL-3<^8IV99C@.>3W5ZYD]?CD4B8ZL#3IK1=K9;G;B M)D4DH1.D*" M3CH)U)[253.28`K"D@B[M=0;=+5>MB!TTTF@ZATUH037+GA&PBSDBGKC3R+H M0-RXG<8T_YRPRM+B=_?&3^+_;KL>!4=ZS8;EQ`^X,UM\RN5_0_CZ=Q*,//CF MF42%IS.U-&70ZW>7NEA@3TH&X7Y,T35-1@`/(;K25Y0>0GB`H]*U?JEL$!X8 MU;0[A]%8UM&QIZF#-;U=:?0`R?8,FAKW!7D*MB?%=%5=9R`Y0);2R4-F&A+KBVT\VHX=V"3;3*\GK^1Y.P7(6N34 MIMQ+`'-*F5GH<@,(=1GCV]'E7;Q;:#HS*=/F6EIGQ=_N+^5M,"+TQG/%63F! MF(')=GRB[+*`M3+D('A:H.5=7BT+P?-R%FHZV5/0;]\.I(5_)4/,K`=?*9D8 MMG5!A@1NM:(\!=)E_L@<.-#I[^)`$I'R[U9:[Z[OC$C[],N"=!':(U_L9[(R M.WSYDRW3P4!H.N&W;=KS(7KHPXZ'GK_^;GSWZ"?'\/VSG[;_X(8!?;BG!EL_ MHC]\?G5CC(D/DG^Q3=8'_W>^DKA[)G`@Q_UUN@YF#L],P:6`IY\Q/,L_Y]-] MJ6QF=[:KZ"N1(4FC&0F:G)X:#,WB3O1P06](D"V>JC+0XVYD=Y.9")EB(AE2 MP_[A0O)YF<@)7I#';&=5%%F-AYF5!O>4:+_9%*VKYR3/G@&KKZX0-UN`TBY/ M=%/+(S+[US6+I*F0^AAM39PMT2YL4XQO$(P^B^V^2SL&MVU)67UQ_M_5F_I_I8^V_X7]:?KJ',-*6UI>N;_US>W-_>75]^.P"" M6NTR6AR?OP#K^,8(:OMLWXG8$20.#V7;Y/;`;/?V=3P^%*_P"J_P"J_PZGA7 MNV-[N5[A*>C\T([6'JAOJO12]THRG'LY!%EIZWM@U)CS^:8@)CZ@4U7::N<- M'M&9IRY77EQ946G>IV6R&0@D8_G).&@/="1CKKI<_T;:,1C90486SP_-Q,N?'%CY*!I;75?IW`RJ%.F-(3P;5$E<)4M=7I M9U-S'^F2!JQ.6Y?K!%8.=%&[;:U3,KK(K6XWF^.?D2Y'3(AJ>DS%GQ[]`2*] MF_R/O6=M3AQ)\OM%W']0^&YC>R+4C!Y(0,_.1GG5LC^UH/+MQGSID5!CM M@,3JX6[OK[_,*HF'`(-``CUR/DQ+1E)EY3NSJC)];\2"L[I$S2J^?Z)+1,C* MX!M=K&-%5S;-?(JHDMCDXAH1LC+X2!<3&U/N*46[2,WB!,H9Y4>"6\=U@@FS M>:T=2AJ5U4,B9%4B>]2559.R1R5RD0A954@CZ8K<;ILD-U7WD1I?B/OR;GP3 M\!=[235MJ%8>TA5:S#]QWVI*Q:;V:"#EEH\K6U.Q*`_I"I6"Q,>N*15)N35! M0NH:;U#?3UI2R#D]6U%DG75/W\46X(R>K*NT<%VBK&Q%D776/7V7$Y>.W%/; M)"Z4C*VX2WIY%FT"_G).QI:OVVIYJ%>I?&SY"$E9BR8(2?E3LN63C/)0KU)9 MV?(1DE1<$X3DE-A#W&;IKYI?W+4/%>^%6`O8S]*:\;T:HSNJD28;:;'N+1;" M?1A_80'S7]EI30EUI=U.5Y#=.V(>(&:HX-I5-XH7'PLB/',2NHQ.;Z/7PO+3 MF08]'`%&3U?3A9'W#OK%^O9;-V`.`&9@%JV]T:KO2`#Q M=!]6U^=G^_)#H=E3=F!P]X!Y0)BAA+-I[F"W0R'N)-P3D+1!>X$TNV;W2PW3?>R=!E$#,5F'@G9;)!-Q#- M14[$5B^,QVWAUZT4%"/'IKC?"K;[Q)1/+3 M%_;J35_!`5U_YL#^$+JF*&G8E[#MAGHQC/7=F46S:\_W>2WG@879YJT^V#$E[!CFVX[GWC(+^XL?.$555]Z;X[Z9G!\'^5!650J>]N]N M%#`[>7[@S68.;WAYR]@C\[&TE/62J:M<[CC15W%R=W][]0N6^]2,]S%RT+Q2 MZ/$L-[CW0B9ZM23]=Y:M[;9U72]90X&J-0PH34\`_C&M)?4'@X??[Y^&TI>; MPSET"W MI9K42V#?,E[["!PUIEAR@L2#RY>K/>HE4#0M:]Q+H-^8]3 MJ8:L&;W3M7Y]Z%ZHD+1;:JV05<290VT/0UU`2$Q9-S02DE*?--SI`I6M#$-. M)/C,@F!EY?.<[D^SCL>>Z/X0LC+X01<[5OY!E96.7HB*C^=4!:+_<$Z7AP0C M@^]S2<'0]#8)1DW=G!H=);N\4],$_&FUKHM:'M(56TW!K'6-X@:?,W[?U-9* M0HKS56LJ%N4A7;%U%&(GNJ94).76!`DI?[Q1MI7E2E:WI?7EK(%';9#5D/7E MMJQV35HZH_7EL@A)&=>7#5E5NR0D35I?KI'[28G7"B9>RU<=L#S4JU3NM7R$ MI`Q%$X2D_.G7\DE&>:A7J0QL^0A)*JX)0G)*["%NJ9+M^Y5LCZIZE2ZX<4`V_I&T;,M0QP%Q.$%`;<4U=L+Q#TO:?#:6'6^GQR\WPYOZI_W3W<%_!":9)E,O5?13ZUHA% MH3.RIM(='B5U.`\=V+!]KOG[`$F!7`V\VM]RW MJQ\D!PN'25B?ZP5>8[8$&(C&U@@ES)?ASO^#A7@%DPU]YSD*/9]_V6>AY4R9 MCV7%GGWX"[R+%2F=&)(@FL^G#(L!BM)D'NH[R471A5_GOF='(P0.R`YWH!%\ M0)L4>OSA<`)&]V4BV1Y@$>8I39@U#2?\M^038\^S@1*>SX+6.A:F;S*O=!;/ M,IY$7"$MF0;@X@2P4W!N`2]^=!5OP1KB`.JG)9!_1AWF,^DY"H"5`D!,B/1X M>4,*X6BC?T>.S^0EJ01X7`4N7X-9.2Z?_`;(CFM'\%'`\<0*5\F<4#F%GWWH M60-?>F93AV%%9?YU!``+SZ$CN\*,,>AX+XK1!2R9F+TZ!8#YU;&9!);``R=+ M&CNNY8X<'/_-92#9?!R!>L<=^Z3(4QF3CSH$7*1EP]K@8\0&'&O\< M`=Z]*!;$`'E[-(W0K=YTMH[Q>/'I3TX(?OXH+DO@32W?>COQXZON<__F)[D@ M8/_>_UP-0(4[!@KLLS/>/)U>2I`14GR@&M#>Q^)S;4WQ"%R^0!<#LBS%0`\L MOR)8_INPX6/?FW'[-8S<:@#^"*J7,;\:P'+G5;IVO%_!^@;.YG'.XZ'65$TK M5&-\'$^]:F#YP7^Q7.>[-/2B<%(-D/_&P(G`*NA#=.GSA9F[(L6`_1NX/?YH M(JT%9;ES-;FC6]Q1[YL+SB=.[-GS)Q@-KH6&<=0G2]\F#A`HB92$ZXD*/L1, M'+R#&"B&.1#:+V!6I%L$*(:[*AKO:>+-P*E+G`^<0F6T]<#SW6CDS1T+L3[# M'.2;]!MGB-7A\YA.@;KE5PB+(&+Y<_[J9"UT!WWE"6&*TQ@KF97MTO-J^0[& M;2L25'SP=@O@3*1_P)]FCIL[2@HDXR.S1I/09ZPP60(31Q8BOKH3Z2^0?3?. M,P'4X%=@3D*D!;$W`N=\Y-7(M8!I,?$Y\G!_?B"NXLP5W*SDGD+X@TAM"%YG M6)8$+!!V^;)\$"0;^QWP)Q9]%W`,@$$L^6$5M\CW\6]KSX:>^+@TMAP?LZ!K MZ;,U(.9>X*PDT)9"'.!?-HJ@2KCB(:8-XA--0_X89H6]Y>()]I+@!G&"3,J3 MF$`P:08$FP02XTG`[5_F#^,*RR+9/+)`2,%/_K;\;.:/H2[!^<,'9JBXOSF8 M6Q65\!!W<\#@R)EC\XL7B")\S/CB[UATTD[RG[CI<&8KR'8X"'$">%@'6&F>]X`3:(Q97CGPOZ@JLLUXW0P=RF%.8^ MFUN^>-;B_;_+]EER2DQ'@QV!`5F^@JB$B]^3Z:6.X+!V+F!`%76*YT[[VF/JW%GSZ!326C\.)5 M>:UL_AYP,;X!LS!#M42RN8SJA/2D%H=V&-\-X[`A7CZ+5Y66QA\UYLSZ`W1F M@G[.JE801+.Y,(1\[>DRB^Q5\Y^/, MPP9WLN0]@[/$Q*+HC_"C;_`-^Z6U_>,VW9`01FJF$CW"P-IBY@0C0$\XUNXVLM5]"!6 M!KG$O:TKZ6D"*$BPDNP8`!4C!>A!,0S`9F!3)J`,$7]^#!H*/:@^CI*99[,I MUR48QXW6X4V45[)I@^N\Q$1(<029?.X_RP%`0=IL[HS"),?H!F.Q2P9@!%\( MZ/6"X;^$*@QTI8/=_."EY7CH/KJQ@A?C^6R,6C)8!(8PU=A4PIN"(<1/`BH1 M%2QB!."+<"KXA"6.F7``/5!>&]#@;AJ(4:9O*\$CLB;,"T@3&T;&K21B%HV7 ML%VK!'D&A0IQ#P]!I#[21:A0.?4<7"\_E7BEZT'MPRCTUIQ&E?N,7;$%88*T M@UDF\1ES^)8#,#F^%\S%A\7&(DS#Q!80O8T`B_#;.'$+P1M%LVC*9>VC`&C% MX,2`)*::.P&VQYV&]50:S&8DFAC#D"PV-[$1=N`1SA4.[D`1,LKM"0\%@)0\ M?-Z7>J!X;LM*@"`JKKQ,421?'?8-5P:^K28-@H5:%"+LLUC1`GM.01)P+U$` M`KBZ,VG+RTBPA-M&O$46<-8*SZ[O/)M8`0_I'33FH(M1K>/*A=@5`P"FH'+" MY48J3%>$$,_[_&'T+",>2,D+9W"0%G?\!#\<\(U'B)RQ4"$N?;V8"7/EMG4] MGMN6ZOY/::+?-M3W,I\%VOGFF=D;OF^='M6T8ZKEG>@<^/$^DGI&B'[5VI]L] M9*8'0G>^F6:E::?3[9U[HO'C9R6I:JJ:<8# M[\-XD;P;>,%IGOLZ9:W@]_XYJ8#7"5-5;=B8=?\ M\L3&.L%*@`W--(M!!M>_F/?*(_`^C8H;H!0UB:P150;D9YW#HX];C,.WQZGE MAF`C;^"O\UG>GGC7Z'3>G\%..(J!/R,%3$/3\X$?]\\Y]HW8_I44&!(!V"`' M+T+7S?78^X`!\X`P0]Z[TSD90F_$F!T@EK_C)FSPWJZ9R\9.>.M[L^$$G+9G MK#6!_B%\4VS!R'4E,:52C@&H\#EE9''#*&I.^/Q=$$2XDZ0X3U#MZ5LGL'/T M7('-ZF#I6E[`8@&N8&N1K],Q:J2*?NT<-Q?PLBZ@'0_==DT-IO,DW=OI:>VT M:ML]U$E`'8ZE3EXN8"7U?G2CP8/3[(P^\;R M70B8P.N.-Z\Q^Z^@1D[J0`VS=B#A!FP)RAI`4B*X1#W#`?[U=- M2T(.H8&BKX.7&BXW6);Q6;)GZU?FO?C6?(*[X7@$QS>Q^6]??Q_N!QR`3FT& M*1SP1U$3ZL$?BNVG'&8L*?7U6M0?NU^6EQHNJTLEWEQ\I#;^RL%!9]LT=;,L M%.*S3?*+G%H0:A\X$TWMM8VR4(Q3)"LI##V5:#M]`L>M2!B&J>6-RJV0Y"NT M[4Y7R5O9O`_V14364%13+0EU3A'83E<[[S3R%5>C;19EV;*Z3Z;&M[F=`9:\ MK:R>7K(O'/`+6=F.HN:MVX^FT"E"J_9,K5,6BAUG9;NI=<[5M;L%*2W=X!]$9%M]S2C(&\L,W5.$5@@5EFH=9255;4L5G8T878T90_C M^!BHZ#3`>PX`.RQ65I?=!A8M!DI2.']_]Q'<5.&,W\2?XIM/O&++1\>..:>8 M\VR%G%ZC*[JB*[JB*[JJU%66X@UIF_NN?5ZM>K+B0"P!Z&K- M[^/V?2,LX^$OVO?%S1*QKI0U#]BGY.(G,0[@5VEAZ8OU'MEI)*Y'!_EVUJY0 MB_+MY9_>L09Y=<_.BJ.50%'PP]%8Z^2/M.77.ZGVB\*408L0EJ_0EX+F'4.MP" MD#`62,OM]6LO(9%MDLAS2Z2X]]?N\_7>MG2$'@QN;K)WA$[\@5THR^HG0O5$C:+;56 MR"I`2#1M#T-=0$A,630B+M`M_Z]V+M!G;,2]+%A_3O?G.(Q>'&.7 M<7\(61G\H!A9YU?Q'U19Z>B%J/AX3E4@^@_G='E(,#+X/I<4#$UODV#4U,W9 MMK/Q4-SFDVX3K)O*KOW/=TU1KHM;PR/\G>CG7&Z5H"&DD\[A@-64BALVL"%D MW6MJ:R4AQ?FJ-16+\I"N4"E(G.B:4I&46Q,DI/SQ1ME6EK4\B:+EM/N&UI>+ M3[!6%%D-65]NRVK7I*4S6E\NBY"4<7W9D%6U2T+2I/7E&KF?E'BM8.)5:VE& MN0+;\E"O4KG7\A&2,A1-$)+RIU_+)QGEH5ZE,K#E(R2IN"8(R2FQA[CE!U-2 MT5[R:W%QUSY4O!=B+6!?.Q,_3R8A/@MC_GRE\L](NY&T.FEI]6:E=-CQU<%V ME1F[<4,G?/NG8[,[=XP:#J(`^!O[X[XE!=!@Q+A" M6D!%R`YGIQV2M?T'VE\QCD2S;**I*:V.0J)9*"WOX662 MS+I0\TC)3*WR5-BG*SFBB5LO4014Z;;,RYZ=JC\M"ZJ'2Z)`HE`U6A94B)9$ M(>"7R4/ M6Z]*KNB$*\WC+8B%\7WCSP8>NK]9;]<)604W"T2W,5=X"VW9,UH[MD M#!(7$A<2EYWB8BBR:JHD+B0N)127..U6(G%1VQU94,!(^\/Z@_GC+6IV'T&[4[(RA!%7*PS@"&K6KM@)4^<0&)3 M.[%IFR0V)#:E1M;.H.)B8J,:H_I* MEV?1)N`OUO8U[9U1'M(56Z6M4VLJ-K;X'BDW4FY5(!TI-U)NI-Q(N=62=,5* MP<4/G9%R(^5&RHV4&RDW4FZDW/*M"7^>3''9SE15L#$G;3JD3;I%Y"Q*M$G7 M:,MZM^CU](IR`(D+B4M:7`S9U`P2%Q*7$HI+"8^`F)K7"R9KP)2K]:EJ'-7[%%[; MG7V?.;8]96F.;?.Q%WS9ZN+6M?3_,_-JP3O:BMF_MA5!5A1ZS43/X6L^[[(= MV+=SH/02BVE8]^[T%O596+3&R+QG\(8UA6'&GB]9[EM:#J(`;#OS@^NWQYBF?=<> M,O_5&;'@"=S)ZZDW^N.7__XO2?I+>AAO?.NX3L@^.Z_,OG-#RWUQ@$+](&!A MDXN++R"SHM7YAXY^O_AKY_,FOJO)5_8HM M5+X^>5_-K[J"-\;5+['#L$#!BO.0-MOQO7##U^SX2@ MP_$1L.R]^-9\4@Q_I;9MI-F-KNB*KNB*KNBJ>5?[G:UR)1B4H_(+F3?WF>U6 MKUHM_H[UU<_5D>[_&,0]-R[.21JR>W%XD' MM[[4U5:[6G)1/5K>0&PTP]A_@Y3/OO3C>NB;[\BKT>;9!X_#6U("YU8"A^=+ MCS:CY3^@GE,R$-,LQ705$4S<^`,=AR&KW>K2`:CW<:29+:-D!Z#,3F_)%20K M93[\M%NQ'[=AH`J*W3RG5F]6-?43M3HA*X-ZCY%U?O6NR9K6*5C!-XL3R'// M5<%WR&TOJ8(G9%7!?U?EKI%3-2D2&_+@\U?P7?+@2ZK@"5E5\.!5V32+5O#- MX@3RX'-5\#WRX$NJX`E9U?#@-3VG`I4A7:(6'Q`K5E(J-+=Q!RJU4 M)KELJ;4*]EVBQ$&#\VW-V.BJJK*N="G/1@%8Q6TL^2@5#,#*5W:O/-2K5`Q6 M/D)2&-8$(3G%,(M;JI](]1.I?F))T7.X*TWU$[,56,G*F#5&X:+(@?3_[5UK M<]LXLOV^5?L?<'UG:I,J6N%#HB1G,E6.\]C,W4WFQIZ=NI]>190^C. MK"'\E6OVL(&7#%FG`]][7+YE')`[2D(ZX.:8/8['#Y!?$I^NWP8I%I_Z.AM$ M=MO"4RP6D?MPA?_65Y.1@DD\2K)&OGI\G4<<,)`TK(P99N@XR8FU22Y6C0:.EX5&.8-_)V[D;JSI(G#%T*S\#\^T_0#K MB$F@LK0I75O,#`#I'[%N`%A'+"!.!&N-.(6B=_IYR/*;*$9;C.)M6;=`\3"A M84+#A*;LDJ9>[Q56KZ)-P,^H==8H>40G]NWD?.:IJ10;^](YC%LA:\R:TD(> MT0EEP6SQ6U,I-M:XB5R'2\<0>&[*B@Z>&XP;/#<1L:U;O6<3`/(+#6,FWI+#J ME6I+3[[TT?)(3ZE=/?D$B8V])I!$W`*OOLR01WI*GS2Z1\_ZPG/<;,M-O2V&_FA'_TA_.?[N4`[^1J>V[Q^C!%DH< MDP<++;300@LMM)K76G5]"IYL5R;VG3[`8I#=@I,R=UH6''-BV4\A>J^?#EP% MCJ24AP`NP%7F0S8OE1I9S&*Y^)[@.`K)T_V*`ZPQ&9-G$,YSA_?VY`Y/X43F M<(&2+"M&'L0`,922Y/;:JP+2D(,=A9:<@-L"_2L0PI4C(#C8T%3)(3S.4L*/ M$"C)CV$016M"%%TAZ\H)PT<&;.D/OIP$B1^_,`2\\0/J@_I*2;+*$GF,AV'L M_B<-C@`;P4:P<5.-O)I/PV`]6-]PUL/]!O5!_492'^ZW^C($&^LB2;C?8#U8 MWS36_YY^@0[/RZ?@`PV=$:UTYB_]X;_2T`V&Y,7_42>,X'64;'^R:W'GQ,7G M<>W-Q#-/X]JK_GQY51I/;P82)WTUD$3)W1]T$/.ZG\X"W2X$*7SU*<8$(2O\ MH![(58]<8:4-`260`W*@K[)0`CD@!_HJ"R60`W*@K[)0`CD@!_HJ"R60`W*@ MK[)0`CD@!_HJ"V4]D,NN2ST@/2U_[5.A2UN%$]*;T!E2UOL_(X8N:_H.^^JK MJ1.S'J\'/PO3[0)R!4L`9A56H1[(_5`Z8`?TK.BZ91VM8^E0`9`'Y#FA'*:A M]=JFN"$I*/>7(`J(LD842[-[SRFR7&\5P"P#\NQTT=H&R`/R@#RGN6CMGL`% MCH)RAXL&HFQRT?H69AG,,C5"K@(6&0840?E#EF>^A:;&(,0*Y*Y*J8 M0VRM9W6A#/(I`Y!3B$8O^III"*21@@I0XLH?C%&/,5W--D5LE4$7@%QS6,3< MMX[(>0?*`.0:0*,77I:( M4@E([@;*U)(RC#&6+J(^#Y0!R#6'1J:I=76D>)-0&8"<0C1ZT==L(86OX;^! M,;5DC&%INBWB?4XH`Y!3!#DE4AJH`64]D*O@'.B$L[>^L',@0=+XY,>./W+O M/$J<**)QQ*8N=L_D[@\ZB$D<$&<2A+'[G[3LXT5YNM[HU`-`3B7DA$Y5=R%Y M-1MXLV"%0@(Y4+D6L$(A@1RH7`M8H9!`#E2N!:Q02"`'*M<"5B@DD`.5:P$K M%!+(@"IE=J_0"GAHU66]"9TA9[_^,&+JLZ3OLJZ\\=T#]B$;E*7>C MHPJ`7,-BZWI:3]>A"_+I`I!#:-U*JH!2JP5!#8$ M<'D$A]SOI\I0XBS1R/T.LP:S!K,&LP:S!K-6(\'!K,&LP:S!K-5,<#!K,&LP M:S!K-1,S!K,&LX9S9*`G/:M5A%-1]+)K!<)P4"X661>` MW"[D?B@=L`-Z5G3LM&5H?2%58NNA`V`/V%-)<=A\3`H*_B68`J:L,<74-4-( M3=AZZ`#F&;!GMY=F"RD%6P\=`'O`GBHJP,))`U'J1!33T/I""K_60P62G4&24?&*4.(P"P5$P;C!N M,&XP;C!N,&YUE!V,&XP;C!N,6RUE!^,&XP;C!N-62]G!N,&XP;C!N-52=C!N M,&XP;CAK!GHJL%I%.!5%+[N>A^IDE\Z=1^<_SB,;9Y^.YW$\2]/6>?K'BW36 M>IUA;MH_OIZ%,J4]):\SV/-)[8SD$EN.I!PO=68A[#*[*X^*FG\Y[2D94,_+ M)?CFC-V67T=9@%%ZG3]F0/V8AFVGJ.QS<'V$R).V'Z%Y/@GMP'(>NI3P9)&%)_\$CBT/$CSXG=P"?.\(\DBB?,*$,+_PK1<,_OSY MKW\AY*=--WA@0@O"QZM4K/'RK\B`]9!=?*7W;\[>)6$J[%M#OS5N>0G'VYO@ MUKZU='[1.?LYG^+G'5^8[E<<:^?]CO$C:2,9P`MH`6T@)9J:*T_8_-Z7*[]9_VD M[>>C7[)M6ZV^^>.S3D5*?L][3=S"7_S6C99]`D8+&Q"9/E2]H[>9(\5E'F!J MS;C`4#3/=@-J&BVS_6.5*>OK+\M?$I\^R=/2M361WH7D5>$6=Z$'?-L/9)2? MC/U6WP89A6,;(.193/R\%/<4[VW#=$N5U?OWS\CS[TQE]`\ MT;U1L=^7_ORK\XU,'*8LKN-%PE2Y,#PKQTNH6VRUS%Z=P!*0ML[H9I/K5HQV MGKX;*W:RF+QUIM;N=9X4`W0IB2[MEJW7"2P!=#$[+:LM&5UTK=/I@RX%TJ42 MA^BT\%_I':+?@_!/UJ7S:1@,:%2J2U1RWD,E;/Q6EPA@'>$;'9+45XBQ[VFV MW1-LZZ$)1[A&`.L('ZDRVMA:7Q?M(C5+$[!G5)P(/KB^&XWID(R"8(A-(UD] M)("EQ.Y13S-L[!Y)Y"(!+!6VD2Q=:[=M\$9U'ZGQ;Y%7[\8W`;_<2ZHN)J,A MHA.:5&;FOM54BA)G%1$J5ABW8ES9FM)"'M$)9<',QZZI%&'%>2WVVI@?_!AO/E_BJD0S?^P%9VGAN[-$)NX,-U M86638U4UT$(++;300JMYK577YHB)='5&WCE[EYT=\]FI+YLWSO4;;/:4&YF_ MT[9;>AOY.WD@9*%:6MRT`R7;&R MK'?^3C"RJM"6W'MK3BZ&?P3^Z)SIRH0,Z5V<"H3O^!OMUR%]"+P'-E8R2/>4 MR7VVJ?PH3.$;_P+MH>=.]0)+1$2PWNKMQ*C\$$?+U-C4_:08H$M)=&%+HUKE M:1!!%_G2,[0MT*5@NE3B-C4^%N*9*@K\CO&)ZAME)8_TQ$8$YXY;?079V'`Y MF+A"_-CZ,D,>Z8DU<8@(KJED8>(.77MDEX@(/C0B>$]L[[:0X*]T$(Q\UI_A M)[[G[-Z[='@9132.+@?_3EQVNTM_^`_7N6M.'/CE:!32D1-3XJ0'!,3)3P@NA'E]C0_(.PPL MJ]5%<:E#S];M5K?08-^UH^PZHY?/-U"U`WEI["P%";`6>-DMV.*#EPU4M4K\ MO6?6^S`E]??RU'*YMU>FC]>L-.S/]/$4!4O$.TI;7;O*JA88AO&D%4+LNZ+B MK\;O4A0L,05Q=AO?\KEB:EW+`EM4]X:>N?LEJS?T,0B&WUS/PUY7U;8=>UW/ M=X@J>VF[:YN"33ST`!M10C>B*B"-9G<[H(WJGE%-]XD^^;'CCUP>H8>M(@D, M6.VVBJIQD2I;!UM]K((EMIE)L;(H4D?.O=`P1Y\G6E!;RB$YTW>M""YA+)D48MR8P1/[U MAFRO:IA%"L4LZ%TVG%Z+WYI5%*Q2H_@J.W\S--.V]JJH!F`O5B&/%'NQ"N[%RI?K6![I*;4=*Y\@L6G1!)+(OR,K'S/DD9Y2 MF[+R"1(FK@DD><[:([M$7OY#\_(7DF!_>_;^!^HG]$,83-Y_CVGH.]Y5$C'U MIF%T&<>A>Y?$[%[!AR!DV/M73+/9'VGT]O%CGNW>'5R&U$$F_\.5;`O?-F>P M0K)_M-!""RVTT$I;JVY5L7/MZKR^TPW>P#!.9H/>".$_,WMF3F-W2JX[`K;\L;\8AI63"/AI'A#+S M/UR3J>C\[+\D/GU2*4O70$WYJ=EN=4%-L;+\S'X,9M9%FB6 MF!7JN;)5X&WS@EYJ^\UW8SHDU[$34S')/XU:O30M=(_`;)GM.H$EXIU9LV7M MQ&B;,1+WSFR;IW@N[)U9T`5TJ3M=>GH;=`%=)*1+>X_[5SY=C+:EF<6EQP5? MP)>:\T77]%X??%$CAF MH?7;A97!!&_46I37**-2]2K:!/QR:U_3`AKRB$YLQKU\U5-3*38XW1Z,&XR; M_**#<8-Q@W&#<:NEZ,0:M\I?*(-Q@W&#<8-Q@W&#<8-Q*S8+?#D[Q;*]+Z5D M=4Y$'QX[-]<&K&:\#-)I:U;/1+`NZ`*Z'$*7CF:;HH_1%=4`T`7O@JS0Q;!- MK6?IX`OX`KXANR':3%09/%BY]>)='YR'&F M%]>#,1TF'OUR_Y4^4#^A'\)@\OY[3$/?\:Z2B&D@#:/+.`[=NR2FPYL@3\QU M-WAGYK MW/+\\KZT+/CYQ+*?W@AX_12M(FXD93P#:#WO&9O7$0MN<+Y5P!8Y\Q^GRR4R MH)Z7`_;F3#]+KZ,L^":]SM>G6?&D^?HTWPU@RU'/F4;T8M9XG3V'R5!O\075 MC"[?E.A1`>]D^H&:Z>[$KC8;=E@X=B9?E[^@4Z/+]\ MH*$SHJ73\?UW&@[JWVI*] MK6J96D?7G^\S0@$.`LO*UF6U`4O,.W?MG1B53Q+6)=/$C"+S>W;;/:?38E.D M]YQFJXYAF0Y0L[+W/],!`EA'.$`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`ZJ759WJ0+H\7UT)I,1>=U6EM_@9KR4[/=ZH*:8F7Y>76G M`LQ46)HG,G/E"$UAGTYRH*&ME60,+;AZ%N:1=5D*>D\%5``55).EH`R:H$+! M5+!;/1-4P*P@+WR@0GUDB5FAGBO;YKS#OA0*(TR5&__FX&%@Y96]:P.6B*3' M9LN2[%7T=E>SN\:38H`NH`OHLHLN/;T-NH`N$M*EO:>8!UQ'*BLN3[MM8U M1"^^H0F@3_+()VV9O5,!.N"+J#+(73I:+8I^AA=40T`7?`NR`I=#-O4>I8. MOH`OX,N!?-$MO)N+,"W5MSRP9:3@?KA\I8;ED9Y2P0SR"1*[XDT@"4RS]BH:QX_K$/['H>T@Y[5>^^FTJURO,;NXJ:57(_HX'K]^<(ZN#;VUI+VS55J9QGZ6JK0#4/F*IA,'?_Q;]&" MG.X>9V@2;HNF7#HIC'%:\M+QA\1W5RKLD;6*=X37R4B_S*L$D&^4"=2)V+T\ M+_@679P@A/U3QA],\.[]8_:G_.+"Y;4`SMTA#4:A,QV+$9D0`:&%%EIHH866 M4JW]<_M"0$Z^M&7>U#P@)W7OF0?I>?FRY\V9?I9>1UFP2'J=KZ>R8C_S]52^ M>F7+)\^91O1BUGB=/8>P![6XY[8<>I*Y&-FJ>7F)56#`2J??,NWRZL86$/F3 M_F6QCI'XT#F]99^`46.*/\U`/+C@N-%KZ:B#)E:6-^G"J/85QT'-8JEIZJVN M#FH*E>7GU9T*,%-A:9[(S)4M9(5].LF!AK964>I6[[5L%$`7*TM!59]!!5!! M-5D*JOH,*A1<`%W'PA^S@M3P@0KUD25FA7JN;!7(;570&\YO0R<-9?&3.'1C M-_`='ELTG7ITPGH9I;$L03RF(?&=.`G9I[.@(V%ZW_C7QP\-GMR=J48UL`2D M6]"[TF7S:?GO3`F_>K\"U]YOS!>EKG6;E9%S6=:=X!U MQ"HB!ZN"581FF`5E.`1M0)OFT*9M@S:@C=1@;5U45$8;HZ/UC(+J&X`WX$V# M>&/U1>]=-4L5%%J+URAY2_4JV@3\C%H78Y9'=&)30'5K+<7&9O:"<8-Q4T%T M,&XP;C!N,&ZU%)U8%E3^TAF,&XP;C!N,&XP;C!N,6[$)I\O9*9;MG2JS2*&8 M):85:7S0X3,/"!4%JR'O@+0UJR?Z/%U1#0!=0)=5NG0TV^R`+J"+A'21\!40 MV]1ZE@Z^@"_@RX%\T2W18<&*J@#"M!3:\L"6D8+[X?)5[Y-'>DH%,\@G2.R* M-X$D,'$J2P\F#B8.)@XFKL;24RJP03Y!PL0U@20P<2I+#R8.)@XF3F#X5G;) M"XJN;M_//AW/MY>7M/T\_>-%JNQY\5"^?3S;4D][2EYGL.=N9^P/_+YQ*Y[-?._+.(."$E[*<1B<>.S[KT(__6(/#3*<&)>:F` MV>U;8J^:;,R.]#=D.TN*@R>+%3Z^2Z'SD M.-.+:SKB=1B^TFD0QDPOW[G1P`NB)*0WS`E\ZP6#/W_^ZU\(^>GI!QX;PN@C M]6GH>)?^\'(X<7TWBD,G=A_H^^]3ZD>4"Y1[D5_I_9NS=PG_+/!O#?W6N#5U MP[J]"6[M6TOG%^TSDOAN]LW?6,,PS\B0#ESF+$5OSLZMLY\[7=OL,$=@L=>' M=**XCK>S?K>/Z[?19QVOM-\SP)*^MMV4`O'-8F:BW M3D2'5\&$?YYVZ3(,'7^4%BUY^_CTE5^=1_ZGRV]..'S_[\2-'S_Y[.Y)6MPD MS:YZP\SZY356;O\1^*,;&DYFO>'N+!LJ_R+_Y3_IY(Y[MWN@['97 M&%<)*`H(IKTDF+9PP716F:FR8#XG?,Q?[M-/H\LD'@_!87X6\W8^!.%']MMX`X9S2RH M"=YS.5KH0#:`.`Z\(0VCS%]A*[RUAT7SG8RC8/@Y/U:8;YXL'#&L;N[GU]EA MW=)N_Z9]ID[V>OF&%`[+9WS%O&8N8"]J]W@VGXB6L[&VY1AL;3U\^7Y/+S^_(EYN_O_]*WO_O;Y]N_H]<_G[Y]=WU,\"I:ORK MXBVD=3.FY#[PO.";ZX](=KH6)1,V9-;GB'6.DRU(^4V<`5L_,&J281*FWV:_ M]5E?R83U=1P1FI:'_27QZ=/]+5TCG(07)P"^_TS[CR2*W?O'[$_YQ87+#_W. MW2$-1J$S'9>S[XL66FBAA19:S6OMG]NKB^KIK0?UZ"?%]!S]0NURE(#\$0%K M#K;P%_M/0FC!_\M4X63,NL5#]G3W[DJLWND0,HUF-/#YFOT`."O,1%A_2>8; MZL']FB#O0O)J.;*CV"?G>RS@(#C8<`[.=A7/\VW%TJDXV\!)8OHO8 M%J3[C<\J!*A*A6KW.SXB4G%9IM;1=0A?`N&K!I6`7'72T2,]"8?(Y(OP0EP0KR7TRS9 M*^/EU"AG!=`K";V:5C&31W!"L][46H9-364$LP;TZHN>Q*Q6$4Y%T:O`IV[V M&>OFES1P%B+A=@&@DO_\J(O354ED#Z@DI@F.6;$!J::#"O04VX"4+Q6W/+)3 M:`]2/C%*O&&!;4C)C1O0DQ4]B5FM(IR*HK?B66>7Q^2=KF6*F$O/(XMY8%8V M%[=M)A+Z?>J&E`3^CC>H-R\1S^=@#F\,8K(E(99K\@='3@)ZV/J?;&O\E\O*TKZ",>/W?/T M-NX#A;SSUKOCJ#^D`\H`'?)\_`-*AZF2_&!U;/:)EV;?9WK$ M?Y!O_:H'HVW,%2Y:5IIY=Q>[=S!& M[4,P,A@+2L3(.!$CRSH`(]`I:WWQR2^.GSCAX]/?S%ZJ$Y:6@9>G%R3.E&D# M5PHNP,])'#H#RFS3P/'()_XBJY_:/G9U%833($LMF-Z'\(S*YSRE,LER%))Y M4F7"LRJ3%_R.9^E7^?79RU3R_(_,AM/P86Y4>[K.HY,7K/N",OTM6K?U;A0E M#GL88?X:S4S__#&M66\O\6&S5/O_A'X@_2[WUSX_%*_^_=B,.93C/\]T_7%N]`CME@(7$7 M^$GTDDSS5(],=&VM9W;3WUN&UNWU#H,KG7,X7I1QE'U]2GG:.NH]MLA-RB0V M79T/G&B\-*KL9R.>B9II!KO9.V8ZEET6P]">1K3U8XM[1$O,OG?Q9%+?-:UF-T_3BT5DV'B>8_D(4TEO^FFEZE@MLU< MW;:E6;W.$2)\4N.]!#C$",Y<^,Q6%5=UY- ME13":T\XH0='I./M]&R[_

?`YBNJ%ZC60Y7U7+Z2I-VM;T9MT6N?[[Y=?W MY-??OE[]_?+Z/3*RKB\,CE_=+7NELU7DD-B69G;M]%9&3]>F9MF]6<^[_;6> M\RV.;$K:ON0>4V_(5('$S']G=NEQ-F7&;I@N,%R^)`_61I?^)/,`\P>2?S,W M-4ZS2,W'J?&%.&7JO'T[9;9N7P8J[961.I/\"WW-[EK;1K#0^34`=D[>BP_\ MYJ1;`!,WSI=/\ZV*9,HO.QWFJYG,"QH.W=R/SKN3S=QNO."!SW_+B.;G[H\? M9#M'F5O(?0M>A6[FC&1KLIN%#CF#09"P*3;;$YD)9_;,:*:1@R"*R83&XV!8 MJ;]PZ&RW89+\E#JU&S4W.XO2KRW6# M_L[MW78/=7\MGSXSD$\]W?.DHKJU'\'E*A:G=VN]PL:QBPC3W-Z5#>4O#GKZ MX0N(%4TZ_NF7`T;,D',EBO^9FOMC2K3,B7\=LXF'+]VN/">*&/C\`:D5F'WC M*IU:T[\?6/#-8I['GM&M][ZH\6XL?"ETN";SN2H;[F9#)E:\S"6N6KR=\H9K ML,7`,X?[F^],>+':_[!Y@M[%G_(]GDWU1//2@08;Z)+B7K';N_$'9^!Z?.]E M<4A?Z4/@/;#99_D[!PZO;2[7#MS=U^5QK=2]R0SXN^P@+;/B7YY.4"^'O'`% M%\YS:DDM=E]GLYS16>C[B?T1.*B#RO"NC*G7UJ4>T_&^$QM4NV]*/:B#RO>N MC,GL]XTRQO3E?MMMBF12S^K8MKUG/-N[(F`1YVMV_)-(R3^-*WC:Z^ M5[VJ$,=1%.EW;*O?[XL=QMJOV"+2'13*#=/N&/NYL;DCA8_A)%XPG]PZ@!%43IA&=S\GRA7#L7Q@*^#>LX;P7^?G'X(@]H.8DFN:;A6>G[./?GKU_2[T M6./_`5!+`P04````"`##9?YASPZ$-``"TRP``%0`<`&YU='(M,C`Q-3`V M,S!?8V%L+GAM;%54"0`#SE2Z5`L``00E#@``!#D!``#M75MWXC@2 M?M]S]C]X,R^S#X0$8<`EF@NV>?YAA;!.T8BY5LDLROWY*QB0D6 MEFQHB\M+`E@JZZOZ7*K2S9]^>YTXQ@Q1AHG[^>3\].S$0*Y%;.P^?S[Q6GU]>O9>^]YD4!KD!6(JI^>+*]'] MB7MG7)&[Y@U M1A.S3:P`T>>3L>=-[\KEEY>7T]G[ZRNP3`Q3OLN#>$C>)BO.K>$UY[#+/=*WW\BOR7ZI!Z?/;V]MR<'51E.&D M@B#VO/S[8[L?Z*6TN`%HSS`^4>*@'AH9@:0[[VV*/I\P/)DZO`7!;V.*1I]/ M7-^C)6Z!LZOJ&,B30OY'K9,Y]0BDS(O55:2&R"74G]YNW@75UEW5">3*45C*(-GJ`4/ MXP1M4`.I=])3)R8;/SCD99-<$,C_B?@;F%D.83Y%-8`;D#O$6FJ2PZ-80I@73I:+TMEY&+;^$O[\Q]QBD63''"(GR!=B%_^X MJEY6;J\NKBYO;BK79U?GUQ>1C8IH:]VG%-2_MLEA&=[RZ^KUY04T^>+JXN;B MNA)K>8Q?-;H,PJ16)!\^KE!NV7QAB3+S)Y-`6@D#0Z+Z(THF4AH-[T]4L!!J M(PKIWHGA,V@BF?+;F\Z)\8+P\]@+KA1A*1Z&@6/@_YK0*EWT_&1P()2=76U[#ICK1HX.U1=#;\:KW:0E_+$KJFR'V961AA:MZ*;=:.@ M_0W:+[!FO,A^6"\546BMJF[6>J)H:F*[^3KEX0_XF:XW1E2F$Y6HN1^VS0HT M-/F%;B9OH!&"5ML#\W4.HHW-(78@)T4LU1'+5=X/P^?`&MK^4C?;/U$R1=1[ M>X+,Q@,J\XABRA,5L;->5T57.TO&SLK0=.USHSQ;8,+H\HZ;:RT,73O8C^,> M0*WFJ^7X?-(MQ6PR57?/]6J MTO5WW-+Y<(;6O]+-^C$0$!#T/6+].28.M)7QX,![$Q@]K=JR3BO%#8_&&IH. M13^&9M+S*G?3,.HZEJO6B([\E\X^-[RX6U MMF*V`4\)@!H;E/K(EGXJA>7WRZP*&'5-J-O$?1X@.FEC%W5'=0ASL-#5)A35 MVIZRSE86EZXV#%*1>%`JE8\E5M@'>RJBTW4\13HD3PX.M;5BGG!6$JJN#VJ= M3";$#4"LG?/_4$P_-Y4YY,;+?V3BC&!U?69[?/F>B^RF25WL/C,(^_P)-P:R&VB$+6&XE%YQCXR>$:RN?6^L M^4$TD;"EH$T8'_WKC@;FJS@+4I&R1W38!')=)SX&%)G,IV^IW?AJP3VRL"2X MU+F/TL**G\H?ECAO?]US^JZAF`V$*Z$KLBNA^P/X]]CL#/I&]P$N/3[UFE^A M7.M[TVAUX'M3[]71"2I*\8!K:BQ'_%?%311`@]X]4FUF8H>/T@U(+&`)'Y![ MDV%+@%11BGZ>0-54JRYA$RK0-?1_!_8`6@,?XF'7AT"G.T7S3<+L'HT(#14' M.D/L$;N$@D-MN1ZBB'G!UI"XE+F_?43>F-A\627S`E=W:**!Q-62^I&G:#,GC%!*JDU7@GRAT.(G2D;"Y#=60C]" MR*I_U7!IL'0U6-]T$.NA&7)])%X`^Z&4?H9+4W_"@+$$)%V-5B<,XB^^.#`8 M,T=TABW$^M#/":-M485],*4BNM3QQ%)1SR)R'+[H$[G@A?B&X9H]P2YF'O=) M,Q3NOA`]HE*5]3-W=I>;`[&V%*A-"/7P7X'2NJ./2X-%HXEK*^V3R3,@31U( M+LK44009\K2!AN*]@BLE]3.J?K&TK-JT=08+584([L'3B0-K06G]F++-E%T. MOK86%TV)/,"#@Y_=^3(RZVU`39>95F`UUPZ^A3:T_^O/'Y)HA.Z).TRXX'D4 M#WUOKNDG,VT)T,]J@W[LS#_:6;P"=9TQ_Q'<'MFU&?0)SZCC3X:(=D<-[/A\ MSF4,B%C7]_B)>WSWDX"@BE*TF4X0M'NEP>LF$Y1DZ/=P;<)TJP]N0]<-&3V[&#(&6FM*L9I[1K_:_&0[O[0_-COOB9 M!J"1)TIF&.#?OWT#W;7('[)JN!8KA$T5R@^C+50Z4%LHJT771]A<3N]P9=MT&9E,R M/WNZ.UH[J;*VSH$20ETGJ4NUBQII;;Y:B+&!^1J.$_/IAB#)"][%P4?O(&V: M,W]5A0+*Y))YH)3:O,X4%I87AZW@Y@X%LF4`/-_[?< MU8-PQ7-^J54/E"&951/2Y%H[_[&**/9R$&F"Q.H#J1)&JJB7BBW?!MJG/,PA>QB"-OLJDH MXH]VX[T"]9DG1O<^PBR!F MFQ]=$KRQ:GY%M"=+1<3.L">/K5<)E5M%J=/8107**\B$[^&098]0P)$[612D M[18!@?(6L[.;[-LDA>X,PS;?M^71D*ZSY8#10L@.=F"UN;M-.?U76'YG>)'' MB@F>1TD?NJZTZJ%IZ$&[(QD6",L?*`O4]*%M=_.T`"&UBDI4_$!)H*0.J9W* M4XJ#/;,!5XKN'5J,^?SUX,$9>2DGW:;6.U2*9-*+KD=@1H1_(!0Z:&NF_SN>(7<.*_8G>%;CNQX*SJ2[^.VLH>R@9GE$.93M+IPK,$/ M-7?D]DQ>G`%?C9+Q+@^^U.KU[C>^-[+7K#=;WVOW[:;Q:RCUGR=:;Y%_25+;'ZK&>`K.L81\UQ MR`L/N"&X:A!_Z(U\9Q5>"@-49.PG(7)K0&'T8\NN/K825,W'5U=]?*OSO=D9 M='NM9G]7?'L$_TU\%&B\R#)!*L7Y[D6C>N;+(\0>%)O.?(JPAQBBLS7+1-(J MZO?(IEH@::E')IBZ^NT%G!^$_LE7WA*>T"C96UQSOPRNB%/7]18+/`_\A,\Q MLH/37I4L+JZY7Q97Q"D_"[GU+`MRQ/F64L6^]R(IO_KWMU:_-6AU.SO3^4:+ M6^ID,L1NH%`(G\BSB_^"]-P&Z^(1-A>GG48+7[B=7[###\"-OTN1`<^0+>[' MMW:W(MQ#1C")(.H2>QNV=C_]7-&661EW83]7J[H&-Y'F!-2++A\T4]8J0=<8 M9I/T_GCT=;!R>S`VW13V_-0V'#1%B]>T-I%=3'T?D:@%>I>K@=Z7;K?QH]5N M&[5.PVAU!K7.EQ8?3*_U^\W!SH1^/&;W4!O/5FTMCN#65XK/W%2!%(4=+KBF MF<'`L3JZH)I^SB6#/5;=1B;8NH8R:\#$W@,K<7:;NJ##HX>*(K1=;J@0_+YK MJUJ<R$98 M%6HC#]&-,FA)XI%&4AJ1WP.H15<[9JSES M]NKNY.Q;'A;5SJGD&8C0RS6H6$[2&XAPZIHPM^#Y'8GAR!-93'WE.`SDZ(4<___.O?_GRMT9#NV$8N=C07I?:(V:,F*9V0]F< M,N1R`EJCL6[X6W?XH!E4]RQLNYJ^[O5&W-FV7Y<18XHU[?SXY.SXXN*X]=&[ MBQS>FM.39$Z/3[:_;,:G]I5VT3R];)ZV3LZUSU>MRZNSWM^/V5F<>433FIUEES MVTO90OS7V#1KB*\:)Z>-LY/C=\.G6"037/QJ^%N._@;GS=7/_J; MD@C2Q'9<9.L?I/=8>3N3K4\N+R^;\M=M4X>$->1D3YJ_/3Z,I`H;VP&XHC7M M"Z,F'N*))BE=N&68]/%7?9>4/,V'!WFE74Q.0A2]\N M5_IV7=+CJ7#7>:UYETIJ622[B.D;F=8?_9QL*1#;;1K$:J[;-)%I!@56#+OQ MEL(MGTL]^'H&U5<`5_PSMD6(U3"HA8B=D445F>+YE>0;%K9>,::;WR""=$(YYFV(+4.>!]YFW5+P4T3HY!L6 MO[O8-K"Q_9:X8HQVJ]TZT1K:!R7^3^?FEY?^J#_N#YY&VM_7Y/Z18M&0H@DX MJ!Y@PA01/`TW7DEJ@IQ728_O&9^+!I.LYQ,:.XU=)=^G[;XQ>/U9@$[UB4^ZJ,I)IUB!L"&^==^(H9%*V MWK+^880=%A2"3XX-U?4\R3C]*3,PXYO9#;4)HU8>M:^9I`G$]!S.-)4>'IEP M`!,?&<:W`:^1`+J=?B6!N._6HA&,,.+JH,Q5%``R(XP(]@93/JV01;$\'B0N>Q;%G+Y]\@,6X`>`_'2 MKLO(3*XLT(-!7GK`0\W<#WUVD0'`/T3V%$>X2]_O-3C(T_( MX_4<;%.IGA6K>YR>@QP#T'.($WK@7_1=;*78A?JZE(2"S!^F#H#V1`G$/JD] M\0Y>JWS1E4YM%[^[/1.+S.SUD;-*T7[\;E('&]='+O-JRC(\HZ5,&H_I.B+< M"(R=>T8=%=#QW2!,N;2PQTLU9X0RXBZEI0&:HS?4>B6V/#D?8IU.;?('-OH& M%X9,"-H>/Z[%,GPGE`_\9V)RW6"'M_$L;#QAM_/JB%RD&S/-2QNU4N,Y*\9X M2E?*#V)[H8+>>(SQ#JN6Q5I=DO$@Q&$53>4"3#:)1J$9ZT9-"MOZ^!F2WZK0 M%#X4``VY(HUTMQQ'%@*,9\B.,8^*>8#D_@YT.4J@Y1_$T.,T7FT,5['QM@_= M>./U".*9#V2B.I#/1Q*2P27= M+.23N#B3V*]*$]^$B;,IDWQF1,<=TUS7:<>NL[WW.=:Y&&/T?HL-3W=E6XMZ M]N[*5.G(E1K->3ZCJ50QT):;Y'*GM[B2QJC4MCX5F[TH2`6`5ZAGS'DS[BA; M[Y?ZGL_&-Q^ZS\\:)VG6ZW_-.X\W?>[#SVM,QKUQA44 M_RIFU\%X=5]A9`KX[8)B+Z[RX?T7\HNS$1MWIU'5,J"O67 M`A>&NS]T2:4#`!%M!+\?W#XA*[H$-345(,55&6P^(=CA8O]9`0==ZE6M$11? M,*;P:&.&#&PA]MV1GP0'XKKA,W)%54%HP5**?A`.*3.:\C:02R9I&=C<>(Y+ M+'22XCKY[,UHITFV#FB=H\0)MC%W>F#,O*'35TA9"%<.:8 M%]E"%`%@L;[%"VS2.=\E8'UF4Y-.ERO.(^L-8WM!.-++`7%B.0$@&!-')HRL M4U.I_QY!*=%U:CW`MX`405S;^_LR>\29.N]ZZ8G'F>^+6V*CJ>RDZMS+A<28647_=!MHB!;@!&3Y9T0>4P"HBGL MK8'IEX0T)"!$:L6:0!KIH<,O]Q;)YW^RSC!F?7H[CX)9)2MT@,/DSC&OH$EQ'G86$-ZR_\3J!Y_[0)$P+`DA=D*[)N(+PID-,PM3&I00!4 MW9$3AD`QPN6G%JCZC.S0A(H%`*TA7E!SP?U=D.GH(^3H/A#"OB@C#!PN1XM2 MQG&G8LB.KG.1^$!W&+G<::N+85(2@!"HQ<&112X`D^=7Q.1#0X;(C2J"V6]6 M?S5J2I>_+P(P]4?ZF;"&0)R]RH14R@?DZ'.H'[23SP9)\0Y>52Z#.?/(O/-L MPQ'#JQV%JB4$!ZTVGJT_4+$/P/1['J,&-4W$(@.E_680G'&TZM6\`]#[,^.3 M66GTRE80CI.3:7V/]3)6D)'+`RG>>#G$#F8+M4)C6T,XV$VPDD2)`"UQ&PS( M]@XF(S-@#W66.284('A?+23X/-1RQ0=J3\>864+BP62UAU&@%MX4@F](`5ZX M$-"FDY^[[>Y^]3*'+F6,OHG])IKS7]RE"JU4)"#XFC0HIA(.&KHO-EH5QV%# MRNPXGGBUNGB4D.VH3@WB.D%P:BD0C!,'&F9)UL?ZUD7%PR`SSBAXV@\*,9@2OPBY8$&6UA8]6)SQHQ-,'5# M+8NX0O([C)\QT_DG+E:*�AO4JAOBPE($TH:>E/'`WC3=KA`IEWE*V>:DGT MC6FN7U@U6/D/._2QB+E)5IO,;67&MQAI04,\?J-%0RQ)5@MQ]K1.,=+"AIA3 M+GP>KXE6"W/V!%!1\M9<5SF:(88WSRE.^1C?B_T*R]'7SK"G/;\,;[YV1KT* MGMM;T)O8MU?+1R[5OW>7\MDD4467D3WJB+5$=E]FA24C:[8BRC$BVL,IQ4R` M2^"5J&J9`$3#?J:B"P)#&@(IU(BULD`%8(@8AJ-['^UX0%#%9?&WK.X&-9#[\1=HA3J;ZZR\X:8L5Y>`L7''C8K' MIW//1:LCX!YB-K&GXF5HTBB2Y4F*&:26M\GFX[R[#"<0D9PI=42(Z9TB+3#P M#MLR%0D@(`EG+_:)X?'=@.2;*IAZ\>8"[,'Q)6$..K<%S`XJN^;4L^8F76*\ M>B7-YC]_J*.^LI"\+X0\65*KWL:MR<4#.V<3VV]<\JTX\O7EZXI647B*KYA` MXU!O9^24/O(%Y071AI"'+-,4"U+386RVM[FFV,UV.^=FNWTPF^U50")2)@)H M'@:AE8TS\2H"L5XXW>5'FW7)B-1JPGJ$O/1KN=)J(EOX^H@]<;`)Q$UL0<@& M;L(&A`80R&P8BMQJ[#8"LID,,[(P90/:ZV50-^A]7#H(*MMF;6YQKEQ8WQ;% MU-P_"VYXXS/U'BMA1P@;K'!3^BAE3"8)@#D1N\RJ5MFX7501A.O;/Q6G%D5Q M1%[O=JB;ILR*59V<%6U^ZG$@;*9*LLOBE06MV$#NL<1%9FS<\FVB/5V5DZ\8 M#Y=?6>N;@1*$+.L!91U;5;!S\YG:#(S?OXQFRU_OY7['CBL?"K[0R MIBXR[Q!ALDBGZ*4K)S,0"F>`K6\Y-?K#F/G..K]`Q!1AR!UE][RO*HE9WG`0 M"H*`F6JLSNI.UP#@>-Y[C4@LSO@=X9M3P=%>DA4>8+8B.$UZD*G2L6J]@W6-1 M0S>?"<-*<@5KOSW$]&8)MA!Z>6M?&Q#\T&HM\/,6F9.+:`\D&QIKK0%PU.+\ M2."`SIT6`UBYU[PB=^=!;?_W[RV@')O\/$#*G ML>8E%.]GNI0''E.&R=2^D<,0'%'WHVH)(AF41)614@!8;M9>;<#6/BWJT#*T M*9P'WU?FW<,5`0=,OQ#1AVWJ]D`<>Y1YAD`2)LF/A`MHGYX;J\J.2+M\2\ZW MNT_\\_IBT,B;SU>G-ML2H"?Q;A)D;KA5^Z@\U""$!+'6N?5C>20M`TP)=:*N-9Y!IQ`M_)2YT##D8$^< MD8F=M=!/6)FKWFT%87IFMH!=83+E?K\T5XI:YT[Y-_\#4$L#!!0````(`,-E M_D:(MWOP'3\``/`!!``5`!P`;G5T&UL550)``/. M5+I5SE2Z575X"P`!!"4.```$.0$``.U]ZW/CN)7O]UMU_P?L[(=TJN3NZ6OOWCP`4H$"5(@<>C=+S-N M"3@OX?SP.CCG3__YN@O0"R:Q'X5__N;C^V^_03AT(\\/MW_^)HTOG-CU_6_^ M\S_^[__YT[]<7*`K@IT$>VA]0)\Q(7X0H*N(["/B))0`NKC(&O[WY>,=\B(W MW>$P06[6ZZN?/!?]+HGO;3%"OW__\;OW?_SC^V_+WI=.3%M3>IS,[]Y_++[) M^4?A#^B/'W[W_8????OQ]^C??_CV^Q^^^SV:?RX:?J8J;/S6EH$?_OH#^\^: MLD2OL?]#[#[CG7,7N5RC/W_SG"3['SY\^/KUZ_O7-0G>1V1+27W[W8>BE[(% M^]=%WNR"?73Q\7<7WWU\_QI[WR!J^##FO#68Y,W9MWY#>S^,$R=TR_8G]+]^ MQUM__/[[[S_P;XNFL5_7D)+]^.&_/]\]<;M<%`RH]1#Z$XD"_(@WB%/Z(3GL M\9^_B?W=/F`2\,^>"=[4"QP0\H'U_Q#B+?M1F86^9Q;Z^`=FH7_-/KYSUCCX M!K&67QYOE;I_7Z&5=>*::9GW@]!'C`?6^8[^E:G`"#<0X7PS2TIFP*\)#CWL M"4LQVI%;:1"P,1:1JJ'"-"$7;*A^^X?OOA5FH)_\[3ISI7GH+<+$3PZWX28B M.SY&Y^LX(8Z;Y(2X^(*2;K^.9F+*,"9S4M7((6XN!/VSQ6Q9BP]N1(?3/KD( MLI^,=]^0:-=-!2%&U*'3WX)UCR&2ZUY1G.`X2HE;#'JM$2/KV_4W*V2G/1E2 MX_#BRU,'9?XC9X*!#2C_XF8/@1;WT&\F%R[^R.`;"A&=`!V*88 M&WZJ-@`'7ZNH?8=>-@>75!$C.^[0NZ(CGSC!+5VVOOX7/BA5/VT'?O`I5*N. MOJ-&H(>?2M8SQU]&%G&ZB!(>:P3F"](5)5NC]-'7@,=;G2+Y,)._`SJZ:D4\ M>Y?!J(T]DAXP\2.ZA?*NZ:3>H.EQNPF,K5K5C@=9I1'PT58OZ]G#3I"E^UL/ M,<)CC<`Y9>XQ`6X"9UNC]?'W@$=L$?\4.48-:0U/`HZQ-P7S`J=H!'7NMXO8=AAEA)"@C1GITD,N6H4*2 M1[R/2.*'6[:#3H\/3C2:`QZ<.HH>[2-JVP(=I%HBG[NKR,9K01X)^N..U1L_ MP.2*NL@V(NK-[7$K\".S5JWJ@*PT`3T.ZR4]<_AQHBBG.C)`1KM=%#XED?OK MT[-##;9,$W:%RF[8U=[8W`G\D-11^@@R&WJ`'K!:@I\+GYP'XDQF2+!!$I^Q M=];E@N:&?E(WVZM;`AZ[+>H=[Z^/F@$=I6W2GKW'EM>@G+2=T2BV^GKCL=IV M,B.R1L7Z,2DUG,2HK)/7U+C,CH",C$P#=\O+S8T?.J'K4ZVCV&^(W^G8%>@H M[F.`VAOIAGX`QW@O\7N?!BSOGY9WM]?SU>(:7<[OYO=7"_3TXV*Q>K(WXN=Q MC).X96R?-`(^BNN5DL=KM07@D:D0M/?!*">'?LD)G@1-&%$HP23&=V-K9=N) MLM,3+5\Z;3L)EU*H>.I91PW!.YA*WO-&Y*PX48/A<*:US+5S./4?[#G@E1,_ MST./_6_QC]1_<0(J5CQ/KAQ"#G3G_9,3I*H@5=V^P!VTDPEDA]7J"-B!N\G? M>ZA3\CP(F_\A,9HA)T$Y+\29#>+B^_SJO:F@/&+6UQ.Z]^LJ(HY+Z#%'ZQ7K,TB)L%)V)I'.(!U(U2IP`O*KCH=1M M^$(5B\B!:JFPR%$3X"A4IY",.O+W@%&F5LR^PZX@QK'$#H0,HI"/3\Y.QD&) ML;09#P@>"-X[OK=XW>,PQG1QMDR>,:GLOA6VT.L)'#8ZJ"^CB48WP"#31?J^ M@SOC@3(F?"?*V:"CDR8[L#2F";!@$G,;1-P&;N4#]UH MAU'BO-J<\77F]HG-XJWS]51F9K,3T"@S;>O&VJA**\8.S/3Y0*(])LGA@6K# MTZK$_7W+"I#O:MNZ0+T!NZ&6V/V7A8+X#''R(E%.SH!/B^]M MK8E'T7I?:(U+K:T>AGV*(N^K'ZCL(GT-W#V/%9%=,?\.L-N=B-AWL.6$[/C1 M1-1HF[B-J5'<-3L[=@K.+B&W"LW&/`!/J#;^.L!B@4(Q;O'J!BE[]M""!YI= M@6-%%P-4#]+;^P'&F$[B]S_9S9G(NUWTKN"$-V7]46.(0UJBAC5FU#P"#5+&_?X5D]?B$VX&@ M(74,H_`"RAE!RR%CJV]VZ0_<7SN;HL-9^R3\NKL.YD_<;?N]!1O(Y^Z6CQJ$ MRHU'I?#]N*K$Z3D[8`\\$M#L^YTQ#]0-G:3;GATEYY^''D]$\!P%'@41=OJ8 M'%K>)G7H#MRGNAI"]CK=OH#]LK,*?8>]Q*@X>4\.UI\[6=-?9O6;S!H@X$#O M<6)CA^FXO,8S177K:;BUZ:=\$FDXKQ8'U#=7,2A96'R_F$>T/S@'%LVN][[E MI#%P!VU6LNY-2[4E8,=L$?CLAPX972#O5X;2^6-]8]@NV2+S&>.5449U4Z8UQQQ8USSH&M):5GO1`-\;]=QP4OXWP&`< MS^':#HT&4*X:BBDM2RVZ7!1N5YCL[OP0+S=7!'N^TNGJFT)WNP8%*XY7TPZR MZS6)V]OY*-$+.A/M$"/+HHX$8?M7(`.KZ^'U,(J]8+*.K*MV0?!+%+RP&`N7 MTT<;QV708_'#2X MMG(\!HR%0BE$^X()OD?6J*-8A@/VN3HI#2R\K:^W#2VT0?A-YPO:*5_)=KN$ MG>2UZX`7C747BVB>),1?IPD[-45)A!X<$--@/N MK"K%*HDCC]H`=DREJ+VO#RNE/CC-&;J-XQ3;R@4XD(8QHVCQ1L;S>!)V)WAP M?.\VO'+V/IV^)6U51^(Z'8$[H;[RE7LOP'[>0?B^PSQG@7(>Z)W$!65L++T8'%-_G/&P&E>1:\=/ ML"B:[0E^QF'LO^!;_IS@+HK9>X7E9N6\JF^Y.U(![O<]S7(4F=&%!&!$Z*O) M&9$-!1:(8]4*1R18HG>,Z6_%@^-HP][_6`OQL&:>+,E>Q3SB$9`]2%D1[,0I M.;3NO6L;`@<&M7*R[Y^V`NS>#<+V/LC-2%9VX6:]\WNA6(BWS!&:_'-(_2SO MP4^/\[3/_>"[FEJYYM-HP*[6(.P(I\]V+H@&T%G<$\4U!\X@+EIKWS6U7Y^I MN@%W4UW%N[SC`^S"VJ*;?;=G_7)W&&5/;GRYRK`\6RSABSJD+??`ZM;`_;A% MS6IFK-JF@+VV3>+>5S%RX=BG%?W?Y\7]Z@DM;]#5\O/#X^+'Q?W3[4\+='M/ M_[VPN%)T`AP_XA<` MO:Q.RM[)@ADM)(A92AAL7)M]K38C/NO88^(D?KC-Z@3%+;NV_L'["0<#R]^*0RA30>7ON[?S09YHF M_@O.=%@)VZ8X*]+Y+$&QF*&/$UZQ55KGG6]I/CFR' MK60'I\+*8L3.+B*)_T^'Q0DN-\?IOA6&:^T$W/?UE*Z$WS3V`.SKFH+WCAZ1 MR+/-VDD&?TM!-.-J[1]G[`>P]"Y#A=K6.I66P#VW0;W:A7;9#+"/-DE[_GJS M$M]F9X<[A(*96FQXH$C0CT*+CD=!!E/C)=FJX1JOU7=Z=2V!.UZ#>D=5;HZ; M`7:\)FG[CTM!,U_:SM#U4'E%=,K5#*=?6949YYI:31%?8LL-';E744@!)Z68 MLRS`X1)O(I+%T*Y84OO/?A@1/SGD.M$M0)6*B$OXC)/GR&-EY^.$W?>J9M1Q M)0`/&*/_'*=!!:.P!PUPXUOAS`E=K%/$O%X*C$J)T9J+G`CC-YEM*V5 M%!Q&TP>`GGF/DQ*DYB^.'["0\E4D/7K.XC0OG=AW%1;K3@6X)_A1,V5L'.5%`QG>&.&<[<&'#//5/`,=9&L'1=]1D0\=//O/G MGBV!%'H]@<-A!_6/LA2U=0,,>UVD/R/3C\Z[YQG4=&-CV&BI?`*-W@5U)^@C M)\NML<$-W8CYVU#D)W96>V#76/0+ MZ>=>1>+'5IWDCRP#<*BR\I.<9`D>2P#`\&G'#N>!3",<9X*C7'(DBJ<5;]GX-S8$[KV@)V MX5:1^P[7(M\=I8PX:>M;M,%T+<]ET%YLT'C26L8#CH&ZQ\LTB1,G]*A!6M:X/<@`=^>^AI']O"L-P`#06Y6^#I,S1!E')%BRK:]@ MBB2N!6A87V?;LY.3V4E>@<U2[AP$;D!;D63P?@JCQ4E_%S-J49LB@.B;J15*VDE-#50Z:&0:7O+5 MR2G&2%>$@'!F!%-Q%NPT'V\VV!4)I5C0&(KVXC4!7#!:;E3VZ8;E#52F"#[M M9M%8OZA(3`UL-#09=V=DYU)P;-O(QRS6P:/(0[O<7#GQ\TT0?6U+N-72!3@L MZ"A<3>JO;@_8X;7$'B+5\/SI1W1SM_SYR>I+$:8S?\3B8>_R\"7&WFU8)!*8 MNW12YRF^ZU[+M8Q^8\2!^XE9(QX]-S%`&;#O&5;PG%MO)@?*!4'K`WK'9$%^ M^%M4)ODHY9DI7LW:/K$$8E%NS0V#TDKJ$&HKIQ#`8IWIBN_S^8?^'>`L%EU._J;X:32[ M`H?*+@:0H4^G'V`HZR1^[P,$B0G+$)6Q$2E2)49VH&5T$XB4J`UZVTJ(>N.' M#@6P<,NJ$>BE0SWI`MS-=116IT*MM@?LUEIBFTH(6I!'G#Z$)*@#:^SA#2:$ M3N2;0O4-MEJWP_%#M@9:AM=^O(]B7YBA,:]Q6Q_@GJREKXOH(-;8L$&.EU-TW5JF+)-^?G+AL MSQ]M^OP*)?_,5@WC8>W'*+.0L!!YG+H3Q,QP^TSI&=ISRS%[X-QZ%L/&7UU, M=TK.:Y9XB>5.RV/EL<=>A.$P%AAZNF]2V/=Z)3ML[P4<>C35KAY'-'8!#!^ZDO??@6=K]M&S(KY@LH[:SB!&4EY.C6@_ MA37!#DO4+?XOG=5>.7L_<8+VG=C'*4\U>P-&`!Z*'%&8E3.`KW+ MF?V6>H:T(L@86K_V&-$F5\^T']W)4#N(LBY\SR*5ER_2OHC@4K[-<5RZIQ$[ M*INW%Z=FFKMNE(9)_(A=[+^P5![:%J[M.CGX4!N@&3A.^TT*,AK$-PP6.2=4 MLK*U>QC%#(6^I*`);@'!4K^'E)OZL**MS^3\O$;E9@>7.DS*L^OD-NS2$@LX MKFQ6;Z6"-MWV@>"]XWOY)B7;^\Q#CZ?/:[S$Z$ULQ4C-"*!#:5+0T$DA MPYB1\2Z.$MBB662\'*(DY#E`,HJ5I0=EORQDG)+$"Y.BFC9!KFZ_S(?GZT>*EC\\W MDIB<[[<;I-/J?JI8H*'&T.M\@.`PH%5.U_N!6O^I/+=7&/9LHL!1Q8S1S#VK M!XP\AA2S_XS>6A%$V^;3>JT)#L!$X>N!\H5T)SY-0.MI1`U@ZTAY>@#75\&! M@*X09[KY0L:VZ'&^$+\P(8A'Z@_.(M]P9LQ89H>,*"KY%:7$N"OE3&U=[(QJF+D4 M"\HLL"YX`4*,_#$B?\\X#[WB1:.N!9L(3`TM6HW1B!7*WE-"BG8E3.+$0_$J ME/.;\>B(A>I9J#64&-`H5/QGAS^8!?M&]KRUV"`+//C88L9HYG91@#'(D&+V M=TV@CH?&-!\_'DJ%Q6KW2.#`J\B',L314'?BTP2SGD;4`+6.E*<';GT5'`CD MRHQ%DST:&MNBQT=#9>8C&$=#)'(Q]F*6..&.;3OIYI9N:I6Y`9K:`T>G5E4K MNS958\`8TBYS_^AT05D,84Z;G]5PZG;<>RQE/;RVN*=ZQ/MLD[GRL:`W;-=YKXCMJ3,O')0]]0_'1E.W>*$B"4/L^J>#X6&6BE`&YH# M=\XV1>L./">4]K-5Y/.'ZL#I/KN?6@ZJ*[A$G_)RX3:.4RH4IH#$R],^L:Q= M&LL,53_HOJNKNFK]6]L)LC=KRVYFB9CSX'.N*'C,V=A?&(^AO9_QX'Z?UWNN M4W_\:?DF(G05DEV=:'F[3D?H[JZM?-VDK>X%V>'UA3][U=55E">SE3."MJ"H5UI08>&]Y=PR`7&/#1R(S1S-T2`L8G0XK9 MOQ4$%?HPIOE.7L:\2W/SU=T(6JQTP).4+C<4WGEBTT>Z]%R&/.`U]-C_6%#; MBQ.PU68',#-`%CB3!F30!0YHQU7H7/N`"L,U,+@)B,K!+!8YU;%'& M_Y`$&175VM9B@"R(ED:!!8+:Q8AZO'S`Q(^\XZ0/"N-U)`$<)?H81(:)+OT!XT0O M-TO$$/CXNGQ?UJ MOKI=WEMM``_B!F%[SQ"<)-N#RD\/5O@U M09=TY/TZS.,#C-1+YI!E@#VR2MG?^@JNK MY9?[U1-Z7%PM;G^:7]XM[`W*N\@)X_LHP?&*.%Z1I5_2^]J/W2"*J7,RE.`@ MH3!67UK`!_99)I*'?B]"@)WC/'WZN@_G.D.<[PQQSE(Q#(DY*KD//\.UGC[; M,18HK,FK`AU*35LK;S;U`(X;&NI6T^$JFP/&`!VI>R>[O?^)KMJ6C[>+)U"# MMFT>;.DRO6';.*LUM9_6P#4'NP5Q6'/0L#I#\-8\[]A5M%O[H5:RB98NP+U5 M1V'96YO:`_96+;'[+Y+^\N7VZ9:=#CR]!S5V]><<[<[3&\^:\Y!>SVF-\2%P M.F>#)#ZPIJF1#"&[O3VO_Q1%WE<_".B&\#9,J"8^W0N*.FC:VZ2N-(!C0"^3 MR%#0B0!@1.BG1U]_^+1<7O]\>W>'YO?7Z/9^-;__='MYMT#SIZ?%"KJ'M,V/ MG8F\!1]IG"^[49BZEYB;-G)V_-"Q9)B5UH0UDXYM&J`(7*Z@#,JV^4O=>E+#LG%&4C2=S,`T!Z2,+JR99#!- MK?H@?^G_'`4>59]%9R8'=D/7,D&T=@+ND7I*RX[9W`.P?VH*WG?P/OTX?UR@ MAR^/5S_.GVP>>]?KJ3^[=.D_R=&M.0-I=Y[^E1:`G5$A:.]QMUI>_1=:/O`S:[[+7JY^7#RBQ5^^ MW*[^BN8_SQ^O;4Y#+)U)Q0'GH<<_O&0Y3HKZ+VVS47,65EGV9NCET>&A1M`(#BK:0W;U-Y-[C M=_'I\^+>YLGRL6H=MEQ:/2W=)C2VF`EYNYZT8IG7IY_#Z/Y*U3&F[W^S+D7#VFX!/Q.NTQ/5PI!,8?_SS[R`+&?DW%'I&`T0Z$HR>P$0?15 MI/AFJ7YCASU&(CA)269A+TK7R28-"BH0,*X(#K]*":%_K;H!6FOWR:"7GB'J MH:JY[R1P25,%$TY4L)JAC!E`G!G1'G[&RFI"RU)SBJ'1-O3_B;U;C\KE;WSL MB>"AO)8[1=P[WUG[`4_"2;]+=]CK"!RFN$P&7XR:M1Z&C+"8!%J9U=2$$Y<2 MH5*D/#HP%XHO`R2Q4"870/R#9V&6`#C@JRQ7O%Z@GR7/&#G;+>&E'U!1;F)/ M?!>+@@NL`1,X]D72DR0ZZN2(G\C)M(*`P'G\ICZ:UO68##(JU:U'N9/FDT`L MM=0F?*.(3H8'),,JGB?1]4/NUJY#R('G"-^Q'19KL;KN MN_0I308(.IM'M1O3)#,)X.BNC9D]VO$+![9T`0PS=LQTA#>QV,X5IA-K"_O( M$[%TAWZ"[_P7?/(DY"9E*=CF.W:F+S(G+EY941K<"9(,L9@(5IDT:!V(F:`_ M`70SJJ8)?Q;B7'!Y3C%PAH1,2!8*95*!PT1PQL5QXN]8B3Z&EJ7]<&8_@@/^ M)=VAG4`HBM/UWUD5!?JEW-D^M(JJW7G1[AO'S?;#^DNY]OX3`45M4]0OVUHZ M3P#.]'4PX4Z,5UF_'I7LP"'1N':Q6^N^U+D,X9.K_/%H]>5>I+(1A:P.'?=^ M9Q">#)*<:[QZB.E+=1+8<[9R)IQ/58=S)@K_HDR265X#[P`0K$`8LE*[,ZMX M9[%LL'PQ\(+#%+,ZIHM7:M70":Y2*NV.&GB>),1?IW05MXIN(H+];7C%]L7L M:O/R\`E'6^+LGWUW3K#3Y:K0/,?)`.%@YE9=(1IF-PGH'$YK,U>+7#I1TS>7 M#Q4"HE)"MCW*9$2%D*R:5BDF8G("!%W8/P$+\1(!74[%V&[Q(V07$%_8CMM# MO*B(.#/=9+^'FTL,`<0784*GDY]]#]^&5,`=G^&:?H++PP.)O-3E!ZM/F+SX M;I<]KGE^DP'P@4Q=#]^&F4T"O(?2N2]NM,$UA>.

(7`*`H`S-M/603`VZ M%US1ED3IWA[`YL')91CR)Q+%<19"J#!W:R?@4*>GM(Q7S3T`@XZFX+U3D^;1 MY8]2=#GG4$3*VD&$L?0NH^HM^G`>QD]7FM=9Q/ZI_BTNW9$&=`_O8Y**PW

ACCOUNTS RECEIVABLE (Details) - USD ($) $ in Thousands	Jun. 30, 2015	Sep. 30, 2014
ACCOUNTS RECEIVABLE
Accounts receivable	$ 15,259	$ 16,352
Less allowances	(1,073)	(1,234)
Accounts receivable, net	$ 14,186	$ 15,118

SHARE PURCHASES (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
SHARE PURCHASES (Details) - USD ($) $ in Thousands	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Share purchases
Number of shares of common stock held in treasury	1,000	9,673	1,000	9,673
Additional number of shares authorized to be repurchased	551,723		551,723
Common Stock
Share purchases
Shares of common stock purchased	63,276	99,541	180,301	156,661
Aggregate price at which shares of common stock purchased (in dollars)	$ 1,266	$ 2,368	$ 3,618	$ 3,798

BASIS OF PRESENTATION	9 Months Ended
BASIS OF PRESENTATION	Jun. 30, 2015
BASIS OF PRESENTATION
BASIS OF PRESENTATION	1. BASIS OF PRESENTATION Nutraceutical International Corporation and its subsidiaries (the "Company") is an integrated manufacturer, marketer, distributor and retailer of branded nutritional supplements and other natural products sold primarily to and through domestic health and natural food stores. Internationally, the Company markets and distributes branded nutritional supplements and other natural products to and through health and natural product distributors and retailers. The Company's core business strategy is to acquire, integrate and operate businesses in the natural products industry that manufacture, market and distribute branded nutritional supplements. The Company believes that the consolidation and integration of these acquired businesses provide ongoing financial synergies through increased scale and market penetration, as well as strengthened customer relationships. The Company manufactures and sells nutritional supplements and other natural products under numerous brands, including Solaray®, KAL®, Nature's Life®, LifeTime®, Natural Balance®, NaturalCare®, Health from the Sun®, Pioneer®, Nutra BioGenesis™, Life-flo®, Organix South®, Heritage Store® and Monarch Nutraceuticals™. The Company owns neighborhood natural food markets, which operate under the trade names The Real Food Company™, Thom's Natural Foods™, Cornucopia Community Market™ and Granola's™. The Company also owns health food stores, which operate under various trade names, including Fresh Vitamins™ and Peachtree Natural Foods®. In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all necessary adjustments, consisting of normal recurring adjustments, to state fairly the consolidated financial position of the Company as of June 30, 2015, the results of its operations for the three and nine months ended June 30, 2015 and 2014 and its cash flows for the nine months ended June 30, 2015 and 2014, in conformity with accounting principles generally accepted in the United States of America ("US GAAP") for interim financial information applied on a consistent basis. Results for the three and nine months ended June 30, 2015 are not necessarily indicative of the results to be expected for the full fiscal year. Certain information and footnote disclosures normally included in the annual financial statements prepared in accordance with US GAAP have been omitted. Accordingly, these financial statements should be read in conjunction with the Company's Form 10-K for the fiscal year ended September 30, 2014, which was filed with the Securities and Exchange Commission on November 20, 2014. Use of Estimates The preparation of these financial statements in conformity with US GAAP required management to make estimates and assumptions that affected the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of net sales and expenses during the reported periods. Significant estimates included values and lives assigned to acquired intangible assets, reserves for customer returns and allowances, uncollectible accounts receivable, valuation adjustments for slow-moving, obsolete and/or damaged inventory and valuation and recoverability of long-lived assets. Actual results may differ from these estimates. New Accounting Standards In May 2014, the Financial Accounting Standards Board ("FASB") issued authoritative guidance, which is included in Accounting Standards Codification ("ASC") 606, "Revenue from Contracts with Customers." This guidance provides a single, comprehensive revenue recognition model for all contracts with customers and requires that a company recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the company expects to be entitled in exchange for those goods or services. In July 2015, the FASB delayed the effective date of this guidance by one year. As a result, this guidance is effective for the Company as of October 1, 2018 and shall be applied either retrospectively to each period presented or as a cumulative-effect adjustment as of the date of adoption. The Company is currently evaluating the impact this standard may have on its consolidated financial statements. The Company periodically reviews new accounting standards that are issued. Although some of these accounting standards may be applicable to the Company, the Company has not identified any other new standards that it believes merit further discussion, and the Company expects that none would have a significant impact on its consolidated financial statements.

STOCK OPTIONS AND OTHER EQUITY AWARDS (Details) - 9 months ended Jun. 30, 2015 - $ / shares	Total
Number of Options
Options outstanding and exercisable at the beginning of the period (in shares)	32,500
Exercised (in shares)	(25,000)
Options outstanding and exercisable at the end of the period (in shares)	7,500
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]
Options outstanding and exercisable at the beginning of the period (in dollars per share)	$ 14.22
Exercised (in dollars per share)	14.22
Options outstanding and exercisable at the ending of the period (in dollars per share)	$ 14.22